



The public debate about
agrobiotechnology in Latin
American countries: a











The public debate about 
agrobiotechnology in Latin 
American countries: a 
comparative study of Argentina, 
Brazil and Mexico 
Renata Campos Motta 
193
 
This document has been prepared by Renata Campos Motta, Research Associate with the Agricultural 
Development Unit, Division of Production, Productivity and Management of ECLAC. 
The views expressed in this document, which has been reproduced without formal editing, are those of the 


















United Nations Publication 
ISSN  1020-5179 
LC/L.3591 
Copyright © United Nations, January 2013. All rights reserved 
Printed in United Nations, Santiago, Chile 
 
Member States and their governmental institutions may reproduce this work without prior authorization, but are requested to 
mention the source and inform the United Nations of such reproduction. 
ECLAC – Production Development Series No. 193  The public debate about agrobiotechnology in Latin American countries …    
3 
 
Table of contents  
Abstract ................................................................................................. 5 
I. Introduction .................................................................................. 7 
II. Methodology ................................................................................ 11 
A. Choice of the sources: news media ....................................... 11 
B. Levels of analysis and categories ......................................... 13 
 1. Media analysis .................................................................. 14 
 2. Frame analysis .................................................................. 17 
III. Public debates on Agrobiotechnology ....................................... 21 
A. The economic dimension ...................................................... 24 
 1. Benefits ............................................................................. 24 
 2. Costs ................................................................................. 30 
B. The health and environmental dimensión ............................. 36 
 1. Biosafety ........................................................................... 38 
 2. (Bio) risk ........................................................................... 44 
C. The dimensión of ethics and politics .................................... 53 
 1. Progress ............................................................................ 55 
 2. Critique ............................................................................. 58 
IV. Conclusions.................................................................................. 65 
Bibliography ........................................................................................ 71 
Annex ................................................................................................... 75 








TABLE 1 GLOBAL AREAS OF BIOTECH CROPS IN 2009: BY COUNTRY .............................. 8 
TABLE 2 NEWS MEDIA SOURCES SELECTED PER COUNTRY, FORM, AUDIENCE 
AND NUMBER OF RESULT .......................................................................................... 13 
TABLE 3 NEWSPAPER ARTICLES ACCORDING TO TOPIC PER COUNTRY ....................... 15 
TABLE 4 NEWSPAPER ARTICLES ACCORDING TO SECTION PER COUNTRY .................. 16 
TABLE 5 ACTORS VARIABLE: TYPE .......................................................................................... 18 
TABLE 6 ACTORS VARIABLE: SCOPE........................................................................................ 19 
TABLE 7 FRAMES ABOUT GMOS ................................................................................................ 20 
TABLE 8 POLITICAL CLAIMS ABOUT AGROBIOTECHNOLOGY IN NEWS MEDIA 
ARTICLES 2009-2010 CLASSIFIED PER FRAME AND COUNTRY ......................... 23 
TABLE9 CLUSTERS OF TYPES OF CLAIMS ACCORDING TO FRAMES .............................. 23 
TABLE 10 POLITICAL CLAIMS ABOUT THE ECONOMIC DIMENSION OF 
AGROBIOTECHNOLOGY PER TYPE OF ACTORS PER COUNTRY ....................... 25 
TABLE 11 POLITICAL CLAIMS ABOUT THE HEALTH AND ENVIRONMENTAL 
DIMENSION OF AGROBIOTECHNOLOGY PER TYPE OF ACTORS PER 
COUNTRY  ...................................................................................................................... 38 
TABLE 12 POLITICAL CLAIMS ABOUT THE ETHICAL-POLITICAL DIMENSION OF 
BIOTECHNOLOGY PER TYPE OF ACTORS PER COUNTRY  ................................. 54 
TABLE A.1 DOCUMENTS ANALYSED, NEWS ARTICLES FROM ARGENTINA  ..................... 78 
TABLE A.2 DOCUMENTS ANALYSED, NEWS ARTICLES FROM BRAZIL   ............................. 81 








This study is about the public discourse on the introduction of 
biotechnology in agriculture in three Latin American countries, 
Argentina, Brazil and Mexico. It aims at identifying the discoursive 
disputes to influence public opinion and thus to legitimize policy 
options regarding agrobiotechnology. Based on the assumption of the 
fundamental role of mass media in the public sphere of contemporary 
societies, the research draws on media analysis and the frame analysis 
of news articles to describe the political claims made by various actors 
attempting to frame shared meanings of GMOs. It addresses the 
questions: (1). How is agrobiotechnology depicted on the national 
media of these countries? (2) What are the main issues regarding GM 
crops that are being currently debated in these three different cases? (3) 
How are GMOs interpreted? (4) Which actors defend each type of 
argument? It is a descriptive work aimed at mapping and comparing the 
debates in the three countries, especially in what concern the 
participation of each frame and its main carriers. In addition to looking 
at similarities and differences among countries, the study identifies 
actors and frames that cross national borders in the interpretative 
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I. Introduction  
This study1 is about the public discourse on the introduction of 
biotechnology in agriculture in three Latin American countries, 
Argentina, Brazil and Mexico. It aims at identifying the discoursive 
disputes to influence public opinion and thus to legitimize policy 
options regarding agrobiotechnology. It does not evaluate if GMOs are 
beneficial to producers or bring risks to health or to the environment. 
Rather than yielding general conclusions about the new technology, this 
study describes the political claims made by various actors in the public 
discourse on GM food that takes place on the media, based on the 
assumption of the fundamental role of mass media in the public sphere 
of contemporary societies. It addresses the questions: (1) How is 
agrobiotechnology depicted in the national media of these countries?  
(2) What are the main issues regarding GM crops that are being 
currently debated in these three different cases? (3) How are GMOs 
interpreted? (4) Which actors defend each argument? 
                                                       
1  Doctoral Researcher at desiguALdades.net, Freie Universität Berlin. This is part of my ongoing PhD research in 
Sociology. Suggestions and comments are welcome and can be sent to rena a.motta@fu-berlin.de.  
I would like to thank Mônica Rodrigues and the team from Unidad Agrícola ECLAC/UN, Adrián Rodriguez, Octavio 
Sotomayor, Javier Meneses and Alberto Saucedo, with whom I had the pleasure to work for two months and who gave 
me all the support I needed for the conduction of this work. Their constructive comments and suggestions in the 
construction of the system of categories, in the definition of data sources, in the process of coding material and 
Mônica's carefull reading of the final result were essential for my research. The research stay in ECLAC/UN would 
not have been possible without the financial support from the Dahlem Research School. I am indebted to Dieter Rucht, 
for insisting on the advantages of a comparative research about public debates on agrobiotechnology in lieu of a case 
study of Brazil; this study is a result of following his advice. For all his trust and support, as well as for his critical 
comments, I am thankful to my supervisor Prof. Sérgio Costa. Many others have helped in this research, especially 
Fernando Motta and Maria Julia Abreu, respectively, with data treatment and translation. Last but not least, I would 
like to express my special gratitude to Matías Fernandez, who has helped me to move back and forth from words to 
numbers, sharing with me his methodological talents and giving me all support with the treatment of my data.  
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Therefore, it depicts how specific actors interpret and dispute shared meanings about different 
impacts of the new technological paradigm (Katz and Bárcena 2004: 31); their attempts to shape 
institutional frameworks (intellectual property rights, risk management rules, including debates about 
the criteria for approval GMOs and demands for public participation); their claims about impacts in 
the economy (from direct agronomic impacts to macro impacts on employment, trade balance, 
exports); their claims about effects on health and environment and also their identification of which 
types of actors are the main beneficiaries and which are the negatively affected by the new paradigm  
Transgenic food2 is a subject that has been intensely discussed in the last two decades in 
different parts of the world. In some places, official decisions to liberalize such products have been 
targets of protest by social movements and organizations from civil society and by appeals from 
political bodies not directly responsible for the decisions, emphasizing the risks of the new 
technologies. At the same time, decisions to prohibit GMOs have also been contested by scientist 
associations, economic actors and by other governmental bodies, stressing that the benefits and 
opportunities brought by the new technology cannot be missed. In either case, there is seldom 
agreement: be it to liberalize or to prohibit genetically modified food, the political decisions in this 
area have been constantly contested. In addition, national and international actors take part in such 
disputes, since the international agricultural market is highly interdependent and a decision taken in 
one country may affect actors situated beyond those geographical borders. This study aims at bringing 
this complexity into analysis by identifying the geographical scope of actors who engage in the 
national public debates. 
Argentina, Brazil and Mexico are considered world "mega-producers" of transgenic crops, but 
have different positions in the ranking: in 2011, the first two were on top of the list whereas the latter 
was at the end of the list (30.3; 23.7 y 0.2 million hectares, respectively, according to the table below).  
 
TABLE 1 






1 United States 69.0 Soybean, maize, cotton, canola, squash, 
papaya, alfafa, sugarbeet 
2 Brazil 30.3 Soybean, maize, cotton 
3 Argentina 23.7 Soybean, maize, cotton 
4 India 10.6 Cotton  
5 Canada 10.4 Canola, maize, soybean, sugarbeet 
7 Paraguay 2.8 Soybean  
10 Uruguay 1.3 Soybean, Maize 
11 Bolivia (Plurinational State of) 0.9 Soybean 
16 Mexico 0.2 Cotton, soybean 
Source: Adapted from Clive James, 2011. 
 
From a chronological perspective, the adoption of GMOs in these countries is part of a 
transnationalization of an experience from the USA. Argentina closely followed the pioneers and 
approved GM soy in 1996. After 15 years, some of the results are now under debate. While some 
analysts see the consolidation of power from external agents in the country (Bárcena et. al., 2004: 31), 
it is disputable if transnational firms have been the actors who most benefited from the adoption of 
                                                       
2 The terms referring to biotechnology applied to agricultural crops, namely, agrobiotechnology, genetically 
engineered crops, transgenic food, GM food/crops and GMOs are used interchangeably.  
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biotechnology in the country, since it lacks a strong legal framework for intellectual property rights. 
Also, the new technological paradigm has implied a reorganization of the production in Argentina that 
opened opportunities for some local actors in detriment of others (Gras and Hernández, 2009). Some 
Argentinean firms have pursued transnationalization strategies and now are active in neighbouring 
countries. Another characteristic of the Argentinean experience is the relative absence of voices 
against genetically modified crops in comparison to Brazil and Mexico. Nevertheless, if the adoption 
of GM soy did not raise much public attention and debate back in 1996, the recent years have 
wittnessed a flourishing debate about what has been identified as its negative impacts on society, 
economy, health and environment. Land concentration, land expulsion of small farmers, 
environmental contamination and health intoxications from pesticides associated with GMOs are 
issues on the agenda, as well as the development model of the country (Gras and Hernández, 2009; 
Gruttadauria, 2008).  
From Argentina, GM soy was illegaly taken to Brazil, where its status remained long in dispute, 
between legality and illegality. There was major opposition from civil society and conflict between 
and within the legislative, executive and judiciary powers. The proponents of GMOs won many 
battles, approving GM soy, cotton and corn. International biotechnology firms associated with 
national partners to invest in new products–process in which Embrapa, the Brazilian Agriculture 
Research Corporation, an institution related to the Ministry of Agriculture, played a crucial role–; also, 
national firms started to compete with multinationals, criticizing their monopolistic practices. At the 
moment, after the first years of GM corn planting seasons, other controversies appeared: is 
coexistence possible? If so, who pays the price? Is monitoring needed? Who is threatened by the 
negative impacts and who are the beneficiaries? 
Recently, Mexico has attracted much attention in the GMOs issue, as the government modified the 
legal framework to authorize the experimental and commercial cultivation of GM corn. Although the 
country has approved many other genetically modified seeds, the case of corn is of special interest because 
the country is its center of origin and biodiversity. Thus, while some alert against its risks to biodiversity, 
health and food security, others defend the new technology as the solution to food security and the 
dependence on imports from the USA. Argentina and Brazil are either referred to as experiments of success 
or as a proof of the (transnational) threat of GM seeds to (national) agriculture and environment. 
The configuration of a public discourse and the definition of a policy for GM food in 
Argentina, Brazil and Mexico will be studied as part of an entangled and transnational process of 
political disputes regarding genetically modified crops. This means that each country cannot be 
studied as an endogenous unit, since actors and arguments cross the political-administrative borders 
and incorporate past experiences into new conflicts. Moreover, multilateral rules negotiated under 
trade, health and environmental international regimes discipline national legal frameworks about 
biotechnology.3 Nevertheless, the state has the competence to decide on the agricultural production 
and the commercialization of transgenic crops. Therefore, the transnational trade flows of such 
products depend on state policies that promote or prohibit these products. Thus, the recognition of the 
transnational character of the GMOs issue does not imply that legitimacy can be ascribed a priori; it 
must emerge through democratic processes in order to result in public policies (Costa, 2006). 
                                                       
3  Among these, the most important are the Cartagena Protocol and the Codex rules. “The Cartagena Protocol on 
Biosafety to the Convention on Biological Diversity is an international agreement which aims to ensure the safe 
handling, transport and use of living modified organisms (LMOs) resulting from modern biotechnology that may 
have adverse effects on biological diversity, taking also into account risks to human health. It was adopted on 29 
January 2000 and entered into force on 11 September 2003”. (Available at: http://bch.cbd.int/protocol/, accessed 
on 13/12/2011). The Codex Alimentarius is a joint program from the Food and Agriculture Organization and the 
World Health Organization, all part of the United Nations System. Codex is dedicated to food standard setting 
with two objectives: protecting the health of consumers and ensuring fair practices in the food trade. The 
organization is considered as an international standard setting body serving as a reference in the Sanitary and 
Phytosanitary Agreement from the World Trade Organization (SPS/WTO, Annex I 3.a).  
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This study maps the contemporary public debates about agrobiotechnology in these three 
countries as it is depicted in the news media in the years 2009 and 2010. Instead of comparing three 
similar events in each country —for example, the approval of a same product, probably leading to 
different periods of analysis in each one —, the choice was to identify national debates on GMOs not as 
closed units of analysis, but as part of a transnational phenomena, as above mentioned. This choice of a 
synchronous comparative analysis of these three countries, each dealing with very different policy issues  
—Mexico on the verge to decide about GM corn, Brazil debating about risk management rules for 
GMOs, Argentina with a strong conflict about the long-term effects of the soy-model based on genetic 
engineered seeds—, brought together three distinct time perspectives. So, if in Mexico the claims are 
marked by a future orientation of what would happen if GM corn is adopted or prohibited, in Argentina 
the interpretative disputes regard what are the effects of a past decision of adopting GMOs on a large 
scale and, in Brazil, the claims differ about how to regulate the (possible? desirable?) coexistence of GM 
and non-GM crops, i.e. how to keep the decision always present and open for actors to adopt GMOs or 
not. In sum, the use of countries as units of comparison is not made in detriment of conceiving the debate 
on agrobiotechnology as an object of study with a transnational scale (Costa 2011).  
This working paper is divided in two parts, besides this introduction and the conclusion. The 
first (Section II) presents the research design, explaining the choice of the sources, the categories 
developed and the methodology for data analysis. It describes the sample of media articles and the 
results of the media analysis, oriented by the research questions 1 and 2, namely, the media coverage 
of agrobiotechnology and the main issues under attention in each country. The second part (Section 
III) describes the political claims found in the content of the media articles according to the emphasis 
given by the actors. The debate is thus depicted in three steps corresponding to the three main 
dimensions of meaning ascribed to GMOs: economy; health and environment; ethics and politics. This 
part aims at answering the research questions 3 and 4, which concern the actors and their arguments 
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II. Methodology  
A. Choice of the sources: news media  
This study has identified the ongoing public debates using newspapers 
articles as the main source of data. Three news media per country were 
chosen according to a combination of criteria in order to find the most 
adequate sources according to the phenomena under study but also 
obeying to pragmatic considerations. Given the research aim to identify 
political claims about agrobiotechnology, at least two types of actors are 
implied. On the one hand, there is the political elite as a target of such 
communications (although also political authorities make public 
demands covered by the media), since it is held responsible to take 
collectively binding decisions regarding GMOs. On the other hand, 
there are actors who make political demands about the issue. These 
include: demands for the adoption of biotechnology, usually, by 
biotechnological firms, farmers and their associations, and scientists; 
demands for the prohibition of GM crops, whose claim-makers are 
mostly social movements and their organizations, but also scientists and 
farmers. Accordingly, in order to depict most types of political claims 
about agrobiotechnology, the sources must include newspapers read by 
the political elite, by the economic elite and newspapers which usually 
cover protest events and demands from social movements, i.e., 
newspapers considered more dissident in relation to the newspapers of 
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Besides these theoretical considerations, there were four pragmatic criteria: first was 
availability of full content and ease of etrieval.4 Due to the need to obtain as much content as possible, 
the second criterion was to select newspapers that presented the highest number of articles on the key-
word search. The third criterion was geographical scope: all papers were to be targeted at a nation-
wide audience and local sections were neglected in the sampling of articles. Last but not least, the 
selection of sources aimed at achieving a reasonable degree of comparability. Thus, three standard and 
elite newspapers of large national circulation were selected, namely, Folha de São Paulo, El Universal 
and La Nación.5 The next set of papers focused on the business elite: Valor Econômico, El 
Economista and El Cronista Comercial. The third group of papers was chosen to offer an alternative 
coverage to the first and second sets. These were Carta Maior, La Jornada and Página/12. These three 
news media are partners, what confirms their comparability. Nevertheless, it is important to highlight 
that Carta Maior is not a newspaper as the others, but a news blog. The choice to include it in the 
sample is rather a negative choice, since there was not a daily newspaper in Brazil comparable to 
Página/12 and La Jornada. There is a weekly printed newspaper, Brasil de Fato, but its search offered 
a very low number of results and failed the criteria of the need to obtain content. Other sources tried 
were the weekly magazines Caros Amigos —leading to still fewer numbers of articles— and Carta 
Capital—– which offered problems of access to content. Thus, Carta Maior was included because it 
matched the criteria of access to content, higher number of results, scope and comparability.  
The search was restricted to newspapers with full text available and included the period from 
January 1st 2009 to December 31st 2010. Types of articles included news, editorials and opinion 
articles. The search was conducted online using the key words: biotecnologia, transgenico, 
transgenicos, transgenica.6. In order to be included in the sample, articles had to comply with two 
criteria: topic and geographical scope. They should refer to the countries under study (cover national 
issues)7 and to one of the main topics: 
                                                       
4  The data were collected during a research stay at Agricultural Development Unit from ECLAC/UN, Santiago de 
Chile from 14/03/2011 to 30/04/2011. Cepal had subscriptions to a few newspapers and to Proquest, an electronic 
resource to search and accede to full content from many databases of scholarly journals and news material, 
including the “Latin America Newsstand”.  
5  Although Folha de São Paulo and El Universal are the leaders of circulation in their categories (not uncontested), this 
has not been the criteria for their selection. In addition to being available at the databank from Proquest, they presented 
the higher number of search results. If the criteria were circulation numbers, El Clarín should be chosen (288.519 daily 
copies) instead of La Nación (160.368 daily copies, the second in circulation, IVC, 2011). This choise was not due to 
the fact that El Clarín was absent from Proquest databank – since its content is available online. Two other criteria 
were decisive in the choice for La Nación. The first was easiness of retrieve, since it was possible to make a single 
search in Proquest combining key-words applicable to all countries. The second, and more important, is the overall 
comparability of the sample taking into account the political bias of El Clarín. La Nación presents a historically 
consistent coverage of the interests from agribusiness which has not changed in face of short-term conflicts between 
the rural sector and the government or the latter and the media. This has not been the case with El Clarín, which started 
to oppose systematically  the goverment in the conflict with the rural sector in 2008 because of its own disputes with 
the present government. Given that the Argentinean debate about agrobiotechnology cannot be desimbedded from such 
a context, La Nación´s systematic political bias in the coverage of the interests from agribusiness in Argentina ratifies 
its choice to represent the first set of newspapers in the sample.  
6  The papers that were available in Proquest were searched and collected from a single search combining the words 
“biotecnologia” OR “transgenic*”, which enabled a search for content in both Portuguese and Spanish languages. 
El Cronista Comercial, to which ECLAC had a subscription, was searched directly in two turns, with the words 
“biotecnologia” and ”transgenico”, which also yielded results for the feminine and plural versions. La Pagina/12 
required to register, which was free, and offered a good search engine for combined searches. La Jornada was 
searched per google advanced engine as well as Carta Maior, but for the latter, due to the little number of results, its 
own search engine was also used with each of the key-words.  
7  Exceptions to the scope criteria were made when in articles referring to a survey from USA production, for 
example, the survey is used to make a claim about the country’s GM food policy such as "if Mexico had adopted 
GM corn, it would have saved money". 
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− GM food/crops policy: articles that refer any agricultural commodities for food and feed 
purposes (corn, soy, rice, beans, etc.), to debates or decision regarding GM crops, be 
their commercialization, the approval for research or of new rules relevant to it.  
− GM crops production: articles with information on any agricultural commodities, such as 
season revenues, costs, expansion of crops, exports. 
− GM crops research and development: articles about biotech firms’ investment in the 
countries selected related to a food crop.  
Besides these topics, three others were added because in their coverage it was common to find 
references to the debate about GM food policy. These were country-specific: for Mexico, articles about 
biodiversity and climate conditions were also included; for both Brazil and Argentina, articles about 
glyphosate and its use.8 9 The final sample of articles can be seen on Table 2 below and in the Annex.  
 
TABLE 2 
NEWS MEDIA SOURCES SELECTED PER COUNTRY, FORM, 
AUDIENCE AND NUMBER OF RESULTS 






La Nación Argentina Print Elite   48 12 8 
El Cronista Comercial Argentina Print Business 174 31 28  
Página/12  Argentina Print Alternative 212 62 27 
Folha de Sao Paulo Brazil Print Elite 216 45 35 
Valor Econômico Brazil Print Business 109 40 38 
Carta Maior Brazil Online Alternative   58   6 3 
El Universal México Print Elite   75 24 23 
El Economista México Print Business   43 13 13 
La Jornada México Print Alternative 394 93 58 
Source: Own elaboration. 
 
B. Levels of analysis and categories  
The information from the sample of articles was coded in two levels:  
− The media level:  the article as the unit of analysis. 
− The article level: political claims as the units of analysis. 
                                                       
8  Articles on these issues were only included if reference was made to the main topics. The relevance of the article to 
the topics was assessed using the 150-words rule: by headline, sub/headlines lead and first 150 words (starts 
counting after the sub-headlines, with the first word of the first sentence until the end of the sentence in which the 
150th word is located). These should mention the topics of interest. This rule is justified not only in pragmatic 
grounds but also due to journalistic practices that instruct reporters to summarize the main information of the article 
at its very beginning (the so-called inverted pyramid). Exception to this rule was made when the main topics are 
referred to as titles to subdivisions in the course of the article. Thus the article is considered only in its subdivision 
when coded for "topic". The topic criterion was applied in a wide way, based on the assumption that the researcher 
can judge if an article is implicitly about GM but not phrased in that manner, e.g. an article on technology that 
refers to a well-known biotech company. 
9  Given the need to be the most efficient and precise as possible, articles with the following topics were discarded: 
biotechnology in general (research policy or results) when not directly quoting application in agriculture —or, when it 
does, it is only in an enumeration—, when applied to other fields such as medicine, when referred to transgenic animals 
(even when for food uses as fish, but because of the need to refer to agriculture), when just part of a enumeration (such as 
listing areas of bilateral cooperation); references to financial results of biotechnology seed industries. 
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Each level has different analytical purposes. The first one offers quantitative data about the 
articles and is suitable for media analysis: what has been published, in which sections the conflict was 
most reported, in which months, who wrote more on the issue, etc. The second aims at extracting the 
content of the articles for a qualitative analysis, including quantitative methods as well. Note that in 
both levels of analysis, the article is the data from where information is extracted, but into different 
units of coding: the first requires the "external information" about the article, i.e. looking at it in a 
holistic way in its relation to the media as its context. The second requires reading the "internal 
information" of the article and breaking it up into categories such as actors and arguments (frames). 
Below, the categories and results of the first level of analysis are presented. Then, the method and 
categories of the second level of analysis are presented, while the results on political claims will be 
depicted only in Section III.  
1. Media analysis  
Articles were classified according to topic, section, authorship and type. The topics vary across 
countries and indicate how GMOs relate to broader issues in that society, such as development 
models, environment, land use, among others. The importance of classifying where the article 
appeared (section) and by whom it was written (authorship) is to see to what audience it is targeted 
and if it is a wider issue or a concentrated topic dominated by specialized journalists.10 As for the type, 
only news articles were subjected to frame analysis in order to get information on which actors appear 
and which type of arguments they use (see Section III). The results of the media analysis will be 
briefly presented.  
a) Topic 
The media material revealed that the GMOs issue in Argentina is usually depicted as part of a big 
"technological package" adopted in the agriculture that includes genetically modified seeds, glyphosate 
and the system of "siembra directa" (“no tillage agriculture” or “cero labranza”). GMOs are thus highly 
associated in the Argentinean debate with the other components of the package. Since about 95% of soy 
in Argentina is genetically modified,11 most debate about “the soy model” contains references to the use 
of biotechnology as one of its components. Whatsmore, the soy in Argentina is genetically modified to 
resist to the herbicide glyphosate from Monsanto named Roundup - thus called soy RR or Roundup 
Ready -, so all debate about the benefits or effects derived from the use of this herbicide are interrelated 
with GM soy. Thus, the combination GM seeds-glyphosate-siembra directa in soy plantations represent 
the “development model”. Also, usually actors refer to GM soy, although there are other components in 
an enumeration of elements. Thus, it is difficult to classify an article as pertaining only to 
agrobiotechnology. As can be seen in Table 3 bellow, while the majority of articles were about 
agrobiotechnology (40%), there were about just as many articles specifically about glyphosate (35%). 
The third most commented issue was the “development model” based on soy production (16%).  
The Brazilian sample was mostly concentrated on agrobiotechnology as a topic per se (88%), 
including articles on GM crops policy (debates or decision regarding GM crops, be their 
commercialization, the approval for research or of new rules relevant to it); articles informing about GM 
crops production (such as season revenues, costs, expansion of crops, exports), and articles about GM 
crops research and development. As mentioned, many articles were about the first yields of GM corn and 
the efficacy and feasibility of coexistence rules. Also, the debate on the approval of GM corn was 
covered. GM soy only was mentioned when there were announcements about crops production or about 
                                                       
10 The journalist from Le Monde and responsible of the dossier about GMOs, Catherine Vincent, makes a parallel 
from what happens in a redaction and society: at the beginning, scientists conduct research, convinced of the good 
fundaments of their research; and the economic actors are conscious of what is at issue in a new technology. The 
same happens in the paper: two types of journalists are interested by biotechnologies, the ones from the scientific 
and the economic sections. Their parallel ways cross and become a big venue where concerns from all society 
converge: farmers and consumers, journalists from agriculture but also other areas, until the chef redactor notes that 
it is not a purely scientific or economic issue anymore (Ricroch, 1998). 
11  According to declarations from Monsanto (quoted in Colombres, 2010).  
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research, patents and development of new varieties. Glyphosate was a topic in 4% of Brazilian articles, 
all published by Valor Econômico, to cover the debate about anti-dumping taxes to Chinese imports of 
the product, and the importance of its costs due to the large-scale adoption of GM seeds resistant to it. 
Other 3% of the articles related to the use of pesticides related to GMOs, including glyphosate.  
 
TABLE 3 
NEWSPAPER ARTICLES ACCORDING TO TOPIC PER COUNTRY 
Number of claims and percentages (in parenthesis) 
 Argentina Brazil       Mexico 
Agrobiotechnology 42   (40) 81   (88) 116   (89) 
Glyphosate or pesticides 37   (35) 6     (7) 0     (0) 
Development model 17   (16) 0     (0) 0     (0) 
Biodiversity 1     (1) 0     (0) 8     (6) 
Other 5     (5) 5     (5) 7     (5) 
Total 105 (100) 92 (100) 130 (100) 
  Source: Own elaboration. 
 
Regarding the topic, the media material revealed that the GMOs issue was highly debated in 
Mexico (89%), as the vast majority of articles sampled with the key-word search had 
agrobiotechnology as the main issue. The sampling also included articles on biodiversity (6%), 
climate conditions and climate change (3%), food crisis (1%) and indigenous knowledge (1%), since 
in the context of those issues actors made claims for or against the adoption of GMOs in the Mexican 
agriculture. Among these, it is necessary to highlight the relationship between claims against GMOs in 
Mexico and the defense of biodiversity in the country.  
While in Argentina GMOs are associated with soybeans, in México, the debate covered regards 
corn ("maíz"). The Mexican Biosafety Law foresees the creation of a special protection regime for the 
native corn, since the country is the center of origin and biodiversity of the grain. This is a point of 
(stated) consensus and even actors favoring GMOs publicity argue for the protection of native corn 
from the flux of genes of GM corn i.e. from contamination (Enciso, 2009a). During 2009, a series of 
legislative modifications were made in order to create the framework to approve the experimental 
cultivation of GM corn in Mexico. Actors against GMOs perceived these modifications as a menace to 
native corn and framed their opposition to the possible adoption of GM technology as a defense of the 
native corn.12 GMOs mostly refer to GM corn and claim to preserve biodiversity (the native corn) are 
usually claims against GMOs in Mexico. Thus, the issue of agrobiotechnology in Mexico is deeeply 
associated with the defense of biodiversity and especially, the native corn. Articles covering the 
legislative changes were classified under the topic “agrobiotechnology”, while articles expressely 
concerned with the fact that Mexico is center of origin of corn were classified as about “biodiversity”.  
In sum, the debate about genetically engineering in agriculture refers, in each country, to 
different issues and products: in Argentina, GMOs is a synomym of GM soy and, above all, the “soy 
model”; in Mexico, GMOs come to the spotlight of media attention when referring to corn; in Brazil, 
it is less a product-oriented debate (which ensued before the approval of GM soy and GM corn), and 
                                                       
12 For instance, when the experimental probes were approved in October 2009, the coordinator from the campaign on 
sustainable agriculture and transgenics from Greenpeace Mexico, Aleira Lara, called the people for action: "All 
Mexicans must join in the defense of maize, the basis of food; reason is on our side" (quoted in Perez, 2009a). This 
framing was already available in the discourse from activists and it is not fortuitous that the campaign against 
transgenic crops in Mexico was named "Sin Maíz No Hay País" (something as "No Corn, No Country") and the 
network formed by social movements and non-governmental organisations to coordinate actions against GMOs is 
called "Red en Defensa del Maíz"("Network in Defense of the Corn).  
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more a debate on coexistence and on the overall legal framework for agrobiotechnology – but this 
debate was triggered with the yields of corn because of its specific polinization characteristics in 
comparison to soy. This results shows that there are advantages of not choosing a product as the object 
of comparison, because they indicate that there is variation in how agrobiotehcnology becomes a topic 
of public debates depeding on the product.  
b) Section and authorship  
The great majority of the total sample was published in the Economy section (Table 4),13 and 
strikingly so in the Brazilian case. In Argentina, however, there are variations in the coverage. While 
GMOs appear mainly as an economic topic in La Nación, Página/12 depicts it as pertaining more to 
politics and society in general than to economy. The Mexican sample is very different: most articles 
on agrobiotechnology are published in the section of national politics (67% from the sample of El 
Universal) or in the section “Sociedad y Justicia” (49% of articles from La Jornada). In all countries 
and in most papers, the news articles are mostly concentrated in a few hands i.e. the GMOs issues are 
usually reported by the same journalists. 
 
TABLE 4 
NEWSPAPER ARTICLES ACCORDING TO SECTION PER COUNTRY 




Argentina Brazil Mexico 
Economy 48   (46) 72   (78) 22   (17) 142   (43) 
Society 15   (14) 0     (0) 46   (35) 61   (19) 
Politics 15   (14) 2     (2) 25   (19) 48   (15) 
Opinion 6     (6) 1     (1) 18   (14) 33   (10) 
Agriculture 0     (0) 2     (2) 9     (7) 11     (3) 
Science 0     (0) 3     (3) 7     (5) 10     (3) 
Other 27  (26) 12   (13) 23  (18) 62   (19) 
Total 105 (100) 92 (100) 130 (100) 327 (100) 
       Source: Own elaboration. 
 
c) Final considerations about the sample 
The three samples are very different and, most of all, the Brazilian one stands out because of the low 
number of results from the media chosen for its coverage of protest events and social movements 
activities (6 articles from Carta Maior, 62 from Página/12 and 93 from La Jornada). Moreover, only 3 
articles from Carta Maior were submitted to frame analysis, since the other were opinion articles. It is 
not clear the reason for such low number of results and, as mentioned above, many other news media 
were tried, without yielding more articles.  This small sample is even more puzzling given the contrast 
to the big sample collected from Folha de São Paulo and Valor Econômico. As a result, the corpus 
from media material for content analysis taken from Brazil is unevenly distributed between more 
conventional media reporting and dissident voices (83 versus 3).  
Some problems were also identified in the data collected from Argentina. The majority of the 
sample is composed of articles from Página/12, a newspaper that favors the government in the conflict 
against rural producers and also in the disputes with other media enterprises. Nevertheless, as already 
                                                       
13 Note that all articles from the business newspapers El Cronista Comercial, Valor Econômico and El Economista 
were automatically classified in the Economy section for comparability purposes, since they already target a 
business audience. This division makes sense only for wide range papers in order to show how the media actors 
classify the information over GMOs and target their readers. 
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mentioned, La Nación covers the other side of the conflict from the point of view of rural actors. How 
is the low number of articles about agrobiotechnology in La Nación to be explained? It could be a 
result of an editorial decision not makes an issue out of it; but it could also be due to technical 
problems in the key-word search or in the index of the databank, in which case, one would conclude 
that the use of electronic searching engines could generate errors that might jeopardize research 
findings. Be as it may, for the present study the few number of articles from La Nación was 
compensated by the high number of articles from Página/12 that were left out of the frame analysis, 
since only news articles were codified. The final Argentinean sample for content analysis was 
composed of 36 articles from La Nación and El Cronista Comercial versus 27 from Página/12. Thus, 
there was no major bias in the sample.  
The Mexican sample also shows some inbalance between the sources, what is explained by the 
high activism of La Jornada in GMOs, having published, amongst its 93 articles, 30 opinion articles, 4 
interviews and 1 editorial. Moreover, the paper covers this subject mostly in the section  “Sociedad y 
Justicia” (46 articles), followed by “Opinión”. This contributed for ameliorating the imbalance between 
sources for the content analysis: news articles from the more elite media summed 36 versus 58 from the 
more dissident La Jornada. Even so, there is a certain left-oriented bias in the Mexican sample.  
It is important to state that media selectivity is not a methodological deficiency but a finding in 
itself, given that there was a conscious choice for the data sources according to the research question, 
namely, the analysis of public debates. Assuming that the presence of frames about GMOs in the 
media has passed through processes of selection from media actors of what is relevant and who are the 
legitimate speakers about an issue, the findings show actors and frame that achieve a wider visibility 
and reach a wider audience than the political claims about agrobiotechnolgy ordinarily do. They are 
communicated not only to the directly affected and mobilized parties such as biotechnological firms 
and scientistis conducting research and development activities, social movements concerned about the 
issue or political authorities who are targeted of demands on how the GMOs policy should be. The 
greater the visibility of an issue, the more pressing it becomes for the political elite to deal with it. 
This is not to imply that, although being a, the media determines the framing of an issue as given by 
individuals (Gamson, 1992) nor tis relevance for other agendas, including the political and electoral 
(McCarthy, Smith e Zald, 1996).  
The next section explains the second level of analysis, in which only the news articles are 
analysed in their content (Table 2). The total sample from Argentinean newspapers in 2009 and 2010 
comprised 105 articles so distributed: La Nación (8), El Cronista Comercial (28) and Página/12 (27). 
The Brazilian sample totalized 92 articles, being Folha de São Paulo (35), Valor Econômico (38) and 
Carta Maior (3). The total sample of Mexican articles comprises 130 articles so distributed: El 
Universal (23), El Economista (13) and La Jornada (58).  
2. Frame analysis  
In order to identify and measure how agrobiotechnology is interpreted and given meaning by actors 
trying to influence public debate, the method chosen to read the media articles was frame analysis 
(Goffman, 1974). Aiming at creating both qualitative and quantitative results, I draw on Mayring's 
proposal of a qualitative content analysis. The process of building categories to code the material 
included a mix of inductive and deductive steps (Glaser and Strauss, 1967; Mayring, 2010). After a 
pre-analysis, codes were created directly from the empirical material and drawing on the researchers’ 
knowledge about the topic. The result was a long list of codes that had to be reduced and given some 
categorization. This was done inspired by the codebooks developed for other studies that used the 
political claim-making method (Ferree et al. 2002; Koopmans, 2002; Koopmans and Stratham, 2010) 
or that used typologies for the topic under study (Rucht et al., 2008). The categories about 
agrobiotechology were discussed with the experts from the Agricultural Development Unit from 
ECLAC/UN. Two main categories were chosen: actors and frames.  
Actors were classified in two variables: type (Table 5) and scope (Table 6). The geographical 
situation of actors is relevant due to the global dimension of the debate on GM food and the fact that 
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interests of global actors are at stake. As for the type, five broad codes were created: political actors, 
market actors, social movements and their organizations, scientists and media actors. As mentioned 
before, such codes make sense in the issue area of agrobiotechnology, in which the government is 
usually the main target of policy demands, and the main claim makers are either developers of 
biotechnology (market actors and scientists), farmers who use it (market actors), social movements 
and organizations who contest it and, since I am using media articles as a source, journalists and 
editorialists are also considered as actors who construct media framings about GMOs.  
 
TABLE 5 
ACTORS VARIABLE: TYPE 
Actors types Definition 
Political actors 
 




- Local, regional, national and international levels 
Market actors Socio-economic interest groups: 
- Farmers and their associations 
- Food industry and their associations 
- Seeds and chemical industry (agro-inputs) 
- Consultant firms in agribusiness 
- Other market actors 
Social movements and their 
organizations (SMOs) 
Non-profit actors from civil society: 
- Environmental movements and organizations 
- Human rights organizations 
- Peasants and landless farmers associations 
- Individuals  
Scientists - Scientists 
- Associations of scientists 
- Actors from State agencies speaking as scientists  
Media actors  Editorials and journalists 
  Source: Own elaboration. 
 
Although it would be ideal to have a more extensive list —differentiating, for instance, between 
a Congressman and a Minister of Agriculture—, for pragmatic reasons it was necessary to aggregate 
all codes into five broad categories for the content analysis. This was done without prejudice of being 
able to retrieve the quotations to analyse qualitatively the results. It is important to make the 
distinction between the advantages of each type of data. The numbers reflect the standing and framing 
given by media to these actors. Thus, the quantitative results treat all claim-makers equally, based on 
the media selection of the actors deemed relevant to speak about GMOs. However, such strength is 
also a limitation of the quantitative results, because it neglects the hierarchies present in society. In 
order to illustrate, what equally counts as one quotation can have very different impacts in the issue: if 
the President of the country speaks about the benefits of GM crops or its environmental risks it has a 
stronger weight in the political disputes than the quotation from a small farmer demanding GM seeds 
or any scientist speaking of possible risks.  
The actors participate in the debate over GM food policy making claims on issues and giving 
justifications for their positions. They try to influence shared meanings by strategically emphasizing 
some aspects of agrobiotechnology and silencing about others. The claims about GMOs were 
classified according to the main meaning assigned by actors to agrobiotechnology i.e. by their 
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preferred way to frame it. The frames were categorized in three dimensions of the debate: 
(i) economy; (ii) health and environment; (iii) ethics and politics.  
 
TABLE 6 
ACTORS VARIABLE: SCOPE 
Actors scope Definition 
National  Actors from the country under study. Include subnational actors: 
- State/province/regional actors. 
- Local actors 
International 
 
Actors that are not from the country from which the data is being analysed, including: 
- Intergovernmental or supranational, formed by state actors 
- Transnational: non-state actors 
- Foreign country actors 
Source: Own elaboration. 
 
The economic dimension is constituted by market-based arguments pro- and contra GMOs. 
This type of claims appeals to economic considerations as the basis to decide about adopting 
agrobiotechnology. While market actors take the ultimate decisions– farmers purportedly weighing 
economic costs and benefits and consumers following their preferences–, these depend on a regulatory 
framework that enables their freedom to decide. Thus, arguments classified under the economic 
dimension refer not only to economic considerations but also include demands for a specific role of 
the State —in an utilitarian sense— in what regards the approval or prohibition of GMOs and the 
adoption of monitoring and inspection rules, i.e. a State that guarantees that market actors can choose 
to adopt or reject GMOs. Notwithstanding the importance assigned to State regulation, claims 
shedding light on the economic dimension of the debate about GMOS imply that it is the 
(transnational) market that decides in the end–as an aggregation of the individual choices of farmers 
and consumers– if GMOs will be adopted, even if they are authorized by any given State policy.  
The dimension of health and environment comprises claims regarding the effects of GMOs 
to human, animal and plant health and to the environment. In lieu of economic benefits and costs, here 
what is under dispute is to frame the biosafety or the (bio) risk of GMOs. Since the State is the 
ultimate responsible for protection of nature and bodies, claims under this dimension also imply 
demands for specific (de) regulations. A crucial base to inform decision-making about the effects of 
GMOs on health and environment is knowledge and, therefore, scientists are placed in an authority 
role together with state authorities. Nevertheless, the (transnational) scientific authority is also 
disputed by social movements and individuals who resort to other types of knowledge about negative 
effects of GMOs on their bodies and environments, in particularly, direct evidence of local damage 
and suffering. The role of the State is to know and to manage risks and how this is achieved is also 
object of differential interpretations, according to the preferred frames for GMOs. If safe, there is no 
need for much State intervention; if risky, collective binding decisions are demanded as duty and 
responsibility of the State.  
The ethical-political dimension of the debate about GMOs is overarching in relation to the 
other dimensions, because it handles with the question of “what should be the criteria to decide about 
GMOs?” i.e. the economic and biological considerations are but one type of benefits and damages 
associated with biotechnology that can be taken into consideration. The criteria thus bring to the fore 
the political and normative question of what should be the aims of the technology. A major dispute 
concerns the framing of GMOs as part of a trajectory of pr gress in the solution of the challenges 
posed to humankind–in particular, food securtiy and climate change–or a critique against such 
conception, framing biotechnology rather as a threat to broader societal aims. Moreover, it includes 
claims about distributive questions such as “who benefits and who is affected by the adoption of the 
new technology?” and implicit or explicit demands for, on the one side, more participatory politics or, 
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on the other side, more insulation from politics in the decision-making. There are consequently 
disputes regarding what should be the basis for decision-making regarding GMOs. Thus, there is also 
contrasting views of State and democracy.  
The resulting system of categories for frames about agrobiotechnology include six pairs, 
organized in three dimensions and two positions (pro and contra) as shown in Table 7 below. Note 
these may be complementary ways of interpreting agrobiotechnology, since one actor may adopt more 
than one argument; the choice of one frame indicates rather what is most emphasized.  
 
TABLE 7 




Economy “benefits”: economic, in particular, agronomic 
benefits 
“costs”: economic “externalities”  
Health and Environment “biosafety”: inexistence of health and 
environmental risks; demands for deregulation 
“(bio)risk”: negative effects to health 
and environment ; references to 
uncertainty and lack of studies 
Ethics and Politics “progress”: technology as solution to pressing 
global issues such as food security (hunger) 
and climate change 
“critique”: biotechnology as a threat 
to food security, to culture diversity; 
claims about winners and losers of 
its adoption. 
Source: Own elaboration. 
 
Some explanations regarding coding procedures are necessary. The data were interpreted using 
computer software for qualitative analysis, Atlas.ti. The unit of analysis is a political claim. Thus, not 
all actors who appear in the media article are coded, but only those who are given opportunity to 
frame GMOs, be it by a speech act or some other action, for instance, the coverage of an authorization 
of a GM seed by a political authority stating it poses no risk to health. Also, if someone is quoted 
using many frames simultaneously, by affirming, for instance, that agrobiotechnology bring higher 
yields (frame: benefits) as well as promises to reduce environmental impact (frame: biosafety), each 
claim is coded separately. But if the same frame is repeated along a political claim, it is not coded 
twice for the same speaker, since the framing is considered the justificative given for a claim.  
Again, the “triangulation” of methods, by mixing qualitative and quantitative data, aims at 
using each type to control interpretations about the other. The numbers serve as a basis to make a big 
picture of the whole debates and compare countries, enabling an overview of what meanings achieve 
the public sphere as reported by news media. Nevertheless, the public debates are not defined by 
frequency of arguments, but much more for their quality, their circumstances and, not less important, 
by the speaker. The percentage and totals treat each political claim as equal, but the researcher cannot 
neglect the fact that the public sphere is hierarchized and some speakers and frames have more power 
than others. Therefore, in the description of the results, in order to avoid the horizontalizing effect of 
the percentages, the qualitative data will be retrieved to identify who the speakers are and the context 
of their claims. The results of this analysis will be presented in the Section III bellow. 
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III. Public debates on 
Agrobiotechnology 
The debate on GMOs in Argentina refers to the results of 15 years since 
the introduction of biotechnology in agriculture, in 1996. As the 
genetically modified seeds were adopted together with glyphosate and 
the wider use of “siembra directa” (no-till farming), a technological 
package quickly adopted at a large scale, the debate on GMOs in the 
country cannot be isolated from the combination of factors–including 
new managerial modes of organizing the production chain– that came to 
be called “the soy model” or “sojización”, as it became clear in the 
sampled period. Thus, the main nodes of debate were the effects on the 
economy, the social impacts and the effects on health and environment 
of the soy model. The coverage on those issues varies significantly 
according to the source: while La Nación and El Cronista Comercial 
focus on the economic benefits of agrobiotechnology and its spillover 
effects on the other areas, Página/12 offers a view in striking contrast, 
emphasizing negative effects on health and the environment, and the 
social costs of “the soy model”, and discussing the distribution and 
consequences of the economic benefits. Thus, the media discourse 
sampled offered a varied picture of actors and frames in the debate 
related to agrobiotechnology in Argentina. 
The Brazilian sample of articles is very different from those of 
Argentina and Mexico: both Folha de São Paulo and Valor Econômico 
offer a much more intense coverage of the GMOs issue than all tested 
news media with an alternative editorial line. Differing from media in 
the other countries, the Brazilian business paper offered a much more 
detailed coverage of agrobiotechnology, particularly because it closely   
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followed the meetings of the commission responsible for approving products, CTNBio. Some events 
covered by Valor Econômico did notappear in the sample from Folha de São Paulo. However, in 
general, both media actors overlapped in their coverage and preferred to frame GMOs as an economic 
issue, which becomes clear when 71% of the articles of Folha de São Paulo are in the Economy section. 
Among many nodes of controversy in the mediated public debate in Brazil, there were: the 
public hearing about GM rice, the first yields of GM corn challenging the efficacy of coexistence 
rules, the feasibility and costs of post-market monitoring of the released GMOs and the flexibilisation 
of approval procedures for new GMOs. In contrast to Argentina, where the debate is about effects 
after many years of adoption from the new technology, the Brazilian debate occurs in an adaption 
phase, when the first yields of GM corn pose many questions, but above all: Is coexistence with other 
modes of agriculture possible?  The issue of coexistence poses a serious challenge for farmers who 
prefer not to plant GM crops for a variety of reasons, such as cost-benefit considerations (due to high 
price of the seeds and royalities or reduce agronomic performance), the exploration of a market niche, 
the preference for creolle seeds or a political position in defense of the rights of farmers over seeds. 
There is thus a shift from future promises of the technology to its present results, which brings to the 
fore the debate on legality and reality and pose distributive questions at the fore regarding the locus of 
responsibility. Note that, while in Brazil the debate on regulation of GMOs is an issue on the agenda, 
it does not seem to be the case in Argentina, where coexistence between GM and non-GM crops and 
post-market surveillance of GMOs do not appear in the sample. It is as if in Argentina the decision to 
adopt agrobiotechnology had been done once and for all and belongs to the past. 
The sample of articles from Mexican newspapers in 2009 and 2010 covers an important phase 
of the debate on GMOs in the country: the one preceding and following the first approvals for the 
experimental cultivation of GM corn, which occurred in October 2009. The debate is, in contrast to 
the Argentinean, future oriented: many actors claim advantages and disadvantages of the adoption of 
new technology, but they are evoked as a potentiality, of what would happen. At the same time, they 
recur to the past experience of other countries in order to justify their claims, be those for or against 
GMOs. So, the adoption by some is transformed in an argument to prove the benefits, the biosafety 
and the desirability of the new technology. By the same token, the rejection of those products in other 
countries is used as an argument to prove its costs, its risks to health and environment and its ethical 
implications. Actors that oppose GMOs also draw on the experience of other countries that adopted 
the technology to illustrate their claims.  
It shows a moment in which "the risky decision" of the Mexican authorities to adopt or prohibit 
GMOs is being observed as such by all interested parties. The potential effects on economy, health 
and environment, ethics and politics are discussed, but the coverage of those issues varies significantly 
according to the source: the main narrative of El Universal favours the adoption of new technology, 
highlights economic arguments about the benefits of the new technology, but is also attentive to risk 
claims, which appear in some headlines, in particular the risk of contamination of native corn by GM 
corn. The coverage on GMOs in El Economista is clearly pro the adoption of the technology in 
Mexican agriculture, emphazing arguments of competitiveness and food security. No room is given 
for claims about potential damages caused by the adoption of GMOs in Mexico. On the other hand, La 
Jornada clearly states in some editorials its position regarding GMOs: they imply economic costs, 
damage to health and to biodiversity and threat food security and cultural diversity. 
An overview of the results of the content analysis from news articles is shown below in Table 
8. There are major differences among the countries: whereas in Brazil the economic dimension is by 
far the most debated, in Argentina and Mexico it is the health and environment issues that are object 
of most interpretative disputes. Such dimension comes in second in the Brazilian sample, whereas the 
economic considerations are the second most emphasized meaning in claims found in the Argentinean 
sample. The Mexican material offers a particularity in that the ethical and political dimension of 
agrobiotechnology is fiercely debated, accounting for 36% of all claims, following closely the health 
and environmental dimension.  
 




POLITICAL CLAIMS ABOUT AGROBIOTECHNOLOGY IN NEWS MEDIA 
ARTICLES 2009-2010 CLASSIFIED PER FRAME AND COUNTRY 
Number of claims and percentages (in parenthesis) 
 
Dimension Frame Argentina Brazil Mexico 
Economy 
Benefits 31 (24%) 30 (15%) 46 (17%) 
Costs 4 (3%) 80 (40%) 10 (4%) 
 subtotal  35 (28%) 110 (55%) 56 (20%) 
Health and Environment 
 
Biosafety 21 (17%) 35 (18%) 36 (13%) 
(Bio)risk 58 (46%) 32 (16%) 83 (30%) 
subtotal  79 (62%) 67 (34%) 119 (43%) 
Ethics and Politics 
 
Progress 4 (3%) 11 (6%) 29 (11%) 
Critique 9 (7%) 11 (6%) 71 (26%) 
subtotal  13 (10%) 22 (11%) 100 (36%) 
Total  127 (100%) 199 (100%) 275 (100%) 
 Source: Own elaboration. 
 
In what relates to the balancing of frames in each dimension, there are also variations among 
countries. Whereas biotechnology is framed almost only as an economic benefit in Argentina and 
Mexico— with no room for "cost" frames; in Brazil, its economic costs come to the spotlight, accounting 
for the top way to frame biotechnology in that country (40%) outweighting by far benefit frames (15%). On 
the other hand, actors frame three times more the negative effects to health and environment in Argentina 
and in Mexico - the leading frame in each country, responding to 46% and 30% of the claims— than in 
Brazil, where biosafety claims outweight (bio)risk ones. In the ethical and political dimension, critique 
frames more than double progress ones in Mexico and in Argentina, whereas in Brazil there is a balance 
between those. In Mexico, "critique" is the second top frame.  
 
TABLE 9 
CLUSTERS OF TYPES OF CLAIMS ACCORDING TO FRAMES 

















 (i) market 
rejection; 
 (ii) demands for 
non-GM seeds;  
 (iii) costs of 
coexistence and 
segregation;  
 (iv) burden of 
regulation 
3. Consumer rights 
4. IPRs: the 
Monsanto 
enforcement 
practices in Brazil 
1. Denying risks 
and assuring safety:  
 (i) 
contamination 
or flux of genetic 
material;  
 (ii) pesticide use 
2. Risks under 
control  
3. Risk and trust: if 





1. Knowledge about 
risks  
2. What are the 
risks? :  
 (i) contamination 
or flux of genetic 
material;  
 (ii) risks to 
consumer health; 
 (iii) pesticide use 
3. Risks out of 
control! 




2. The solution to 
food security and 
climate change 
3. Science-based 
decision making: no 
room for politics 





the winners  
3. Threat to 
food 
sovereignty 
4. Not less, 
but more 
politics! 
Source: Own elaboration. 
 
This section looks at what is to be found behind such numbers and compares the public debates 
of the three countries in 3 dimensions: economy (A); health and environment (B); and ethics and 
politics (C). The description answers the questions: How are GMOs framed?; Which actors are given 
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media coverage to defend their framing? The description of the qualitative results of the frame 
analysis clustered by the types of frames are shown in Table 9 bellow. They will be illustrated for each 
frame following the order of clustering. 
A. The economic dimension  
In the debate about agrobiotechnology, there are both pro and contra-arguments based on economic 
considerations. These have been classified under “benefits” and “costs” as ways of framing GMOs.  
Economic-driven claims defending GM crops have been categorized as “benefits”. The most 
common type refers to claim about the agronomic advantages of biotechnology, such as: more 
productivity, less costs, less losses with pests, less use of pesticides, resistance to weather and soil 
conditions (such as draught), labor-saving farming; and more quality of GM seeds (for instance, 
longer shelf-life). Another type of claim emphasizing the economic benefits of GMOs is to argue that 
it is a crucial factor to assure competitiveness in the global agricultural market. A third type of 
arguments emphasizing the economic benefits of agrobiotechnology are claims about the importance 
of a regime of intellectual property rights (IPRs) and innovation as an legal institution that fosters 
innovation and guarantee the continuity of the benefits of GMOs. 
Political claims that focus on the economic disadvantages of agrobiotechnology have been 
labeled under the frame "costs". A first cluster of such claims adopts a counter-theme to those about 
the agronomic advantages of GMOs. They denounce the reduction of the agronomic advantages of 
GM crops vis-à-vis their conventional counterparts such as: the increasing costs with pest resistance to 
the GM technological package and the higher prices of inputs for the GM technological package (such 
as the pesticides associated with GM seeds). A second cluster of claims regards the economic 
externalities of adopting GM crops. These include arguments about market access disadvantages of 
GMOs (and the exploration of market niches for non GM seeds); concerns about contamination and 
loss of market niches; fear of litigations from biotech companies; complains about non availability of 
conventional seeds and criticisms about monopolistic practices and concentration of the seeds market; 
concerns about costs of coexistence between GM and non-GM production, including costs of 
segregation in the whole chain; complains about the burden of regulations, including labeling. A third 
type of claim regards the debate on consumer rights to be informed and to take decisions. A fourth 
cluster of claims sheds light on the costs of IPRs and criticizes the system of royalties payment, 
offering a counter-theme to the frame of IPRs as an institution to foster the economy. 
Overall results  
The debate about agrobiotechnology in Brazil was in its majority concerned with economic 
considerations (55% of the all claims coded), notably with costs (40%). In the other two countries, 
economic arguments are also present, especially regarding benefits, but few actors in Argentina or 
Mexico framed GMOs as costs (Table 8).  
In what regards the types of actors that participated in this dimension of the debate, it is not 
surprising to find that the majority of carriers of economic frames are “market actors” i.e. farmers and 
their associations, biotechnological firms and the food industry. Political authorities in Mexico are the 
second most active type of actors in this dimension and they always frame the economic benefits of 
biotechnology, whereas in Brazil and Argentina, when politicians do make claims with economic 
considerations, they alerted to the costs of GMOs. In those countries, media framing is the second 
most active in this dimension of the debate, highlighting both benefits and costs. Scientists and social 
movements almost do not refer to economic aspects of the issue.  
1. Benefits  
Benefits arguments accounted for 24, 15 and 17% of all claims in the Argentinean, Brazilian and 
Mexicam debates, respectively (Table 8). In all three countries, market actors are by far the first to 
defend such arguments, accounting for the majority of benefit claims, whereas no social movement 
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recognizes benefits from GMOs. Media actors are especially active as proponents of the benefits of 
the technology in Argentina (32%), but also play some role in the other countries (13% in Brazil and 
9% in Mexico). Scientists have also a saying in claiming the benefits in all three countries (3, 10 and 
11%, respectively in Argentina, Brazil and Mexico). In Mexico political authorities defend more 
openly the economic advantages of adopting agrobiotechnology (13%), while in Brazil they have a 
minor (7%) participation and in Argentina, no saying about it (Table 10).  
 
TABLE 10 
POLITICAL CLAIMS ABOUT THE ECONOMIC DIMENSION OF AGROBIOTECHNOLOGY 
PER TYPE OF ACTORS PER COUNTRY 
Number of claims and percentages (in parenthesis) 
  Argentina  Brazil  Mexico 
  Benefits Costs Benefits Costs Benefits Costs 
Political actors 0    (0) 2  (50) 2    (7) 14   (17) 6   (13) 0     (0) 
Market actors 20  (65) 1  (25) 21  (70) 35   (44) 28   (61) 3   (30) 
Social movt. 0    (0) 0    (0) 0     (0) 8    10) 0     (0) 5   (50) 
Scientists 1    (3) 0    (0) 3   (10) 5     (6) 5   (11) 1   (10) 
Media actors 10  (32) 1  (25) 4   (13) 18   (23) 7   (15) 1   (10) 
Total 31 (100) 4 (100) 30 (100) 80 (100) 46 (100) 10 (100) 
 Source: Own elaboration. 
 
Arguments coded as adopting “benefits” frame will be described bellow in the following order 
of clusters: a) agronomic advantages; b) competitiveness in the global agricultural market and c) IPRs: 
the Argentinean exception. 
a) Agronomic advantages 
Arguments about the advantages of GMOs take specific forms in each country when narrating the 
aggregate effects of its adoption to the economy. In Argentina, the “technological package” that 
includes GM seeds is held responsible for the high increase in the agricultural production. Media 
framing from El Cronista and La Nación is active in defending the new technology. Below, an excerpt 
from the journalist Julieta Camandone, who mostly writes on agrobiotechnology in El Cronista, 
holding GM soy responsible for higher yields: 
The spread of transgenic soy resistant to the herbicide glyphosate (RR) started in the early 
nineties, enabling a strong increase in yields. This technology, together with the technique of no-till 
farming, which avoids plowing the soil and improves it for cultivation, explains much of the growth in 
production14 (Camandone, 2009). 
In the Brazilian sample, no such a narrative of a “technical revolution” in agriculture is found. 
Contrasting with Argentina, where the benefits of agrobiotechnology are taken for granted by its 
proponents and are not specified, but only mentioned in the context of the big package, actors in the 
Brazilian case clearly need to emphasize and compare the economic advantages of the new technology 
vis-à-vis the conventional seeds. The use of benefit claims is aimed at influencing the discourse about 
GMOs, because market decisions as well as policy regulations are evolving. This is because the first 
yields of GM corn were due in 2009. After the political decision to approve the product, the market 
decisions were the focus of attention: would farmers adopt the new technology? What were the 
perceived economic benefits? The debate thus is more focused on the specific agronomic benefits of 
                                                       
14  In the original: "A principios de los años noventa comenzó la propagación de la soja transgénica resistente al 
herbicida glifosato (RR), que permitió aumentar con fuerza los rendimientos, y esta tecnología, de la mano de la 
técnica de siembra directa, que evita el arado del suelo y mejora el piso para el cultivo, explican gran parte del 
crecimiento de la producción".  
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agrobiotechnology such as productivity, cost reduction, quality, among others. Among actors that 
defend their benefits are producers and their associations, consultant firms, scientists and media 
actors. Below, a producer and a scientist (agronomist) who approve the advantages of GM corn in 
comparison to conventional seeds are quoted:  
Stimulated by the operational easiness of the cultivation, by the gains in productivity and by the 
cost reduction, the producer João Domingos, owner of Tarumã [name of his farm property], already 
plans to sow transgenic varieties in 90% of the 540 hectares area reserved for corn in the season 
2009/2010. In his view, freed from the damage provoked by the caterpillars, the new hybrids might 
present from 6% to 9% higher yields than the conventional seeds, whereas the production costs were 
4% lower, basically because of the reduction in pesticide use. "I will yield up to a ton more per 
hectare with Bt corn, which means R$300 more per hectare", said the producer. (...) Cláudio Doro, 
agronomist engineer from Emater-RS [tecnical rural assistance entity from the federal state Rio 
Grande do Sul] calculates that 6,7% of the area intended for corn in the country (14.3 million 
hectares according to Conab [National Suppy Agency]) were soewned with transgenic seeds in this 
season (...). According to him, in the experiments conducted in Passo Fundo, the productivity of Bt 
corn was up to 14% higher than in the conventional varieties.15 (Valor Econômico, 2009b). 
Also in Mexico, agronomic benefits specifically associated with GMOs are quoted by actors 
trying to influence the debate and the policy, since the political decision to approve or reject GM corn 
has not been taken. Constrasting to the data from Argentina and Brazil, arguments in Mexico are 
always future-oriented (prognostics of higher yields, less losses with pest control and draught) or 
deduced from experiences of other countries, in particular Argentina, Brazil and USA, in the defence 
of the need for Mexico to catch up in competitiveness with other countries. Many market actors, such 
as associations of producers, biotechnological firms and their associations (especially Agrobio 
Mexico) argue for the increased yields to be expected. Actors argue that Mexico has a special need to 
increase productivity, and GMOs would be the solution that would decrease the country´s reliance on 
imports,16 as can be seen in the quote from the director of Agrobio:  
“The difference in the average productivity that can be achieved between a biotechnological and 
a conventional corn will vary between 10 and 20%, and, if we say it will spread in the most productive 
states, then in three years we could reduce imports, because we would have 5 million tons more grains 
and we would reach 29 million tons of annual production", explained Sallamanca17 (Martínez, 2010).  
Among the multinational biotech firms, Monsanto is the most quoted in all countries as an advocate of 
the economic benefits of the GMOs. Below a quote from the Monsanto representative for Latin 
America summarizes the argument about the many agronomic advantages of the technology: 
The company adopted as its own moto the committment to double yields in the production of 
corn, soy and cotton by 2030, maximizing efficiency in the use of resources by means of genetic 
                                                       
15  In the original: "Estimulado pelas facilidades operacionais do cultivo, pelo ganho de produtividade e pela redução de 
custos, o produtor João Domingos, dono da Tarumã, já pretende plantar 90% da área de 540 hectares que será destinada 
ao milho na safra 2009/10 com variedades transgênicas. De acordo com ele, livres dos danos provocados pelas lagartas os 
novos híbridos devem apresentar rendimento de 6% a 9% maior do que os convencionais, enquanto os custos de produção 
foram 4% menores, graças basicamente à redução na aplicação de inseticidas. "Vou colher até uma tonelada a mais por 
hectare com o milho Bt, o que significa R$ 300 a mais por hectare", disse o produtor. (…) Cláudio Doro, engenheiro 
agrônomo da Emater-RS, calcula que 6,7% da área de milho no país (de 14,3 milhões de hectares, segundo a Conab) 
foram plantadas com sementes transgências nesta safra. (...) De acordo com ele, em experimentos feitos em Passo Fundo a 
produtividade do milho Bt ficou até 14% mais alta do que a das variedades convencionais." 
16 Some actors imply that the country imports corn from USA due to the higher productivity of the GM corn adopted 
there, but do not take into account other factors that might account for the competitiveness of corn from USA (for 
instance, subsidies, infra-structure, etc). 
17  In the original: "La productividad promedio que se puede dar entre un maíz biotecnológico y un convencional 
variará entre 10 y 20%, y hablamos que se generalice en los estados más productivos, entonces en tres años 
podríamos reducir las importaciones porque se tendrían 5 millones de toneladas más de grano y llegaríamos a 29 
millones de toneladas de producción anuales”, detalló Salamanca.  
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improvement, biotechnology and agronomic practices suited to each environment. Thus, for instance, 
the first soybean technology developed for South America, Bt-RR2Y in soy, composed by two joined 
transgenic traits, has demonstrated higher yields in the order of 7.1 to 11%  in comparison to the first 
generation. In addition, it developed Genuity VT Triple Pro, a new technology in corn that maximizes 
yields through a bigger protection against insects that attack that plant in the air and subsoil, and 
confering tolerance to the herbicide Roundup. At the same time, it is researching and developing new 
biotechnological traits such as tolerance to drought, to cold, efficient use of nitrogene and higher 
yields.18 (El Cronista Comercial, 2010) .   
b) Competitiveness in the international agriculture market  
The media tends to cover the launching of new products, occasions in which the purported advantages 
of biotechnology are advertised. When national firms are involved, such events are portrayed as 
bringing the country to join the club of exports of biotechnological inventions, not only of crops. In 
Argentina, a gen resistant to draught developed by Bioceres, together with national universities and 
research institutes, was announced as the national biotech export product: 
The biotechnogical firm Bioceres discovered, together with the Universidad del Litoral and 
Conicet [National Council of Scientific and Technical Research], a gene resistant to drought that was 
converted into the first biotechnological product for agriculture exported from Argentina.19 (El 
Cronista Comercial, 2009). 
In Brazil, when the development of the first GM sugar cane was announced, it was explained 
that the national firms provide their genetic material, while bioengineering is made by multinationals. 
Nevertheless, the country is the one that brings the new product to the world market: 
Brazil shall launch in the market, in five years, the first transgenic sugarcane in the world. (...) 
After years of research, the recent partnership foirmed between the center funded by the main sugar 
factories [CTC Center for Sugarcane Technology] and three multinationals from crop protection 
industry - Basf, Bayer and Dow Chemicals - will bring the transgenic sugar cane into market. 
According to Andrade [Director from CTC], CTC will provide a large database of genetic material, 
whereas the firms will bring in their accumulated research in transgenics to the development of the 
products.  They will also conduct the toxicological studies20 (Freitas, T. 2010).   
Mexican politicians watch such developments and claim that Mexico is “delayed” to enter the 
club of successful players in the international agrarian market. The Secretary of Agriculture Alberto 
Cárdenas Jiménez is especially active in trying to influence the adoption of the new technology, for 
instance, mentioning that "We entered into a cutting-edge issue and Mexico can not be left behind"21  
(Martinez, 2009b).  
                                                       
18  In the original: " La empresa asumió por motus propio el compromiso de duplicar los rendimientos en los cultivos 
de maíz, soja y algodón para el 2030, maximizando la eficiencia en la utilización de recursos de la mano del 
mejoramiento genético, la biotecnología y las prácticas agronómicas adecuadas a cada ambiente. Así, por ejemplo, 
la primera tecnología en soja que desarrolló para Sudamérica, la Bt-RR2Y en soja, compuesta por dos eventos 
transgénicos acumulados, ha demostrado aumentos de rendimiento en el orden del 7,1 al 11% en comparación a la 
primera generación. Además desarrolló la Genuity VT Triple Pro, una nueva tecnología en maíz que maximiza los 
rendimientos a través de una mayor protección contra insectos que atacan la planta en la parte aérea, subterránea y 
confiriendo tolerancia al herbicida Roundup. En paralelo, está investigando y desarrollando nuevos eventos 
biotecnológicos como tolerancia a la sequía, al frío, uso eficiente del nitrógeno y mejoramiento del rinde." 
19  In the original: "La empresa de biotecnología Bioceres descubrió, junto con la Universidad del Litoral y el Conicet, un gen 
resistente a la sequía que se convirtió en el primer producto biotecnológico para el campo exportado desde la Argentina".  
20  In the original: "O Brasil deve levar a mercado, em cinco anos, a primeira cana-de-açúcar transgênica do mundo. 
(…) Após anos de pesquisa, a recente parceria firmada entre o centro financiado pelas principais usinas do país 
[CTC (Centro de Tecnologia Canavieira)] e três multinacionais da indústria de defensivos agrícolas -Basf, Bayer e 
Dow Chemicals- levará a cana transgênica ao mercado. Segundo Andrade, o CTC vai disponibilizar um amplo 
banco de material genético, enquanto as empresas trarão seu histórico de pesquisas em transgênicos para o 
desenvolvimento das variedades. Elas também farão os estudos toxicológicos". 
21  In the original: “Entramos de lleno a un tema de vanguardia y México no puede quedarse”.  
ECLAC – Production Development Series No. 193  The public debate about agrobiotechnology in Latin American countries …    
28 
 
The Chief of Sagarpa [Secretary of Agriculture] said that there was no turning back from 
starting with cultivating these crops, therefore they will concentrate on making up for the lost time, as 
Mexico is ranked 13th in the production of transgenic crops, after more than a decade since the 
introduction of the technology22 (Martinez, 2009c). 
As in the cases of Argentina and Brazil, media framing in Mexico shows a clear preference for 
framing GMOs as benefitial to the economy and argue that Mexico is lagging behind other countries 
that adopted GMOs. This is true for both El Economista and El Universal. But the narrative of “delay” 
in innovation is not restricted to Mexico. Multinational firms always portray their activities in each 
country as crucial for its competitiveness, often in comparison to the other countries leaders in the use 
of agrobiotechnology, which are used as benchmarks. For instance, in Brazil, Monsanto promises to 
invest in local research and development to accelerate innovation and catch up with the USA:  
The goal, according to André Dias, president of the company in the country, is to expand 
investments to "skip generations" and make Brazil match the USA in the development of the 
technology within three years. Only this year the firm received authorization to launch a product in 
the country that has existed for 12 years in the USA. "We are catching up"23 (Freitas, 2009).  
In Mexico, Monsanto states its plans to invest and be a big player, again reffering to the 
narrative of “catching up” with other countries: 
"Mexico is a step behind in this process, since in El Salvador they already had the first harvest 
of GM corn and the first results delivered a increase by 15% in productivity and a reduction by 10% 
in the production costs, i.e. there is an economy of  546 dolars por hectare". Mentioning that each 
experimental cultivation area can cost up to $20,000, he insisted that Mexico will experiment with the 
latest technologies; "our goal is that this process will not be further delayed", and, if it goes on as 
foreseen by the steps provided for by the law, the first commercial cultivation may start in the end of 
201124 (Perez, 2009d). 
c) Intellectual Property Rights (IPRs): the Argentinean exception  
The same enthusiasm from Monsanto is not found in the relationship of the company with Argentina. 
While the overall argumentation of Monsanto – and other market actors - for the benefits of GMOs is 
very similar in all three countries, the firm has a special claim in Argentina: its demand on the 
government for a strong regime of intellectual property rights. Monsanto warns that Argentinean 
producers will be deprived of new products and loose the opportunities seized by countries where 
IPRs are respected, for instance, Brazil and Paraguay: 
In Brazil and Paraguay, in turn, Monsanto do sell soybean seeds because the charge of 
royalties for the biotechnology (what the firm receives) is applied to the grains, i.e. at the end of the 
process, and not at the moment of purchasing seeds. This allows a much higher return to the firm. For 
this reason, in these countries there is a variety of soybean under regulatory evaluation that advances 
two steps foward in comparison to the technology used in Argentina. It is the soybean BT RR2. At the 
same time, the firm assures that they look foward to a regulatory framework that enables them to 
                                                       
22  In the original: " El titular de la Sagarpa dijo que no hay marcha atrás para iniciar con la siembra de estos cultivos, 
por lo que se enfocarán a recuperar el tiempo perdido, en donde México está en el lugar 13 en la producción de 
transgénicos después de que esta tecnología lleva más de una década". 
23 In the original: "A meta, segundo André Dias, presidente da empresa no país, é ampliar os investimentos para 
"pular gerações" e fazer com que dentro de três anos o Brasil se equipare aos EUA no desenvolvimento da 
biotecnologia. Só neste ano a empresa conseguiu aprovação para lançar no país um produto que já existe há 12 anos 
nos EUA. "Estamos recuperando o atraso."".  
24  In the original: "“México va un paso atrás en ese proceso, pues en El Salvador ya se obtuvieron las primeras 
cosechas de maíz OGM y los primeros resultados arrojan un increment de 15% en la productividad y una reducción 
de 10% en los costos de producción, es decir hay un ahorro de 546 dólares por hectárea”. Al mencionar que cada 
área de experimentación puede llegar a costar hasta 20 mil dólares, insistió en que en México se experimentará con 
tecnologías de vanguardia; “lo que pretendemos es que no se retrase más dicho proceso”, pues de continuar bajo el 
esquema previsto por la ley, a finales de 2011 podrían iniciarse las primeras siembras comerciales". 
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bring the new soybean technology to the Argentinean market, the third biggest world producer of the 
grain25 (Camandone, 2010a).  
In the words of the spokesperson of the company:  
Notwithstanding the inexistence of a legal framework at the local level that allows for the 
charge of royalties, Monsanto stated that it will keep striving to find a solution that permits it to bring 
the launchings to the country. "We will continue working together with the seed industry to develop a 
plataform that enables us to launch new soybean technologies in the country so that the Argentinean 
farmers can experience the same benefits as other farmers around the world", said a source from the 
company26 (Colombres, 2010).  
Monsanto is not alone in this demand. National agrobiotechnological and seed firms such as 
Satus Ager (Camandone, 2010b) and agro-chambers and associations (La Nación, 2009a) also defend 
that the benefits from agrobiotechnology are dependent upon the payment and enforcement of 
royalties. They subscribe to the view that innovation needs a IPRs regime. Also media framing 
promptly amplify such demands for a strong enforcement of IPRs, as becomes clear in the headlines 
and subhealines from El Cronista, or in the news from La Nación bellow:  
Due to the informality of the soybean market in the country, the North-American multinational 
now leads the corn seeds market and, in Brazil and in Paraguay, the soybean seeds market 27. 
(Camandone, 2010a). 
The issue of intellectual property acquired urgency for another reason. In 2012, Brazil will 
launch a new soybean resistent to glyphosate and to insects, which is not yet present in the country. 
Unlike Argentina, Brazil already has a mechanism for recognizing intellectual property. The fear is 
that this soy gets smuggled into Argentina. In 1996, when transgenic soy was approved here, it soon 
was smuggled into Brazil and was sown in many regions in the South. There it was called "soy 
Maradona", because of its small size and its robustness. Not few fear that it will now arrive, with the 
soybean to be launched in Brazil, the "Ronaldinho or Ronaldo soy"28 (La Nación, 2010).  
Therefore, in Argentina, the importance of a IPRs regime applied to seeds are especially praised 
and the debate about negotiations to establish such a regime is a context in which the benefits of 
GMOs are constantly evoked by actors to justify their demand. Using the same narrative as in Mexico, 
actors in the Argentinean debate compare the country with others fearing that it is legging behind. But 
the context is different: while in Mexico GMOs have not been given the green light and this is the 
object of demand, in Argentina, the issue is the absence of enforcement for IPRs. Fearing that it will 
                                                       
25  In the original: "En Brasil y Paraguay, en cambio, Monsanto sí vende semillas de soja porque el cobro de la regalía por 
biotecnología (lo que aporta la firma) se hace sobre el grano, es decir, al final del proceso, y no en el momento de 
comprar la semilla. Esto permite un retorno mucho mayor para la empresa. Por eso en estos dos países está en proceso 
de aprobación una semilla de soja que avanza dos pasos respecto de la tecnología con que se siembra en la Argentina. 
Se trata de la soja BT RR2. Desde la empresa, al mismo tiempo, aseguran que esperan un marco regulatorio que les 
permita traer la nueva tecnología para la soja al mercado argentino, tercer productor mundial del grano". 
26   In the original: "Pese a que a nivel local aún no hay un marco legal claro que habilite el cobro de las regalías, 
Monsanto aclaró que seguirá trabajando para encontrar una solución que le permita hacer nuevos lanzamientos en 
el país. "Continuaremos trabajando en conjunto con la industria de semillas para desarrollar una plataforma que 
permita lanzar nuevas tecnologías en soja en el país para que los productores argentinos puedan experimentar los 
mismos beneficios que otros agricultores alrededor del mundo", dijo una fuente de la empresa". 
27   In the original: "Por la informalidad del mercado de la soja en el país, la multinacional norteamericana lidera ahora 
las ventas de semillas de maíz y apunta a la oleaginosa en Brasil y Paraguay".  
28   In the original: "El tema de la propiedad intelectual adquirió cierta urgencia por otro motivo. En 2012, en Brasil, se 
lanzará una nueva soja resistente al glifosato y a insectos, que todavía no está en el país. A diferencia de la 
Argentina, en Brasil ya se resolvió un mecanismo de reconocimiento de la propiedad intelectual. El temor es que 
sin acuerdo en la Argentina esa soja ingrese de contrabando. En 1996, cuando se aprobó la soja transgénica aquí, 
luego fue de contrabando a Brasil y se sembró en varias regiones del Sur. Allí la bautizaron "soja Maradona", por 
su porte petisa y robusta. No pocos temen que ahora ingrese, con la soja que va a salir en Brasil, la "soja 
Ronaldinho o Ronaldo".  
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jeopardize the ability of biotechnological firms to profit from its wide adoption and from farmers to 
have the latest launchings at their disposal, the demand is for regulation. Thus, another type of 
argument about the benefits of GMOs appears in this debate: their dependence on a legal regime that 
protects intellectual property rights. In this case, the IPRs are seen as a legal institution beneficial to 
the economy.  
2. Costs  
Claims about costs of GMOs basically only appeared in the Brazilian debate, where they were the 
leading frame of the public debate on agrobiotechnology. Both in Argentina and Mexico they comprised 
only 3% of all claims (Table 8). Therefore, this section only briefly describes the costs arguments in 
these two countries, but concentrates on the Brazilian sample. There, all types of actors participate in the 
debate emphasizing the costs that GMOs would imply in many regards. Market actors were the most 
concerned with the economic disadvantages of the new technology (44%), followed by media actors 
(22%) and by political authorities (17%). Social movements and scientists have a relative minor 
participation, but are also present (Table 10). These claims will be described in the following clusters: 
(a) reduction of agronomic advantages; (b) economic externalities; (c) consumer rights and (d) costs of 
IPRs.  
a) Reduction of agronomic advantages  
Claims about the reduction of the relative agronomic advantages of GMOs in relation to non GM shed 
light on a number of issues: decrease in productivity, including costs of pest resistance, costs of use of 
pesticide. In the Mexican material, scientists from del Instituto Nacional de Investigaciones Forestales, 
Agrícolas y Pecuarias (INIFAP), social movements grouped in the campaign against GMOs, peasants 
associations such as Unión Nacional de Organizaciones Regionales Campesinas Autónomas (Unorca) 
and other activists such as a Canadian farmer victim of a litigation from Monsanto, argued against 
almost all purported 29 economic benefits of GMOs. They adverted for the higher costs of production 
due to seed prices and costs with pesticides and pest resistance to GMOs; risks of contamination and 
of legal action from biotech firms; the problem of unavailabilty of non-GM seeds in the market. 
Greenpeace Mexico is especially active in the campaign against GMOs and published a study about its 
cosps, as reported by El Universal: 
Zero increase in productivity, null profit, additional costs, higher use of agrochemicals, crop 
failures and difficulty for commercializing its production, these are some of the heavy costs caused by 
the sowing of transgenic seeds in countries that bet on those crops, affirmed the organization 
Greenpeace Mexico. In their repport "Transgenic crops: zero profits" presented this Monday, the 
organization explained that it documented, "for first time", specific cases in which transgenic crops 
have had high costs for the different sectors involved in the food chain (El Universal, 2010a).  
Although such arguments could be read as speaking against biotechnology, they have also been 
employed by market actors who defend the use of GMOs and want to continue with its use. In Brazil, 
farmers start to question the relative economic advantages of GM seeds, among other reasons, because 
of the costs of royalties:  
At the beginning, the great argument in favor of transgenic soy was the reduction of total costs, 
which in 2003/2004 were 9.8% lower than those of non-GM crops, says the advisor from the State 
Federation of Agricultural Cooperatives (Fecoagro), Tarcísio Minetto. Today, this difference droped 
                                                       
29  In the original: "Cero incremento de la productividad, ganancias nulas, costos adicionales, mayor uso de 
agroquímicos, cosechas perdidas y dificultad para comercializar su producción, son algunos de los gravosos costos 
ocasionados por la siembra de semillas transgénicas en países que le apostaron a dicho cultivo, aseguró la 
organización Greenpeace México. En su informe “Cultivos transgénicos: cero ganancias” presentado este lunes, el 
colectivo explicó que documentó, "por primera ocasión", casos específicos en los que los cultivos transgénicos han 
tenido elevados costos para los diferentes sectores involucrados en la cadena alimentaria".  
ECLAC – Production Development Series No. 193  The public debate about agrobiotechnology in Latin American countries …    
31 
 
to 2% to 3%, and, moreover, producers even fight in court not to pay Monsanto the royalties of 2% 
over the yields resulting from multiplying their own seeds30 (Valor Econômico, 2009a).  
Also, both biotech firms31 and Embrapa have recognized that there were costs of pest 
resistance.32 But most claims of this type were from producers complaining about the prices of 
pesticides associated with the use of GM seeds. While glyphosate was the object of a controversy in 
Argentina regarding its toxicity, in Brazil, the main node of controversy was the prices of the product. 
The impact of higher prices becomes acute because of its wide use, leading to its “commoditification”, 
which, according to Nortox, a national firm that supplies glyphosate in Brazil, is due to the widespread 
adoption of GM seeds: 
Nortox S.A., a firm from the State of Paraná, filled on Friday a petition at the Ministry of 
Development for the revocation of the 2.1% surcharge applied to glyphosate imported from China. 
(...). Nortox pleas that prices returned to the historical average of $3.70 recorded in the last decade, 
as glyphosate became a "commodity" due to the diffusion of transgenic seeds33 (Zanatta, 2010c).  
The targets of the claims were both Monsanto and the government. The latter was demanded to 
end with anti-dumping measures attending the interests of Monsanto against the imports of cheaper 
glyphosate imported from China. But there was differentiation inside the government: the Ministry of 
Development, Industry and Foreign Trade (as Secretarariat for Camex) was the demanded party, 
whereas other political actors, such as the Ministry of Agriculture and legislative actors were 
supporters of producers:  
Last week, Congressmen representating the rural sector entered into the fight to defend their 
political base, the largest consumer of pesticides. The Agriculture Commission of the Representatives 
House approved an invitation of the Ministers from Camex to explain the antidumping. According to 
representative Luis Carlos Heinze (PP-RS), Monsanto holds 70% of domestic production because it 
imports from its industries in Argetina and the USA the same Chinese glyphosate that it tries to 
impede entering Brazil. The internal market consumes 280 million liters glyphosate annually and 
Monsanto produces less than 100 million, he said34 (Zanatta, 2010c).  
The battle over the raw material used in the manufacture of pesticides has generated disputes 
in the backstage opposing producers, rural Congressmen and the national industry against the North-
American multinational Monsanto35 (Zanatta, 2010b).  
 
 
                                                       
30  In the original: "No início, o grande argumento em favor da soja transgênica era a redução dos custos totais, que em 
2003/04 eram 9,8% inferiores aos das lavouras não-transgênicas, afirma o assessor da Federação das Cooperativas 
Agropecuárias do Estado (Fecoagro), Tarcísio Minetto. Hoje essa diferença caiu para 2% a 3% e os produtores 
ainda brigam na Justiça para não pagar para a Monsanto royalties de 2% sobre a safra obtida a partir da 
multiplicação própria de sementes". 
31 These started requiring from producers to expand "refuge areas" to avoid pest resistance (Zafalon, 2009a). 
32 At a public hearing about GM rice on March 2009 (Zanatta, 2009d).  
33  In the original: "A paranaense Nortox S.A protocolou no Ministério do Desenvolvimento, na sexta-feira, um pedido 
de extinção da sobretaxa de 2,1% aplicada nas importações de glifosato originário da China. (...) A Nortox alega 
que os preços voltaram à média histórica de US$ 3,70 registrada na última década, já que o glifosato tornou-se uma 
"commodity" em razão da disseminação das sementes transgênicas".  
34  In the original "Semana passada, a bancada ruralista entrou na briga para defender sua base política, a maior 
consumidora de agrotóxicos. A Comissão de Agricultura da Câmara aprovou convite aos ministros da Camex para 
explicar o antidumping. A Monsanto, segundo o deputado Luis Carlos Heinze (PP-RS), detém 70% da produção 
doméstica porque importa de suas fábricas na Argentina e EUA o mesmo glifosato chinês que tenta impedir de 
entrar no Brasil. O mercado interno consome 280 milhões de litros anuais de glifosato e a Monsanto produz menos 
de 100 milhões, diz".   
35  In the original: "A trava sobre a matéria-prima usada na fabricação de agrotóxicos tem gerado disputas de bastidores 
que opõe produtores, parlamentares ruralistas e indústrias nacionais contra a multinacional americana Monsanto".  
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b) Economic externalities 
Economic externalities are the framing of costs that are not taken into account by those who are 
emphasizing the economic benefits of GM crops. They will be described in four categories: market 
rejection; demands for non-GM seeds; costs of segregation and coexistence; burden of regulation. The 
first type of claim makes visible the other side of the food chain, establishing a connection between 
the producer and the consumer. Such claims frame the decision to adopt agrobiotechnology in 
agriculture as depened upon the consumer’s approval. Thus, concerns about the market rejection of 
GMOs, the option for non-GMOs as a market niche and the fear of risk of contamination and loss of 
this market niche have been coded as adopting a “cost” frame. 
Market rejection 
All claims coded as costs in the Argentina debate are related to the same events and to the costs of market 
rejection of GMOs: the Russian rejection to import GM soy from Argentina because it was not approved in 
the country. In Brazil, rice producers feared market rejection of GM rice, due to the precedent of the 
contamination of GM rice in the US which led to major loses from producers. While such fears were 
dissipated when GM rice was not approved, corn and soy producers - specially Abrange, an association of 
non-GM producers36 - remain afraid of losing their market niche due to contamination with GM products. 
Gebana Brazil, a Swiss trading that buys and negotiates contracts in Europe, has refused the 
production of many farmers from the region due to contamination by geneticatically modified grains. 
The contamination occurs for variouis reasons, ranging from the use of a machine that has not been 
cleaned properly to the dust produced in the harvest of a neighbour using transgenic crops. For the 
small farmers from Parana, this type of contract is very important. Without scales of production, these 
contracts for supplying organic soy and corn guarantee them a higher remuneration per ton. "The price 
paid for a ton of organic grains can be between 15% and 20% higher than the price negotiated in offers 
for conventional corn and soy", says Eduardo Mattioli Rizzi, manager from the Agriculture Department 
from Gebana Brasil37 (Brito, 2009c).  
Demands for non-GM seeds 
Another type of claim that refers to externalities of the adoption of agrobiotechnology includes 
demands for conventional seeds as well as criticisms on non-availability of such seeds. They deal with 
the option to decide what to plant and let market actors compare their relative benefits.  
The quick spread of transgenic soy in Mato Grosso made the producers look for new 
alternatives not to lose the supply of this variety. The transgenic soy, due to the increasing activity of 
multinationals, already responds for 60% of the total seeds offered in the State. Three years ago it was 
only 20%. Aprosoja (association of producers), Embrapa Soja, Abrange (which assembles producers 
and processers from non-transgenic grains) and Aprosmat (comprising seed producers) will meet 
today in Cuiabá to settle details of a programm that will promote conventional seeds in the State. (...) 
The aim of this program is to "strengthen and maintain the cultivation of conventional soy", says Luiz 
Nery Ribas, technical manager from Aprosoja, entity that gathers producers from the State. He makes 
it clear, however, that Aprosoja is not against transgenic soy, but the producers have the right to opt 
for the variety they want to plant38 (Zafalon, 2010).  
                                                       
36 There were also counter-arguments for those claims from the President of CTNBio (Zanatta, 2010f). 
37 In the original: "A Gebana Brasil, trading suíça que compra e negocia contratos na Europa, tem recusado a produção 
de muitos produtores da região devido à contaminação por grãos geneticamente modificados. A contaminação ocorre 
por vários motivos, desde o uso de uma máquina que não tenha sido completamente limpa até a poeira produzida na 
colheita de um vizinho com lavoura transgênica. Para os pequenos produtores do Paraná, esse tipo de contrato é muito 
importante. Sem escala de produção, esses contratos para fornecimento de soja e milho orgânicos lhes garantem 
remuneração maior por tonelada. "O preço pago por uma tonelada de grãos orgânicos chega a ser entre 15% e 20% 
maior que o negociado em ofertas de milho ou soja convencionais", afirma Eduardo Mattioli Rizzi, gerente do 
Departamento Agrícola da Gebana Brasil".  
38  In the original: "O avanço rápido da soja transgênica em Mato Grosso fez os produtores buscarem novas 
alternativas para não perderem o fornecimento dessa variedade. A soja transgênica, devido à atuação cada vez 
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Again, Monsanto is a target of claim, being accused of monopolistic practices in selling seeds: 
The firm has been the target of accusations and lawsuits from producers, who claim there is 
illegal charge of royalties and restrictions for the production of conventional seeds in the contracts 
between Monsanto and the "sementeiros" - responsible for multiplying their own grains for planting. 
"We are not against the technology RR. What we are worried about is monopoly, which restricts the 
right of the producer to make his choices", says Gláuber Silveira da Silva, president from Aprosoja 
(Association of Soy Producers) from MT [State of Mato Grosso]. He affirms that, in the contracts to 
multiply seeds, Monsanto requires that the "sementeiro" ocuppies 85% from his production with 
transgenic soy and leaves only 15% for conventional varities. Monsanto denies making such 
requirements. In order to avoid restrictions on non-transgenic seeds, Aprosoja signed an agreement with 
Embrapa (Brazilian Agricultural Research Corporation) to develop conventional varieties in 18 cities in 
the west of Mato Grosso, according to Silva. He, who farms 3.000 hectars with conventional seeds, 
states: "There is a world market for conventional soy and we cannot be left out"39 (Maschio, 2009).  
Costs of coexistence and segregation 
Another cluster about the economic externalities of agrobiotechnology relates to costs of coexistence 
and segregation. It was the ocassion of the first yields of GM corn in 2009 that posed the issue of 
coexistence on the agenda and triggered the whole exchange of arguments regarding who was going to 
pay the costs of it. Folha de São Paulo clearly used its power to set the agenda about the rules for 
coexistence. On May 10th 2009, it published an investigative journalistic work resulting in a series of 
articles published together with the following headlines: 
• The country loses control over GMOs 
• Control is a unnecessary luxury, says government 
• For Ministery, rule does not avoid contamination 
• Producers discard segregation 
• Test does not guarantee that food is 100% free from GMOs 
• Veto: transgenic corn authorized in Brazil was prohibited in Germany 
• Analysis: Pressure from farmers liberalized GMOs 
• Producer losts two contracts because of contamination 
The articles indicate that the issue of coexistence is related to other ones (such as market 
rejection of GMOs and consumer rights) and affect a varied spectrum from actors in all food chain. 
                                                                                                                                                                     
maior das multinacionais, já atinge 60% do total de sementes ofertadas no Estado. Há três anos era de apenas 20%. 
Aprosoja (associação de produtores), Embrapa Soja, Abrange (que reúne produtores e processadores de grãos não 
transgênicos) e Aprosmat (que reúne produtores de sementes) se reúnem hoje em Cuiabá para acertar detalhes de 
um programa que dará força à semente convencional no Estado. (...) O objetivo desse programa é o de "fortalecer e 
manter o plantio da soja convencional", diz Luiz Nery Ribas, gerente técnico da Aprosoja, entidade que reúne 
produtores do Estado. Ele deixa claro, no entanto, que a Aprosoja não é contra a soja transgênica, mas os 
produtores têm o direito de optar pela variedade que desejam plantar". 
39  In the original:  "A empresa tem sido alvo de acusações e ações judiciais de produtores, que dizem haver cobrança 
ilegal de royalties e restrições para a produção de sementes convencionais nos contratos entre a Monsanto e os 
sementeiros -responsáveis por multiplicar os grãos próprios para o plantio. "Não somos contra a tecnologia RR. 
Estamos preocupados é com o monopólio, que restringe o direito de o produtor fazer sua escolha", diz Gláuber 
Silveira da Silva, presidente da Aprosoja (Associação dos Produtores de Soja) de MT. Ele afirma que, nos contratos 
de multiplicação de sementes, a Monsanto exige que o sementeiro ocupe 85% de suas lavouras para produzir 
sementes de soja transgênica e somente 15% para variedades convencionais. A Monsanto nega que faça essa 
exigência. Para evitar a restrição de sementes não transgênicas, a Aprosoja firmou convênio com a Embrapa 
(Empresa Brasileira de Pesquisa Agropecuária) para desenvolver variedades convencionais em 18 municípios do 
oeste de Mato Grosso, de acordo com Silva. "Existe um mercado mundial para a soja convencional e não podemos 
ficar fora", afirma ele, que cultiva 3.000 hectares de soja convencional". 
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While political actors are demanded to play a role in enforcement (and ensure it does happen), 
producers concede they are not segregating production nor have the material conditions to do it; the 
food industry complains for being forced to assume responsibilities that are not theirs and consumers 
have their right to knowledge jeopardized.  
Burden of regulation 
The series of articles published by Folha de São Paulo on May 10th 2009 may frame the issue in terms 
of costs for producers may lose contracts, and as a threat to the right of coexistence and the right of 
information to consumers. However, it appears that the aim of the media actor is rather to criticize the 
government for lack of control and then to advance an agenda for more flexible rules, freeding private 
actors from the costs of complying with their duties.40 The food industry joins the battle against 
regulation, concerned with the cost of segregation, and also positioning themselves against the 
national rules for labeling and post-market surveillance.  
In a letter to the commission responsible for the analysis and approval of genetically modified 
organisms, Abia (Brazilian Association of Food Industry) argued that such monitoring would be 
"unfeasible"41 (Salomon, 2009).  
The claims from the industry to CTNBio do not fall on deaf ears, on the contrary: they find in 
the President of that commission wide amplification: he stands out in the sample as the fiercest 
defender of deregulation of GMOs in Brazil. Bellow, a quotation where he he states economic reasons 
for cutting off post market surveillance.42  
In defense of the modification, Walter Colli reaffirms the autonomy of CTNBio. "I understand the 
suspicion, but it is sillliness. This harms the whole industry. I have support and a legal opinion from the 
Ministry of Science and Technology. I am not doing it because Canada complained. Abia [Brazilian 
Association of Food Industry] has already sent a letter to the Minister about it", he says. Colli affirms 
that "this resolution has always bothered me" and he admits that the current rule has only been created 
because the process of commercial liberalization started requiring "monitoring" of the approvals, due to 
an initiative from the Public Attorney. "Otherwise we could not liberate". Colli states that the regulation 
"is wrong" and that it "gives responsibility to who has no duty and it interferes in the chain where we 
have no right to do so”. "It does not stand judicial review"43 (Zanatta, 2009a).  
                                                       
40 This becomes clear in an Editorial published two days later (Folha de São Paulo, 2009d). After criticizing the 
government for GMOs being “out of control”  in the country, the media actor concludes that control is not posible 
and, as illegality is abominable, the regulatory framework should be modified. GMOs are framed as safe and 
bringing many benefits. 
41  In the original: “Em carta dirigida à comissão responsável pela análise e pela liberação de organismos 
geneticamente modificados, a Abia (Associação Brasileira das Indústrias da Alimentação) argumentou que tal 
monitoramento seria "inexequível"”. 
42   But he also defends simplifying overall approval rules, based on the argument that the risk assessment that has been     
made to approve the product is enough and no further control is needed (such claims will be analysed in the 
dimesion of health and environment). However, in December 2009, when the President of CTNBio states that the 
post-market surveillance rules are rubbish, Folha de Sao Paulo reacted in a disapproving way: “In Brazil, the law is 
in force but is not enforced. This has been the regulatory pattern on GMOs in Brazil. Under pressure from 
adversaries of the technology and from part of the public opinion, the CTNBio creates innocuous rules that are later 
revogated. The end of monitoring, as demanded by the food industry, is justifiable. By speak of “rubbish”, 
however, the president of CTNBio disqualifies the previous work from that body and awake unnecessary suspicion 
about the independency of the commission in face of the industry’s interests” (Folha de São Paulo, 2009b). 
43  In the original: "Em defesa da alteração, Walter Colli reafirma a autonomia da CTNBio. "Entendo a desconfiança, 
mas é bobagem. Isso prejudica toda a indústria. Tenho suporte e um parecer jurídico do Ministério da Ciência e 
Tecnologia. Não estou fazendo porque o Canadá reclamou. A Abia [associação da indústria de alimentos] já 
mandou carta para o ministro sobre isso", afirma. Colli diz que "essa resolução sempre me incomodou" e admite 
que a atual regra só foi criada porque o processo de liberações comerciais de transgênicos passou a exigir, por 
iniciativa do Ministério Público, "monitoramento" das aprovações. "Senão não poderia liberar". Colli afirma que a 
resolução "está errada" e que "dá responsabilidade a quem não tem obrigação, interfere na cadeia onde não temos 
direito". "Isso cai em qualquer instância da Justiça"". 
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c) Consumer rights 
After the lost battle in which GMOs were approved in Brazil, social movement organizations for the 
defense of consumer rights keep fighting for the right of information as a basis for consumer to decide 
what to eat. 
IDEC (Brazilian Institute for Consumer Defense) and the FNECDC (National Forum of 
Organizations for Consumer Rights) sent a letter, on May 7th, to the Ministry of Agriculture, in which they 
demand immediate measures regarding the lack of inspection in the cultivation of GMOs in all stages of 
the production chain, including the sector of poultry and bovine meat. (...) Depending on the answer 
received, it may serve as basis for the institution entering a new representation to the Public Attorney, 
which is already ahead of four lawsuits requiring compliance with labeling rules44 (Brito, 2009b). 
Also in Mexico opponents of GMOs framed their resistance in an economic fashion, for 
instance, Greenpeace Mexico when it entered with a dennounce at the Interamerican Commission of 
Human Rights arguing that producers and consumer rights were disrespected by the Mexican 
government in their right to know (El Universal, 2010c).  
d) IPRs: the Monsanto enforcement practices in Brazil 
While in Argentina farmers and biotechnological firms demand the government a legal framework for 
the enforcement of IPRs, Monsanto in Brazil has developed a system to ensure the payment of 
royalities, explained bellow in the article from Folha de São Paulo:  
In order to guarantee the payment of royalties by the Brazilian farmers, Monsanto had to 
diversify the collection system for the technology of transgenic soy. The Brazilian legislation that 
allows the producer to 'save' grains harvested to use as seeds in the following season made the 
multinational create a mix system. If the producer does not buy the certified seed produced by 
authorized sementeiros [seed multipliers] -—who issue notes for charging royalties— he has to pay 
for the non-authorized use of the technology at the moment of marketing the product. Those who buy 
authorized seeds pay from R$0,42 to R$0,45 per kilo and receives a virtual credit to commercialize 
from 61 to 74 kg —varying from State to Stat—- of soybeans after harverst. The farmers who opted to 
"save" grains to use as seeds have to declare to the buyers that the product is transgenic. When he 
delivers it, he pays 2% of the value to Monsanto. If he does not declare that the soy is RR [Roundup 
Ready, patented product from Monsanto], the buyers, who have contracts with Monsanto, make a 
test45 (Folha de São Paulo, 2009a). 
However, far from satifying all, some Brazilian farmers are denouncing it as illegal and unfair, 
without putting into question their choice for GMOs and their agreement that royalties must be paid 
for the purchase of seeds. What they contest is Monsanto’s system to control the commercialization 
                                                       
44  In the original: "O Idec (Instituto de Defesa do Consumidor) e o FNECDC (Fórum Nacional das Entidades Civis de 
Defesa do Consumidor) encaminharam no último dia 7 carta ao ministro da Agricultura, Reinhold Stephanes, na 
qual cobram medidas imediatas em relação à falta de fiscalização da produção transgênica em todas as etapas da 
cadeia produtiva, incluindo o setor de carnes de frango e suína. (...) A depender das respostas, o conteúdo pode 
embasar nova representação da instituição ao Ministério Público Federal, que já está à frente de quatro ações que 
pedem cumprimento das regras de rotulagem". 
45  In the original: "Para garantir o pagamento de royalties por parte dos produtores brasileiros, a Monsanto teve de 
diversificar o sistema de cobrança pela tecnologia da soja transgênica. A legislação do Brasil, que permite que o 
produtor "salve" grãos colhidos para usar como sementes na safra seguinte, fez com que a multinacional criasse um 
sistema misto. Caso o produtor não compre a semente certificada produzida por sementeiros autorizados -que 
emitem boletos de cobrança de royalties-, ele tem de pagar pelo uso não autorizado da tecnologia no momento de 
comercializar o produto. Quem compra semente certificada paga de R$ 0,42 a R$ 0,45 por quilo de semente e tem 
um crédito virtual que permite a comercialização de 61 kg a 74 kg -varia conforme o Estado- de soja após a 
colheita. Já o agricultor que optou por "salvar" grãos para usar como sementes tem de declarar aos compradores 
que o produto é transgênico. Ao entregar, ele paga 2% do valor à Monsanto. Se ele não declarar que a soja é RR, as 
compradoras, que mantêm acordo com a Monsanto, fazem um teste. Caso seja constatado que a soja é transgênica, 
o produtor paga então 3% do valor comercializado".  
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buy charging royaltiers over the harvest. Moreovers, some farmers claim the right to multiply seeds, 
which is being jeopardized by the inspection practices from Monsanto.  
Coordinated by the newly constituted Association of Soybean Producers from Rio Grande do 
Sul (Aprosoja-RS), organizations representating farmers from that State will take judicial action 
against the charge of royalties by Monsanto on the marketing of transgenic soy. The lawsuits will be 
initiated in many counties of the State this month, demanding the suspention of payment or holding 
funds in escrow until merit is judged, said the president from Aprosoja-RS, Pedro Nardes. According 
to him, the issue is not charing royalties when selling certified seeds. The battle is rather against the 
2% paid by farmers when they deliver to tradings or to cooperatives the harverst they obtained from 
seeds multiplied by themselves in their properties - R$0,86 per bag based on the average value of 
soybean in the State46(Bueno, 2009b).  
Thus, it is not only for its practices on the concentration of seeds market and for the costs of its 
glyphosate-based product (Roundup) that Monsanto is targeted. Producers and their associations also 
complain that the system adopted by the mulitinational to charge royalties has become expensive and 
can lead to decreasing advantages of GMOs.  
In sum, the economic considerations are an important dimension of the debate about 
agrobiotechnolgy. Not only biotechnology firms and farmers want to influence discourse and policy on 
GMOs by resorting to frames such as benefits and costs. Also politicians, scientistists, social movements 
and media actors participate in such exchange of ideas. The issues that enter the public debate may vary 
from country to country in their specific expression but tend to include agronomic considerations; 
competitiveness issues as well as interdependence with import markets; a regime of IPRs that is 
considered appropriate for all parties; the feasibility and costs of coexistence between GM and non-GM 
production in the whole chain, from seeds supply to consumer rights; the legal framework for pre-market 
approval as well as post-market monitoring. As for national specifities, they can be summarized as 
follows: whereas actors in Argentina emphasize the benefits associated with GMOs and thus appear to 
have succeed in treating its adoption in agriculture as an irrevocable and unquestioned decision, Mexican 
actors are striving to shape discourse and policy in a fashion that also silence costs and highlights the 
advantages that the technology will bring to the national economy. Brazil stands almost alone in the 
debate of a country that has adopted agrobiotechnology and is experiencing many disputes regarding the 
mix of benefits and costs that affect different actors in very distinct ways. 
B. The health and environmental dimension  
Arguments about the effects of agrobiotechnology on human, animal and plant health as well as on the 
environment are used both to frame GMOs as safe and as risky. They have been classified as 
"biosafety" and "(bio) risk", respectively.  
"Biosafety" is the name given to the assessment of adverse effects that modern biotechnology 
can have on biodiversity and health. Many national laws and international legal instruments applied to 
GMOs adopt the concept.47 "Biosafety" frames mean that GM crops are safe i.e. that they pose no risk 
                                                       
46  In the original: "Coordenadas pela recém-constituída Associação dos Produtores de Soja do Rio Grande do Sul 
(Aprosoja-RS), entidades representativas de agricultores gaúchos recorrerão à Justiça contra a cobrança de 
royalties, pela Monsanto, sobre a comercialização de soja transgênica. As ações devem ingressar em diversas 
comarcas do Estado neste mês pedindo a suspensão do pagamento ou depósito dos valores em juízo até o 
julgamento do mérito, diz o presidente da Aprosoja-RS, Pedro Nardes. Segundo ele, a questão não é a cobrança de 
royalties na venda de sementes transgênicas certificadas. A briga é contra os 2% que os agricultores pagam quando 
entregam às tradings ou cooperativas a safra obtida com sementes multiplicadas por eles em suas propriedades - R$ 
0,86 por saca com base na cotação média da soja no Estado".  
47  In the multilateral level, the most important instrument specifically created with this purpose is the Cartagena 
Protocol on Biosafety to the Convention on Biological Diversity. It was adopted on 29 January 2000 and entered 
into force on 11 September 2003. Both the Brazilian and Mexican Laws for GMOS are called Biosafety Bills: the 
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to health nor to the environment. Among the claims coded as “biosafety” are denials of risks and 
assurances of safety of GMOs in general, the argument that risk analysis has been done (implying 
“there is no risk”) and assertions on the equivalence of GMOs and non-GMOs. “Biosafety frames” 
also refer to claims that risks are under control, i.e. that the existing regulations are sufficient to 
manage any acknowledged risks, thus, they include the overall argument that there is no grounds for 
fearing any negative effects of the new technology. Since such assurances of the safety of GMOs are 
the assumptions used as a basis for demands for de-regulation, these demands and criticisms that 
there are too many requirements for GMOs have been coded as “biosafety claims”. The argument that 
GMOs have been approved in other countries, when used to refer to its safety regarding health and 
environmental issues, have also been considered as adopting a “biosafety frame”. 
Another type of claim also coded under this category arguments that biotechnology can be 
beneficial to the environment and to health. Examples of the former are claims that genetic 
engineered crops not only lead to a reduction in the use of pesticides, but are also associated with the 
substitution from more toxic to less toxic pesticides. Examples of claims about the health benefits of 
GMOs are announcements of seeds with more nutritional value.  
Claims coded as “biorisk frames” refer to the most common usage of “risk” as the probability 
of damage to health and environment. This conceptualization leaves room for two ways of 
emphasizing risks when talking about GMOs: highlighting the knowledge about probabilities of 
damage or making visible what are the damage associated with agrobiotechnology. Thus, “biorisk 
frames” were ascribed to arguments that set the emphasis on the knowledge about the adverse 
effects of GMOs. These include, at one extreme, the affirmation that there is “uncertainty” about the 
future negative effects of and, at the other, the statement that there is enough compiled knowledge not 
to doubt the existence of risks from GMOs.  
Then, arguments referring to specific damages to health and environment were coded as 
“biorisk”, including negative effects on consumer health (food safety), negative effects on workers’ 
health and on the health of communities who live close to GM crops plantations —usually related to 
the use of pesticides— , negative effects on the environment – because of the use of pesticides or as a 
threat to biodiversity. Claims about the transfer of genetic flux, also refered by some actors as 
“contamination” have been coded either as a “cost” or as a “risk” depending on what has been 
considered to be the damage: when it regards the economic losses involved, such claims have been 
coded as “costs”, when it concerns the negative environmental effects of the transfer of genetic 
material from the GMOs to the environment, the claims were coded as “risk”.  
As a counter-theme to “biosafety”, “biorisk” was considered the dominant framing of demands 
for more regulation and stricter requirements of GMOs —or criticisms that risks are out of control—
, since these are based on the assumption that there are negative effects from biotechnology to health 
and environment. This unfolds in the debate about the adequacy of existing regulations and the 
desirability of not less —as demanded by proponents of agrobiotechnology— but more (and stricter) 
regulations. Thus, also as a counter-theme to “biosafety” frames, opponents of GMOs react to any 
proposals by highlightening the connection between risk and responsibility. On the other extreme of 
the possibilities of how to decide about GMOs, (bio) risk claims include demands for moratoria on 
GMOs, instead of unregulated liberation.  
Overall results 
References to health and environmental issues constituted the major dimension of the debates about 
agrobiotechnology in the samples from Argentina and Mexico (62% and 43%, respectively). In both 
countries, risk claims have by far outweighted biosafety claims, whereas in Brazil, where the 
                                                                                                                                                                     
former, Law 11.105/2005 or "Lei de Biosseguranca"; the latter, Law DOF 18-03-2005 or "Ley de Bioseguridad de 
Organismos Genéticamente Modificados". 
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biological dimension was the second most debated (34%), biosafety claims slightly surpassed risk 
ones (Table 8).  
Concerning the types of actors that participated in this dimension of the debate, some findings 
can be described by reading Table 11 horizontally. A distinct characteristic of the Brazilian debate is 
that environmental and health issues were mostly brought to debate by political actors both in terms of 
biosafety and biorisk. In Argentina, political actors are the most active to frame GMO as risk. In all 
countries, there is an absolute contrasting participation of market actors and social movements in this 
dimension of the debate: just as market actors only frame GMOs as safe and in all countries (with a 
minor exception in Mexico), social movements only frame it as risky. It was in this dimension that 
scientists engaged the most in the debate about agrobiotechnololgy in Argentina (91% of all claims 
from scientists) and Mexico (51%), and almost so in Brazil (45% of their claims pertained to the 
economic dimension and 44% to the health and environmental one). Media actors had a high 
participation in the Argentinean debate (32% of all claims in this dimension), but also in the other 
countries they expressed their views regarding the effects of GMOs to health and environment (23% 
and 16% of the debate in Brazil and Mexico, respectively). 
 
TABLE 11 
POLITICAL CLAIMS ABOUT THE HEALTH AND ENVIRONMENTAL DIMENSION OF 
AGROBIOTECHNOLOGY PER TYPE OF ACTORS PER COUNTRY 
Number of claims and percentages (in parenthesis) 
 Argentina  Brazil  Mexico 
 Biosafety (Bio)risk Biosafety (Bio)risk Biosafety (Bio)risk 
Political actors 1     (5) 21   (36) 21  (60) 15   (47) 18   (50) 8    (10) 
Market actors 14   (67) 0     (0) 10  (28) 0     (0) 13   (36) 4      (5) 
Social movt. 0     (0) 14   (24) 0    (0) 5   (15) 0    (0) 39   (47) 
Scientists 2     (9) 15   (26) 2    (6) 6   (19) 4  (11) 21   (25) 
Media actors 4   (19) 8   (14) 2    (6) 6   (19) 1    (3) 11   (13) 
Total 21 (100) 58 (100) 35 (100) 32 (100) 36 (100) 83 (100) 
Source: Own elaboration. 
 
1. Biosafety  
Biosafety arguments have a similar participation in all countries, accounting for 17, 18 and 15% of all 
claims in the Argentinean, Brazilian and Mexicam debates, respectively (Table 8). In Brazil and 
Mexico, political actors were the main actors to assure the safety of GMOs (60% and 50%) and 
market actors followed. In Argentina, market actors were the first to defend such arguments (67%). In 
no country did social movement frame GMOs as safe. Scientists have also a saying in all three 
countries about the biosafety of GMOs (10, 6 and 11%), but decided rather to enter the debate by 
framing GMOs as a risk issue. Just as they did with benefit frames, media actors are especially active 
in assuring the safety of the technology in Argentina (19% or the second most active type of actor 
doing so), whereas in the other countries, they preferred to frame GMOs as risks (only 6% in Brazil 
and 3% of in Mexico of biosafety claims were supported by media actors).  
The spectrum from biosafety claims starts from contesting claims that GMOs pose risks be by 
denying their validity or by giving assurances of safety, including the claim that existing rules are 
sufficient to control the recognized risks and unfolds into proposals for de-regulation. At the other 
extreme of the spectrum is the transformation from (bio)risks to (bio) benefits, that is, instead of 
talking about negative effects of GMOs to health and environment, proponents speak of their 
benefitial impacts. Accordingly, examples of claims coded as adopting a “critique frame” are 
described below along four clusters: a) “denying risks and assuring safety”; b) “risks under control”; 
c) “if they are safe, why regulate?” and d) “converting damage into benefits”.  
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a) Denying risks and assuring safety 
There are generic assurances of safety from GMOs as well as arguments contesting claims about 
specific risks. Examples of generic include approvals of products in each country and also claims that 
GMOs have been approved in other countries. In all countries the authorities responsible for 
approving GMOs usually manifest themselves publicly for the safety of the products under their 
scrutiny. Bellow, an example from Brazil: 
The National Technical Commission on Biosafety (CTNBio) approved yesterday by 15 votes to 
5, a favourable opinion to the commercial release of the fourth variety of genetically modified cotton 
in the country. (...) The CTNBio members resolved that the transgenic cotton does not present 
potential risks to human beings or to environment48 (Valor Econômico, 2009c).  
Besides those generic claims, arguments about the safety of GMOs vary in each country 
according to what is claimed to be the risks involved. While the issue of pesticide is more urgent in 
Argentina and Brazil, which have long time exposure to the technological package, in Mexico it is the 
threat to biodiversity due to the transfer of genetic material that is primarily addressed in the claims 
assuring the safety of GMOs. But also in Brazil the flux of genetic material from GM seeds to 
conventional varities is object of disputes between advocates of safety and risk claims. 
Contamination or flux of genetic material  
In Mexico, proponents of biotechnology assure that the cultivation of GM crops will not take place 
where native corn is to be found and that this will not be threatened. These can be seen in the 
quotation from Monsanto bellow:  
GM corn will never occupy the place of native corn nor its food richness. Monsanto's commitmment 
is not to sow genetically modified varities in the regions of origin of the grain49 (Perez, 2010).  
Biotechnological firms, usually represented by Agrobio Mexico, avoid the word 
“contamination” and frame the relationship between GM and non-GM crops in a positive way as 
“coexistence”. While they quote Brazil as an experience that attests that coexistence is possible, the 
same is disputed in that country. Thus, actors in the Brazilian debate, in particular, the political 
authorities responsible for GMOs authorizations (such as the presidents of CTNBio, Walter Colli first 
and then Edilson Paiva, and its executive-secretary) contested the scientific basis of claims that 
existent rules for coexistence were inneficient.50 The main elements of such argumentation were: the 
denial of the risk of contamination —using the language of probabilities— , the denial of the scientific 
basis or evidences of claims that contamination did take place, and assurances that existent rules are 
sufficient to manage the (negligible) risk.  
The president of CTNBio, Walter Colli, said yesterday that there is no evidence yet of the 
contamination of conventional maize by pollen from transgenic plants. In an interview to Folha, he 
maintained that the mininum distance of 100 meters between GM and non-GM crops is sufficient to 
ensure the coexistence among crops. "The risk of contamination is lower than 0.9%", affirmed Colli51 
(Folha de São Paulo, 2009c). 
                                                       
48  In the original: "A Comissão Técnica Nacional de Biossegurança (CTNBio) aprovou ontem, por 15 votos contra 
cinco, um parecer favorável à liberação comercial da quarta variedade de algodão geneticamente modificado no 
país. (...) Os membros da CTNBio entenderam que o algodão transgênico não apresenta potenciais riscos para os 
seres humanos ou o meio ambiente". 
49  In the original: "Los maíces transgénicos nunca ocuparán el lugar de los criollos ni su riqueza alimenticia. El 
compromiso de Monsanto es no sembrar las variedades genéticamente modificadas en zonas de origen del grano".  
50  Only one market actor make claims assuring that the existent rules are sufficient, the biotech firm Monsanto (Folha 
de São Paulo, 2009c). Other types of market actors, in particular producers and the food industry, put into question 
such affirmations, as will be seen bellow in the description of risk claims. They have more to lose if the rules prove 
to be inefficient.  
51  In the original: "O presidente da CTNBio, Walter Colli, disse ontem que não existem ainda evidências sobre a 
contaminação de milho convencional por pólen de plantas transgênicas. Em entrevista à Folha, ele sustentou que o 
 




In Argentina, the main claims about biosafety related to glyphosate used in association with 
genetically modified seeds. They were a reaction to the events in April 2009, when social movements, 
and some local authorities started expressing concerns about negative effects of the GM-technological 
package into health and environment. Producers interest-groups such as the Chamber of Fertilizers 
and Agrichemicals Industry (Ciafa - Cámara dela Industria de Fertilizantes y Agroquímicos), Chamber 
of Agricultural Health and Fertilizers (Casafe - Camara de Sanidad Agropecuaria y Fertilizantes) and 
Soybean Chain Chamber (Acsoja - Asociación de la Cadena de la Soja), where the most active in 
defending the safety of glyphosate: 
On April 16th this Chamber (Ciafa) and the Chamber of Agricultural Health and Fertilizers 
(Casafe) stated in a joint declaration that according to Senasa [National Animal Health and Agrifood 
Quality Service], the active ingredient glyphosate in its normal use is classified in the group of actives 
with lower toxicological risk and it is successfully used in the whole world. Approved by the bodies of 
environmental protection in the United States and Europe, it is marked in more than 140 countries. 
They add that it has no negative effects on fauna, micro-fauna and human health, nor does it have 
unacceptable effects to environment52 (Verbitsky, 2009).  
In this conflictual debate about the toxicity of glyphosate, by risk claims by challenging or 
denying their scientific basis was a common strategy used by proponents of GMOs such as the media 
framing adopted by La Nación and the quotation from Acsoja bellow:  
An study of alledged scientific validity that alerted of the damage to health that the herbicide 
glyphosate would cause and which was attributed to the The National Scientific and Technical 
Research Council (Conicet) is not registred in this center of investigation. (...) By its turn, the 
Association of Soybean Chain (Acsoja) expressed its concern about the recent decision from the 
Ministery of Defense to prohibit the cultivation of transgenic soy in the lands owened by the military 
services that are situated in the proximities of urban areas. The organization, which unites 
institutions, producers and firms constituting the soybean chain, expressed its especial uneasiness 
about "the declarations that, without support, state that the cultivation of transgenic soy and the 
technological package that accompanies it produce negative effects to environment and human 
health.53 (La Nación, 2009b, emphasis added). 
In Brazil, the toxicity of glyphosate came under debate when GM corn resistant to it was 
adopted. When Valor Econômico covered the increase in the MLR of glyphosate for corn, it was 
framed rather as an undesired action, as involving higher ingestion of pesticides. Nevertheless, Valor 
Econômico resorted to the science-based authority of international organizations as national 
governmental bodies in order to assure that such an increase does not pose damage to health. The 
scientific dimension of a biosafety claim becomes clear: in a reference to a damage (consumers’ 
health) that would intuitively raise concerns (the increased ingestion of pesticides), media framing 
                                                                                                                                                                     
espaçamento mínimo de cem metros entre lavouras de milho OGM e não OGM é suficiente para assegurar a 
coexistência das lavouras. "O risco de contaminação é menor do que 0,9%", afirmou Colli". 
52  In the original: "El 16 de abril esa cámara (Ciafa) y la de Sanidad Agropecuaria y Fertilizantes (Casafe) dijeron en 
una declaración conjunta que para el Senasa el principio activo glifosato en su uso normal está dentro del grupo de 
activos de menor riesgo toxicológico y se lo utiliza con éxito en todo el mundo. Aprobado por los organismos de 
protección ambiental de Estados Unidos y Europa, se comercializa en más de 140 países. Agregan que no presenta 
efectos nocivos sobre la fauna, la microfauna ni la salud humana, ni tiene efectos inaceptables para el ambiente”. 
53  In the original: "Un estudio de supuesta validez científica que alertaba sobre los perjuicios a la salud que causaría el 
herbicida glifosato y que se atribuía al Consejo de Investigaciones Científicas y Técnicas (Conicet) no está 
registrado en ese centro de investigación. (...) Por su parte, la Asociación de la Cadena de la Soja (Acsoja) expresó 
su preocupación por la reciente decisión del Ministerio de Defensa de prohibir la siembra de soja transgénica en las 
tierras pertenecientes a los cuarteles militares que estuvieran próximas a las zonas urbanas. La entidad, que reúne a 
instituciones, productores y empresas que componen la cadena de la soja, señaló su especial inquietud por "las 
declaraciones que, sin sustento, manifiestan que el cultivo de soja transgénica y el paquete tecnológico que la 
acompa.ña produce efectos nocivos para el ambiente y la salud humana". 
ECLAC – Production Development Series No. 193  The public debate about agrobiotechnology in Latin American countries …    
41 
 
resorts to scientific knowledge (toxicological studies) and scientific-base political authorities, national 
(Anvisa) and international (from Codex Alimentarius, UN).  
The alteration in the maximum residue level [MRL] for corn affected the Accepted Daily Intake 
(ADI), a reference to the maximum that a person can consume. This global limit is set today in 0.042 
mg/kg in Brazil. With the change in corn, the total ADI came close to 35% allowed by law. Thus, there 
would still be the margin of 65 percentual points to raise the MRLs. The Codex Alimentarius, linked to 
the United Nations, established the MRL for corn in 0.3 mg/kg, for instance54 (Zanatta, 2010a).  
b) Risks under control  
In some cases, approving a GM product is not a once and for all decision. Rather, there are risk 
management measures to be applied. Biosafety claims are found in such a context where, in face of 
denounces of risk, there is a recognition of a probability of damage, but assurances that the rules in 
force are sufficient to guarantee safety, control and responsibility. This applied particularly to the 
issue of coexistence between GM and non-GM corn (risk of contamination), and also to the issue of 
MRL of glyphosate (risk to consumer’s and workers’ health) in Brazil, as show in the quotes in the 
section above. Also in Argentina, some actors recognize that glyphosate is toxic, but assure that it can 
be used safely if the risk management measures are applied: 
Daniel Dechanzi, agronomist from the agriculture cooperative La Ganadera, a firm which uses 
agrochemicals and also has experience in the application of such products, acknowledged that they 
are "lightly toxic" and clarified that "if the corresponded precaution is taken, they are not dangerous 
for human beings"55 (Waigandt, 2010).  
In Mexico, the established consensus on the importance of protecting native corn puts special 
pressure on assurances of control in the enforcement of risk management measures to experiment with 
GM corn. A scientist guarantees that these are sufficient to avoid any risk:  
Regarding the situation in Mexico, Francisco Zavala García, subdirector of Research and 
Graduate School of Agronomy of the Universidad Autónoma de Nuevo León, commented that the 
institution was assigned to evaluate the projects for experimental cultivation of corn taking place in 
the country. He said that the crops fulfil a series of requirements and monitoring mechanisms to 
ensure safety and avoid any risk56 (Martinez, A. 2010).  
The political authorities in Mexico are the most keen to reaffirm the belief in the efficiency of 
regulatory framework to control any risks:  
Interviewed in the context of the presentation of the Mexican Network of Genetically Modified 
Organisms, the chief of Sagarpa assured that in this way it is under legal conditions to start the 
experimental cultivation, since we can identify both benefits and risks of the authorization of GMOs in 
what regards its release in field and environment. He explained that monitoring will fall under the 
responsibility of the Secretary of Agriculture, whereas the issue of biological diversity will be for 
Senamart and sanitary and epidemological surveillance will be treated by the Secretary of Health. (...) 
                                                       
54  In the original: "A alteração no limite de resíduo do milho impactou o índice de Ingestão Diária Aceitável (IDA), 
uma referência para o máximo que uma pessoa pode consumir. Esse limite global está fixado hoje em 0,042 mg/kg 
no Brasil. Com a mudança no milho, o IDA total chegou próximo de 35% do permitido pela legislação. Assim, 
ainda haveria esse espaço de 65 pontos percentuais para elevar os LMRs. O Codex Alimentarius, ligado às Nações 
Unidas, fixa o LMR do milho em 0,3 mg/kg, por exemplo". 
55  In the original: "El ingeniero agrónomo Daniel Dechanzi, de la cooperativa agrícola La Ganadera, una empresa 
expendedora de agroquímicos y también con experiencia en la aplicación de estos productos, reconoció que son 
“levemente tóxicos” y aclaró que “si se toman las precauciones correspondientes no son peligrosos para el ser humano”".  
56  In the original: "En  cuanto a la situación en México, Francisco Zavala García, subdirector de Investigación y Posgrado de 
la Facultad de Agronomía de la Universidad Autónoma de Nuevo León, comentó que a esta institución le tocó evaluar los 
proyectos de investigación que se realizan en el país para obtener maíz transgénico. Expuso que los cultivos cumplen con 
una serie de requisitos y mecanismos de vigilancia que garantizan su seguridad y evitan cualquier riesgo". 
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We will have more institutions to help us to evaluate how the crops are going and, if any symptom 
appears to affect us, we will immediately react, explained the federal official57 (M rtinez, 2009b).  
c) Risk and trust: if GMOs are safe, why regulate? 
Some actors defend that there is a logical implication of acknowledging that GM crops are safe (or 
that their risks are under control): that there is no need to regulate them. Many claims about biosafety 
include demands for de-regulation. The credibility of such demands rests on the authority of bodies 
responsible for the risk assessment and a fundamental plee is for trust in the conduction of their duties. 
Claims clustering around risk and trust are more frequent in the Brazilian sample. The high 
participation of political actors in the Brazilian debate is mostly explained by the active role played by 
the President of CTNBio. He makes constant assurances of the safety of GMOs, guaranteed by the 
scientific authority of the CTNBio, especially in the context of polemics about pre-marketing approval 
and post-market monitoring procedures and labeling. He recurrently asks for trust in the institutions 
responsible for approving GMOs.  
According to Colli, when the commission authorizes the marketing of a certain genetically 
modified organism, it has already ruled out its risks for consumption as well as to the environment. 
That is why he considers monitoring unnecessary, except in few cases where monitoring would be 
restrict to environmental impacts. "What is the reason for demanding such a thing if we know that it 
does no harm? Is it to know if a soy product causes stomach pain? If [GMOs] did harm, the 
Americans would already have died", he argued58 (Salomon, 2009).  
So confident are some Members of CTNBio in their claim to be trusted in their biosafety 
assessment of GMOs,59 that they advance proposals of deregulation, lifting the need to monitoring the 
effects of the adoption of agrobiotechnology (Zanatta, 2009a). The main benefited sectors are biotech 
firms and the food industry; they are disobliged of many responsibilities. The proponents of such 
deregulation advance different groudings for their proposals. One reason is the assurance of safety 
based in the confidence of the risk assessment. A connected reason is that risk assessment would have 
proven the “substantial equivalence” of GMOs and non-GM seeds, a well known argument used by 
proponents of the technology. The logic of argumentation is: if proven to be safe (by a trustworthy and 
competent scientific authority) or proven to be equal, then, there is no need to question such 
evaluation. Monitoring would be unnecessary since the evaluation of risk will not be proven wrong. 
The president of CTNBio, the biochemical doctor Walter Colli, confirms the proposal to alter 
the rule. "This things do no harm. And, if they do, nobody will know because there is no way to 
monitor everybody. The juridical argument that imposes itself is that monitoring is only justified if 
there were doubts about the risk assessment. If the product is identic to the conventional, there is no 
reason to monitor", he says. "We are suggesting leaving it as non-compulsory. The commission will 
tell in which cases it will be necessary. (...). It is absurd to monitor effects on humnas because 15 
                                                       
57  In the original: "Entrevistado en el marco de la presentación de la Red Mexicana de los Organismos Genéticamente 
Modificados, el titular de la Sagarpa aseguró que de esta manera están en condiciones legales para iniciar las 
siembras experimentales, ya que podremos determinar tanto beneficios como riesgos en la liberación de los 
transgénicos en el contexto de su repercusión en el campo y medio ambiente. Explicó que el monitoreo que se 
realizará recaerá en la responsabilidad de la Secretaría de Agricultura, mientras que el tema de la diversidad 
biológica será para la Semarnat y la vigilancia epidemiológica y sanitaria en la Secretaría de Salud. (…) tendremos 
más instituciones que nos ayudarán a revisar cómo van los cultivos y si alguno de ellos presenta síntomas que 
afecten, actuaremos de manera inmediata, detalló el funcionario federal". 
58 In the original: "Segundo Colli, quando a comissão libera a comercialização de determinado organismo geneticamente 
modificado, já afastou riscos ao seu consumo, assim como ao ambiente. Por isso, considera o monitoramento 
desnecessário, com exceção de poucos casos em que o monitoramento esteja restrito a impactos ao ambiente. "Qual é a 
razão de pedir uma coisa dessas se a gente sabe que não faz mal?  Para saber se um produto que usa soja está causando 
dor de barriga? Se [os transgênicos] fizessem mal, os americanos já tinham morrido", argumentou". 
59  When CTNBio approved monitoring rules for alerting about adverse effects in animals fed with GM corn, Walter Colli, 
President of CTNBio, assured: "I am sure that nothing will happen" (quoted in Zanatta, 2009b).  
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thousand products have soy derivatives in their composition. How can we know if the problem lies in 
the product or in the water that the person drank?", he questions (Zanatta, 2009a).60 
The question that follows is, if it is not feasible, why was this risk management rule proposed 
and adopted in the first place? Again, it is the President of CTNBio who, in the same article, advances 
an explanation. He implies that there was a conflict, in which they had to make a compromise and 
establish post-marketing monitoring rules. The reason for the rules was political, but he considers the 
rules to be an error. Thus, this error should be repaired, according to him. The issue of responsibity is 
brought to the core of the debate. The juridical dimension of the debate is alredy pinpointed in the 
quote above: “monitoring is only justified if there is doubt in the risk analyses”. Based on that 
“juridical argument”, CTNBio Members not only propose to discharge industry from accountability 
for post-marketing monitoring, but also to free CTNBio from the responsibility of revising its 
decisions if adverse effects of GMOs do appear (Zanatta, 2009c).  
At the last meeting under his command, the former president Walter Colli launched the idea of 
suppressing the obligation of post-marketing monitoring. He also preached removing the 
requirements about the objective of the monitoring plan, what would relieve the commission to 
reevaluate its decisions in the event of adverse effects to environment or to human and animal health. 
Colli sugggested to alter the terms "risk" and "risk evaluation", eliminating them from the text. "This 
would make the norm vague and imprecise", he affirmed, in a note to the vice-State Attorney, Sandra 
Cureau. Colli's proposal would also exonarate CTNBio from the obligation to manifest itself about 
biosafety aspects and eventual questions received after the public hearings promoted by the body61 
(Zanatta, 2010d).   
The proposal from the President of CTNBio of taking out the wording “risk” and “risk 
analysis” from the regulation of GMOs is exemplary of a crucial framing strategy of the proponents of 
biotechnology: to dissociate GMOs from the word risk. In the next section, this is made by shifting 
from the risk/safety dichotomy in what regards effects to health and environment and, instead, to 
frame such effects as “benefits”. 
d) Converting damage into benefits  
Claims that GMOs are beneficial to health and environment include the arguments that biotechnology 
minimizes damage caused by pesticide use and that they bring nutritional advantages. In Argentina, 
besides assuring its overall safety, actors argue that glyphosate replaced other much more toxic 
pesticides, representing a benefit to the environment, as in the quotation bellow from La Nación: 
An eventual ban on the use of glyphosate would have serious consequences to the system of 
agricultural production in Argentina, compromising the process of soil conservation that has initiated 
with the adoption of no-till farming, increasing deeply the costs and forcing, in some cases, to revive 
some pesticides with high toxic levels that had been long abandoned. (...) Gustavo Duarte, consultant, 
                                                       
60  In the original: "O presidente da CTNBio, o médico bioquímico Walter Colli, confirma a proposta de alteração na 
regra. "Essas coisas não fazem mal. E, se fizerem, ninguém vai saber porque não tem como monitorar todo mundo. 
O argumento jurídico que se coloca é que monitorar só se justificaria se houvesse dúvida na análise de risco. Se o 
produto é idêntico ao convencional, não há razão para monitorar", diz. "Estamos propondo deixar isso como não 
obrigatória. A comissão dirá em quais casos seria necessário. (…) É um absurdo fazer monitoramento de efeitos em 
humanos porque 15 mil produtos têm derivados de soja na sua composição. Como saber se o problema é do 
produto ou da água que uma pessoa bebeu?", questiona". 
61  In the original: "Na última reunião sob seu comando, o ex-presidente Walter Colli lançou a ideia de suprimir a 
obrigatoriedade do monitoramento pós-liberação comercial. Também pregou retirar exigências sobre o objetivo do 
plano de monitoramento, o que desobrigaria o colegiado de reavaliar suas decisões em caso de efeitos adversos 
sobre o ambiente ou sobre as saúdes humana e animal. Colli propôs alterar os conceitos de "risco" e de "avaliação 
de risco", eliminando-a do texto. "Isso deixaria a norma vaga e imprecisa", afirmou, em nota, a subprocuradora-
geral da República, Sandra Cureau. A proposta de Colli também retiraria da CTNBio a obrigatoriedade de 
manifestar-se sobre aspectos de biossegurança e eventuais questionamentos recebidos depois de audiências 
públicas promovidas pelo colegiado". 
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added another point of view. To this expert, agriculture without glyphosta would impact a higher load 
of agrochemicals less environmental-friendly62 (Bertello, 2010).  
There are similar claims in the Brazilian debate about the benefits of GMOs to health and to 
environment. Bayer claims the benefits to the enviroment of its product Liberty Link rice, as reducing 
residues and being degradable and Céleres, an agribusiness consultant firm affirm that GM seeds with 
insecticide properties are safer to the environment and to workers’ health as it replaces pesticides (Bueno, 
2009a). Monsanto goes a step further, promising the reduction in the use of natural resources and to bring 
benefits to human health launching new products such as soy with omega 3 or with better quality oil: 
Dalmazo says that the new biotechnological wave is about to arrive, with launchings of 
soybean with omega 3, which decreases cardiovascular problems, and the soybean with higher quality 
oil, which reduces the level of trans fat63 (Zafalon, 2009b).  
In sum, more than shifting the wording from “risk assessment” to “biosafety assessment” in 
order to emphasize assurances of safety and disconnect GMOs from the word “risk” and its negative 
connotation, the framing strategy of proponents of biotechnology include advancing claims that it is 
beneficial to health and environment.  
2. (Bio) risk  
Framing GMOs as a risk to health and environment was the preferred discursive strategy from actors 
in the Argentinean sampled material, accounting for almost 50% of the claims coded. In Mexico, such 
frame was chosen in about a third of all claims and in Brazil the percentage of biorisk frames is less 
significative, 16% of all claims (Table 8).  
(Bio) risk is the prefered framing for political actors making claims about GMOs in the 
Argentinean and Brasilian materials (36 and 47%, respectively). In México only one tenth of these 
claims are made by political actors. Market actors practically do not frame GMOs as (bio) risk. On the 
other hand, this framing represent the majority of the claims from social movements in Argentina 
(24%), almost half of their claims in México (47%) and about a sixth in the Brazilian debate (16%). In 
what regards the framing from scientists, (bio) risk is an important meaning given to GMOs in all 
countries, but more so in Argentina (26%), followed by México (25%), and Brazil (19%).  Media 
actors also adopt (bio) risk frames when covering GMOs, especially in Brasil (19%), followed by 
Argentina (14%) and Mexico (13%).  
Examples of claims emphasizing (bio) risk when referring to GMOs will be described bellow in 
the following order: (a) knowledge about risks; (b) what are the risks?; (c) risks out of control!; 
(d) risk and responsibility.  
a) Knowledge about risks  
Political claims focusing on the knowledge about risks are presented bellow as part of a continuum64 hat 
starts with the affirmation that there is no knowledge to assure the absence of risks and ends with claims 
that there is enough knowledge confirming the existence of risks associated with GMOs. In between 
these poles from unknown and known risks, there are arguments that emphasize the importance of the 
willingness to know risks and/or blaiming others for the lack of it. There is the claim that the inexistence 
                                                       
62  In the original: "Una posible prohibición del uso del glifosato podría generar consecuencias graves para el sistema 
de producción agrícola de la Argentina, comprometer el proceso de conservación de los suelos que se inició con el 
uso de la siembra directa, aumentar fuertemente los costos y obligar a resucitar en algunos casos herbicidas de un 
elevado nivel de toxicidad que ya fueron dejados de lado hace tiempo. (…) Gustavo Duarte, consultor, agregó otra 
mirada. Para este especialista, la agricultura sin glifosato implicaría "una mayor carga de agroquímicos menos 
amigables con el ambiente". 
63  In the original: "Dalmazzo diz que está chegando também a segunda onda de biotecnologia, com os lançamentos da 
soja com ômega 3, que diminui problemas cardiovasculares, e a soja com óleo de melhor qualidade, que vai 
diminuir o teor de gordura trans". 
64  This continuum is inspired in the typology of the not-knowledge from Ulrich Beck (2007). 
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of risks is yet to be proven – in contrasting disagreement to carriers of frames of “biosafety”. Regarding 
the adoption of GMOs in Mexico, the president from the social movement organization Red Fronteriza 
de Salud y Ambiente, Francisca Duarte Ahumada, affirms that: 
(...) the cultivation of transgenic maize presents risks and there is no sufficient information 
about the effects from such products (...). Duarte Almada said "at the global level, there are not 
enough studies yet to to assure us that genetically modified organisms do not have negative impacts 
on human and animal health. "We oppose ourselves to this type of decisions, because it is not 
sufficiently demonstrated that any organism that has been modified in its genetic composition does not 
pose risk to human health", insisted the spokesperson (El Universal, 2009).65  
Another type of claim is based on the insatisfaction of such statements that there is not 
sufficient knowledge about adverse effects of GMOs. It includes criticisms that the lack of knowledge 
is explained by the fact that there is no will to know and the right questions have not been posed or 
demanded. For example, in a press conference to announce the results of a study about the 
contamination of native corn by GM corn, one of the authors, Antonio Serratos, stated that the 
petitions for experimental cultivation of GM corn under governmental evaluation in Mexico were 
nothing more than a burocratic procedure, since the necessary investigations were not made (Enciso, 
2009b). Similar claims are also found in the Brazilian debate. Not only are transnationals blamed for 
not wanting to know or hiding their knowledge about adverse effects of GMOs on health and 
environment; actors also blame, directly and indirectly, the authorities for not requiring such data 
before reaching decisions. In the following quotation, members from CTNBio - dissident voices - 
denounce that two varieties of GM soy were approved without its petitioners having submitted the 
legally established data.  
(...) three members of the commission pointed to the absence of basic tests for the market 
release of transgenic products. "They were released without the studies established by law. We are the 
edge of legality, affirmed one of the rapporteurs from the petition from Bayer, the agronomist 
Leonardo Melgarejo. "I have the impression that the State Attorney should manifest himself". 
According to Melgarejo, the obligatory studies that were not submitted included scientific tests with 
pregnant animals considered susceptible to the product, in addition to long-term data on up to two 
generations, sufficient to rule out hypotheses about cronic intoxication caused by the new seed. 
"Bayer did not present such data", affirmed Melgarejo, representative from the Ministry for 
Agricultural Development in the CTNBio66 (Zanatta, 2010e).  
Assuming that knowledge is conditioned on the will to know, some actors advance the claim that 
risks will be found if they are look for. In a statement related to the confirmation of contamination of 
native corn species with GM corn, a scientist resorts to the principle that negative results should not be 
taken at face value. In other words, he implies that there is a scientific obligation to search knowledge 
and not be satisfied with provisionary results. In a similar fashion to the quotation above, in the 
Argentina sample there are examples of claims about not only the will to know about the adverse effects 
of pesticide use in combination of GMOs, but the duty to do so. Some claims adopt an adversarial 
                                                       
65  In the original: "el cultivo de maíz transgénico implica riesgos y no se cuenta con información suficiente sobre los 
efectos de esos productos. (...) Duarte Ahumada dijo que "a nivel mundial no hay los suficientes estudios todavía 
que nos digan que los organismos genéticamente modificados (OGM) no provocan un impacto nocivo en la salud 
de los seres humanos y de los animales. "Nos oponemos a ese tipo de decisiones, pues no está lo suficientemente 
demostrado que cualquier organismo que ha sido modificado en su composición genética no provoca un riesgo a la 
salud de las personas", insistió la dirigente". 
66  In the original: "três membros da comissão apontaram a ausência de testes básicos para a liberação comercial dos 
produtos transgênicos. "Eles foram liberados sem os estudos previstos nas normas. Estamos no limite da legalidade", 
afirmou um dos relatores do processo da Bayer, o agrônomo Leonardo Melgarejo. "Tenho impressão de que o 
Ministério Público deve se manifestar". Os estudos obrigatórios não apresentados, segundo Melgarejo, foram testes 
científicos com animais prenhes, considerados mais suscetíveis ao produto, além de dados de longo prazo, de até duas 
gerações, capazes de descartar hipóteses de intoxicações crônicas pela nova semente. "A Bayer não apresentou esses 
dados", afirmou Melgarejo, representante do Ministério do Desenvolvimento Agrário na CTNBio". 
ECLAC – Production Development Series No. 193  The public debate about agrobiotechnology in Latin American countries …    
46 
 
character and refers to the existence of a controversy. Besides showing willingness to know risks, the 
claim-maker is concerned with contesting those who state that there are no proofs of adverse effects of 
pesticides in Argentina. The chief of the Laboratorio de Embriología Molecular from Universidad 
Nacional del Nordeste (UNNE), Raúl Horacio Lucero, does not justify his knowledge about risks 
associated with pesticide use using probabilitic calculations made from extrapolations of laboratory 
studies. Rather, he collects evidence from people directly affected over the years. He: 
(...) detailed clinical histories of malfromed childen who began arriving at his office in 1993. 
He exhibited x-rays from babys without toes, girls with arms without articulations, data on stillbirths, 
spontaneous abortions. "All came from areas with massive use of agrochemicals. All. I have their 
names, and I know their suffering. How can anyone tell me that 'there are no proofs'? Let them bring 
their pregnant wives and daughters and they will see the irrefutable proofs", he challenged. Lucero's 
statistical data show a direct relationship between the increase in use of agrochemicals in Chaco and 
cases of malformations, always in areas with masive use of herbicides and pesticides. In all cases he 
analysed the parents' genetics and confirmed that cromosomes represented no problems. "We knew 
that agrochemicals affected genes, but we had no means of conducting studies. This is what Andrés 
Carrasco (UBA-Conicet) has just confirmed. Unfortunately time has proved us right, time bomb 
exploded, there are thousands of affected and to deny it is a crime", he said67 (Aranda, 2009a).  
Similarly, some claim-makers in Mexico emphasize that time has been enough, if not to collect 
evidence of concrete damage like in Argentina, at least to compile scientific information that confirms 
the risks of GMOs. Here, in the other end of the spectrum, the claims contrast those that refer to 
uncertainty and lack of knowledge to point out this opposite: that there is enough knowledge that 
demonstrates the existence of risks and no new studies are needed. So is the statement made by Elena 
Álvarez-Buylla, researcher at the Instituto de Ecología from the Universidad Nacional Autónoma de 
México (UNAM):  
"(...) there is sufficient scientific evidence to demonstrate that GMOs pose risks to biodiversity 
of the planet and to human health". Regarding the experimental cultivation of transgenic corn in the 
fields in the North of the country, she emphasized that not only was it an "obsolete research, because 
results of similar experiments are already know, which motivated the application of a moratoria on 
the cultivation; but also there aren't any scientific questions than can generate new knowledge. On the 
contrary, it favous the lack of transparency, and there are no control over scientists with conflict of 
interests"68 (Solano, 2010).  
While these examples of risk frames emphasize the knowledge base of claim-making regarding 
damage to health and environment attributed to GMOs, the next cluster of claims gravitates around the 
damage itself. They are intimately related, this classification is rather a matter of difference in 
emphasis: the first cluster regards the possibility of answering to the question “are there risks?” and 
                                                       
67  In the original: "detalló historias clínicas de niños malformados que comenzaron a llegar a su consultorio en 1993. 
Exhibió radiografias de bebés sin dedos, chicas con brazos sin articulación, datos de fetos muertos, abortos 
espontáneos. “Todos provenían de parajes con uso masivo de agroquímicos. Todos. Tengo sus nombres, conozco 
su sufrimiento. ¿Cómo me pueden decir que ‘no hay pruebas’? Que traigan a sus esposas o hijas embarazadas y 
verán las pruebas irrefutables”, desafió. Las estadísticas de Lucero muestran una directa relación entre el aumento 
de uso de agroquímicos en Chaco y casos de malformaciones, siempre en zonas con uso masivo de herbicidas y 
plaguicidas. En todos analizó la genética de los padres y confirmó que los cromosomas no presentaban problemas. 
“Sabíamos que los agroquímicos afectaban los genes, pero no teníamos la forma de realizar los estudios. Eso es lo 
que acaba de confirmar Andrés Carrasco (UBA-Conicet). Lamentablemente el tiempo nos dio la razón, la bomba 
de tiempo estalló, los afectados son miles y negarlo es criminal”, afirmó".  
68  In the original: "(...) existen suficientes pruebas científicas para demostrar que los transgénicos son un riesgo para 
la biodiversidad del planeta y para la salud humana”. En cuanto a la siembra experimental de maíz transgénico en 
campos de cultivo en el norte del país, enfatizó que no sólo se trata de una investigación “obsoleta, porque ya se 
conocen los resultados de experimentos similares, lo que generó la aplicación de una moratoria en su cultivo. 
Tampoco ahora hay preguntas científicas que puedan arrojar nuevo conocimiento; por el contrario, se favorece la 
falta de transparencia, y no existe monitoreo de científicos que no tengan conflicto de intereses”.  
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the second answers the question “what are the risks?”. It is not possible to fully separate one from 
another; however, this analytical exercise is justified in order to shed light to the strong scientific 
anchorage of the debate about agrobiotechnology.  
b) What are the risks?  
The three main types of risks identified by the actors in the sampled material are the risk of transfer of 
genetic material from the GMOs to non-GM seeds (mostly quoted as "contamination"), the risks to human 
health of consuming GMOs and the risk of the technological package leading not to less – as argued by 
proponents of biotechnology using “biosafety frames”-, but to more use of pesticides. Considering the 
expression “farm-to-fork” or “farm-to-table”, used in the field of food safety, usually the risks identified by 
the actors in the debate refer to the beginning of the food chain, namely, the farming of GMOs.  
Contamination or flux of genetic material  
In the sampled material, actors associate the risk of transfer of genetic material from GM crops to non-
GM species with two related concerns: a threat to native species (to biodiversity) and a threat to 
coexistence with non-GM crops. The former is more found in the Mexican sample, whereas the latter 
is typical of the Brazilian sample. But it is in Mexico where warnings about the threat that GMOs 
constitute to biodiversity abound. In contrast to Brazilian claims, actors in the Mexican debate adopt a 
nationalist tune and wording that highlight its particularity as the center of origin of biodiversity from 
corn. When the social movement campaign “Sin maíz no hay país” handed a petition to the director 
from Servicio Nacional de Sanidad, Inocuidad y Calidad Agroalimentaria (Senasica) against the 
adoption of biotechnology, they framed it as handing over a valuable national resource: 
They recalled that scientists, researchers and academics who participated in the campaign 
send their comments supported with technical and scientific information, with which they demanded 
the rejection of experimental cultivation with transgenic maize in face of the high risk of genetic flux 
from transgenic to creolle corn. (...)  "If you allow the cultivation of transgenic corn in Mexico, you 
will give step with no turning back, and you will be  responsible for giving away the key natural 
resource of the nation, and for puttin in risk the biodiversity of Mexican maize"69 (Perez, 2009c).  
Thus, GMOs are framed as an external and foreign threat to the “original” and “criollo” grains.  
When newspapers report studies confirming that contamination occurred, the fears are intensified and 
the confirmation of damage is used as evidence on which to base risk claims. In other words, the fact 
that genetic material has contaminated non-GM seeds reinforces the claim that GMOs pose a risk to 
biodiversity and, as a consequence, that coexistence between GM-crops and non-GM crops is not 
feasible, at least in Mexico. For instance, during the forum “Las voces campesinas frente a los 
transgénicos”, the Director of Greenpeace Mexico, Patricia Arendar stated that, for being center of 
origin, "in this country there cannot be coexistence". But not only in the center of origin does the 
coexistence with GMOs pose a problem. Many actors in the Brazilian debate claim that the risk of 
contamination threatens the coexistence between GM corn and non-GM corn. In a long series of news 
articles, the paper Folha de São Paulo denounces the “real” risk of contamination.  
The problem starts already in the field, with the risk of real contamination of conventional or 
organic crops by transgenic plants. The possibility of a plant polinizing the other (...) sets doubts 
about the real assurances that conventional crops will not receive transgenic polen70 (Brito, 2009d).  
                                                       
69  In the original: "Recordaron que científicos, investigadores y académicos que participan en la campaña enviaron sus 
comentarios sustentados en información técnica y científica, con los cuales reivindican su rechazo a la siembra 
experimental de maíz transgénico ante el alto riesgo de flujo genético de los granos transgénicos a los criollos. (...) “Si 
usted otorga permisos para la siembra de maíz transgénico en México, dará un paso que no tiene retorno y será 
responsbalbe de regalar el recurso natural clave de la nación y poner en riesgo la biodiversidad de los maíces mexicanos.” 
70  In the original: "O problema começa já na lavoura, com o risco real de contaminação de plantações convencionais 
ou orgânicas por plantas transgênicas. A possibilidade de uma planta polinizar outra (...) cria dúvidas sobre as 
garantias reais de que a lavoura convencional não receberá pólen transgênico". 
ECLAC – Production Development Series No. 193  The public debate about agrobiotechnology in Latin American countries …    
48 
 
As big corn producer, the adoption of GM corn in Brazil gave rise to concerns about the 
feasibility and efficacy of norms for the coexistence between GM and non-GM crops. The doubts 
regarding the possibility to control risks unfold in a debate regarding the sufficiency of risk 
management measures, which will be ahead.  
Risks to consumer health 
Only in the Mexican sampled material do claims about the risks of consuming GMOs appear. This 
argument is usually associated with the information that corn constitutes the basis of Mexican food; 
therefore, the fear is that GM corn will be part of the daily meal of Mexicans. Making reference to 
studies conducted in other countries confirming damage to health resulting from the consumption of 
GMOs, Antonio Turrent Fernández, scientist from the Instituto Nacional de Investigaciones 
Forestales, Agrícolas y Pecuarias (INIFAP) and also the president from the “Unión de Científicos 
Comprometidos con la Sociedad” states that, independent from the authorization of GM corn, Mexico 
already imports 10 million tons of corn. Since there is no guarantee or control to determinate if the 
imported grains are genetically modified or not, he assumes that GM corn is already “on the table 
from Mexicans”. During the alternative meeting to the FAO Conference on Biotechnology that took 
place in Mexico, organized by the Red en Defensa del Maíz, Vía Campesina Región América del 
Norte, la Asamblea Nacional de Afectados Ambientales y el Colectivo Coa, Turrent states that: 
(...) the quantity of corn that an Austrian or a French eat are not to worry, but we, who have 
corn for breakfast, lunch and dinner, especially the poorer groups, the risk is very different. Turrent 
pointed out that countries where crops for mass consumption among the population, as wheat for 
English-speaking peoples and rice to orientals, do not allow the cultivation of transgenic crops for 
human consumption in their territories. "In the United States there is no transgenic wheat, neither in 
Canada, and Japan does not accept the consumption of genetically modified rice. That is how they do 
in practice, but they see no problem if Mexico consumes altered maize; this indeed is a crime against 
humanity", he added71 (Partida, 2010).  
In the quotation there is a common theme found in the sample material, namely, that Mexico 
displays an acute situation without precedents in other countries, since in no other place there are GM 
crops which are the basis of food. Thus, examples from other countries are used to support the 
“biorisk” argument.  
Pesticide use 
In the sampled material from Argentina there was a heated debate about the effects of glyphosate on 
human health and on the environment, in which Página/12 was particularly active. The journalists 
explicitly stated - and reiterated in most news articles on the issue - that the use of glyphosate is to be 
attributed to the decision, taken by state authorities in 1996, to liberalize genetically modified soy 
resistant to it. They linked the issue of contamination from pesticides to the GM soy, as can be seen in 
the quotation bellow:  
Argentina has today 19 million hectares of transgenic soy, representing 56% of the country's 
arable land, and 190 millions of glyphosate, from which the most famous trade name is Roundup, 
from the firm Monsanto, which markets the soybean seed resistant to the agrochemical. The firms 
Syngenta, Atanor, Dupont, Bayear and others also produce glyphosate. The chemical is used in the 
production of rice, where denounces about its sanitary effects also abound. The agrochemical has the 
property of remaining long periods in environment and travel long distances carried by wind or 
water. It is sprayed (by air or by land) on the fields. The only thing that grows in the land sprayed is 
                                                       
71  In the original: "las cantidades maíz que comen un austriaco o un francés no son para preocupar, pero nosotros, que 
desayunamos, comemos y cenamos maíz, sobre todo en los grupos más pobres, el riesgo es muy diferente. Turrent 
señaló que en naciones donde también tienen alimentos de consumo masivo entre la población, como trigo en las 
angloparlantes o arroz en los orientales, no se permite la producción en sus territorios de  alimentos transgénicos 
para consumo humano. “En Estados Unidos no hay trigo transgénico, tampoco en Canadá, y Japón no acepta que se 
consuma arroz genéticamente modificado. En la práctica ellos están haciéndolo así, pero para afuera no hay 
problema en que en México sí se consuma maíz alterado; eso sí es un crimen de lesa humanidad”, agregó". 
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transgenic soy, the rest of vegetables absorves the poison and dies within days. The publicity of the 
firms classifies glyphosate as harmless for human beings72 (Aranda, 2009b).  
However, examples of claims from actors about direct effects of pesticides on their health and 
environment who do not refer to biotechnology also abound in the Argentinean sample. Many quotations 
from the newspaper Página/12 are from peasants’ families and NGOs. Their claims also inspire social 
movments organizations trying to influence the GMOs policy in Mexico.73 In Brazil, the use of 
pesticides associated with GM seeds was one of the arguments employed by actors to oppose the 
approval of the GM rice. Again, the environmentalist social movement refers to the prohibiton of the 
pesticides in other countries due to health effects, framing it as a threat to human health (Thuswohl, 
2009). Another event which actors attribute to GM technology, the use of pesticide, was the increase in 
the allowed maximum residue limits (MRL) of glyphosate in the corn crop. The representative from the 
Brazilian Health Surveillance Agency, responsible for toxicological studies of human health effects from 
glyphosate, states that the farming practices associated with GMOs have as a consequence the increase 
of pesticides residues which reach the “table” of consumers, in the end of the food chain:  
"Of course that people's exposure is increased. But the practice changes, the residue 
increases", justifies the director of Toxicology from the Brazilian Health Surveillance Agency 
(Anvisa), Luiz Cláudio Meirelles. Even with the increase in the maximum level of residue, he affirms, 
"the residue is within the daily intake". Maize crop "endured", according to the tests of Anvisa, this 
inclusion. "In the light of knowledge, there is no way not to go along this lines", he said. He admits 
that increasing levels is not ideal. "Maybe we should discuss this before.  
We will eat more residues, but this decision derives from the technology of GMOs (which 
demands pos-emergency application), and it is not under our competence". Glyphosate responds today, 
according to Anvisa, for 42% of the total consumption of agrotoxics in the country74 (Zanatta, 2010a).  
This quotation shows the contrast between two types of knowledge regarding the health and 
environment risks of the pesticide used with GM seeds: on the one hand the toxicological tests 
conducted in the laboratory in which the crop “endures” many applications of pesticide; on the other 
                                                       
72  In the original: "Argentina cuenta en la actualidad con 19 millones de hectáreas de soja transgénica, el 56 por ciento 
de la superficie cultivada del país, y 190 millones de litros de glifosato, donde la marca comercial más famosa es el 
Roundup, de la compañía Monsanto, que comercializa la semilla de soja resistente al agroquímico. También 
producen glifosato las empresas Syngenta, Atanor, Dupont y Bayer, entre otras. El químico se utiliza en la 
producción de arroz, donde también acumula denuncias por sus efectos sanitarios. El agroquímico tiene la 
propiedad de permanecer extensos períodos en el ambiente y viajar largas distancias arrastrado por el viento y el 
agua. Se rocía (vía aérea o terrestre) sobre los campos. Lo único que crece en la tierra rociada es soja transgénica, el 
resto de los vegetales absorbe el veneno y muere en pocos días. La publicidad de las empresas clasifica al glifosato 
como inofensivo para al hombre".  
73  The NGO Semillas de la Vida takes part in the open consultations for the authorization of GM corn and send their 
comments, asserting that the product under consideration by Mexican authorities: “far from avoiding a higher use 
of agrochemicals, increases their importance to agriculture" (Perez, 2009e). In the original: "Claro que aumenta a 
exposição das pessoas. Mas muda a prática, aumenta o resíduo", justifica o gerente-geral de Toxicologia da 
Agência Nacional de Vigilância Sanitária (Anvisa), Luiz Cláudio Meirelles. Mesmo com a elevação do limite, 
segundo ele, "o resíduo está dentro da ingestão diária". A cultura do milho "suportou", de acordo com testes da 
Anvisa, essa inclusão. "À luz do conhecimento, não tem como não seguir dessa maneira", disse. Ele admite que 
aumentar limites não é ideal. "Talvez devêssemos discutir isso antes. Vamos consumir mais resíduos, mas essa 
decisão deriva da tecnologia de transgênicos [que exige aplicação na pós-emergência], e não passa por aqui". O 
glifosato responde hoje, segundo a Anvisa, por 42% do consumo total de agrotóxicos no país" 
74  In the original: ""Claro que aumenta a exposição das pessoas. Mas muda a prática, aumenta o resíduo", justifica o 
gerente-geral de Toxicologia da Agência Nacional de Vigilância Sanitária (Anvisa), Luiz Cláudio Meirelles. Mesmo 
com a elevação do limite, segundo ele, "o resíduo está dentro da ingestão diária". A cultura do milho "suportou", de 
acordo com testes da Anvisa, essa inclusão. "À luz do conhecimento, não tem como não seguir dessa maneira", disse. 
Ele admite que aumentar limites não é ideal. "Talvez devêssemos discutir isso antes. Vamos consumir mais resíduos, 
mas essa decisão deriva da tecnologia de transgênicos [que exige aplicação na pós-emergência], e não passa por aqui". 
O glifosato responde hoje, segundo a Anvisa, por 42% do consumo total de agrotóxicos no país". 
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hand, the direct evidence collected from families, doctors and social movements' organizations about 
those who have not “endured” the actual practices of farming with glyphosate.  
c) Risks out of control! 
A third type of claims is clustered together for denouncing that risks of GMOs are out of control. 
Some claims embed a tension between legality and reality in what concerns the control of risks. Either 
it is the law that has not been applied or the legal framework is considered inadequate to control risks. 
In the first case, the claim is that the rules for risk management are only “a piece of paper” because 
they are not actually enforced, implying a claim for bringing the rule of law. In the second case, the 
tension resides in the fact that the “reality of risks” challenges the existent legal measures designed to 
control them, what implies a demand to review the rules of risk management.  
The claims about contamination of corn varieties with GM corn in Mexico denounce its 
illegality and the need to assign responsibilities and enforce the law. The quotation bellow refers to a 
claim made by Mexican social movements' organizations before the Consultative Committee on 
Agriculture (CCA), an annual meeting between the United States and Mexico foreseen by the North 
American Free Trade Agreement (NAFTA).  
The organizations explained that they resorted to CCA because they had exhausted all national 
instances to exposure and denounce this case of transgenic contamination. They affirmed that the 
authorities have violated the laws from General Ecological Balance, from Environmental Protection 
and from Biosafety of Genetically Modified Organisms, as well as the Federal Penal Code and the 
Cartagena Protocol on the Safety of Biotechnology. Quintana [from Frente Democratico Campesino] 
considered that the omission in monitoring and the violation of the law by the Federal Prosecutor for 
Environmental Protection, Semarnat, the National Service of Agro Alimentary Health, Safety and 
Quality, and by the General State Attorney also demonstrate that "there is lack of coordination 
between the responsible bodies for biosafety in Mexico and inability to make adequate samplings. To 
date, they have not yet satisfactorily integrated the previous analyses nor the citizens' complaint 
presented about the contamination of maize in Chihuahua". They demanded CCA to issue a statement 
of facts in face of the lack of effective implementation of the Mexican legislation and "given the 
existence of a systematic pattern of illegal sowing of transgenic maize in Chihuahua, without being 
detained or sanctioned by federal authorities75 (Enciso, 2009d).  
In Brazil not only social movements, but also political bodies such as the Ministery of Agrarian 
Development (not the Ministry of Agriculture) claim that the existing rules are inefficient to avoid the 
flux of genetic material from GM crops to conventional ones. Thus, although legal, the actual 
practices are not sufficient in face of the risks. The most active claim maker in this regard is a 
subnational political authority, namely, the Secretary of Agriculture from the State of Paraná. They 
demand the revision of the existing rules and new federal regulation in face of the experience of the 
first GM corn crops: 
A study by the Secretary of Agriculture from Paraná completed this month showed 
contamination of common corn crops by transgenic varities from nearby fields, despite the fact that 
                                                       
75  In the original: "Las organizaciones explicaron que acudieron ante la CCA debido a que han agotado todas las 
instancias nacionales para exponer y denunciar este caso de contaminación transgénica. Expusieron que las 
autoridades han violado las leyes General del Equilibrio Ecológico, de Protección Ambiental y de Bioseguridad de 
Organismos Genéticamente Modificados, así como el Código Penal Federal y el Protocolo de Cartagena sobre la 
Seguridad de la Biotecnología. Quintana consideró que la omisión en la vigilancia y el incumplimiento de las leyes 
por la Procuraduría Federal de Protección al Ambiente, la Semarnat, el Servicio Nacional de Sanidad, Inocuidad y 
Calidad Agroalimentaria y la PGR también constatan que hay “descoordinación entre los responsables de la 
bioseguridad en México e incapacidad para hacer muestreos adecuados. A la fecha no han integrado 
satisfactoriamente las averiguaciones previas ni la denuncia popular presentada por la contaminación del maíz en 
Chihuahua”. Pidieron a la CCA integrar un expediente de hechos ante la falta de aplicación efectiva de la 
legislación mexicana y “dada la existencia de un patrón sistemático de siembras ilegales de maíz transgénico en 
Chihuahua, sin que las autoridades federales las detengan o sancionen".  
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both areas respect the seggregation distance prescribed by CTNBio (the National Technical 
Commistion for Biosafety, the highest biosafety authority in the country). The contamination, 
according to the survey, was caused by wind pollination. The coordinator of the study, the agronomist 
Marcelo Silva, affirmed that the distance of minimum and maximum seggregation, between 20 and a 
hundred meters, in conformity with the  Normative Resolution number 4 from CNTBio, should be 
revised. "The coexistence between common and transgenic crops is under risk", said Silva. "We have 
a very robust assurance that the CTNBio norm is insufficient"76 (do Vale, 2010).  
In Argentina it is the issue of pesticide use that lead to claims that, although practices are in 
compliance with the legal rules, the “actuality” of the risks urges the elaboration of new rules that will 
be able to control the risks. Bellow, Página/12 reports about an action taken by the Office of the 
People’s Advocate/Ombudsman Office (Defensoría del Pueblo) in response of a demand from the 
network of social movements' organizations Red Nacional de Acción Ecologista (Renace). They asked 
for a new methodology that would not allow for the classification of glyphosate as “not dangerous”.  
The National Ombudsman Office has just taken a step in that direction: he required the 
Ministry of Agriculture to modify the form of classifying agrochemicals, demanded toxicological 
studies to be conducted by independent institutions (not by firms nor by scientists linked to the 
companies), and, until the new methodology is not implemented, he required that the agrochemicals 
should be relocated to the highest category of toxicity, what will imply that fumigations should be kept 
away from rural schools, peasants's houses and suburban neighborhoods77 (Aranda, 2010a).  
d) Risks and responsibility 
The last clusters of (bio) risk claims have in common their emphasis on the relationship between risk 
and responsibility. They shed light on the political nature of adopting GMOs i.e. they depict it as a 
“decision”, a choice among courses of action that have consequences and that someone will be hold 
accountable for that. This attribution of responsibility sometimes is directed to governments, but also 
firms are hold accountable for damage to health and environment from GMOs.  
In the Brazilian case, (bio) risk frames show an attributional function when proposals about 
deregulation of GMOs come to the agenda. There are at least two occasions in which actors call for 
responsibility when making claims about GMOs. One was the reaction from the Public Attorney 
(MPF) against the proposal to exclude firms from the obligation to monitor and report adverse effects 
in the post-marketing of GM products. It highlights health and environment as “juridical goods” that 
must be protected by the State and identifies risk analysis as the instrument to do so (Zanatta, 2010d).. 
Another occasion for such claims was the proposal of deregulation that involved the dismissal of the 
requirement for risk analysis in case of products resulting from the combination of two previously 
approved biotech products, the so-called “pyramidals”. The quotation bellow makes an explicit 
linkage between the role of CTNBio members in risk management and their responsibility for damage.  
                                                       
76  In the original: "Estudo da Secretaria da Agricultura do Paraná concluído neste mês apontou contaminação de 
lavouras de milho comum por espécies transgênicas de plantações vizinhas, apesar de as duas áreas respeitarem a 
distância de separação estipulada pela CTNBio (Comissão Técnica Nacional de Biossegurança, maior autoridade 
em biossegurança do país). A contaminação, segundo a pesquisa, ocorreu por meio da polinização empurrada pelo 
vento. O coordenador do trabalho, engenheiro agrônomo Marcelo Silva, afirmou que a distância de separação 
mínima e máxima, entre 20 e cem metros, conforme determina a Resolução Normativa número 4 da CTNBio, deve 
ser revista. "A coexistência entre lavouras comuns e transgênicas está posta em risco", disse Silva. "Temos uma 
certeza bastante robusta de que a norma da CTNBio é insuficiente."".  
77  In the original: "La Defensoría del Pueblo de la Nación acaba de dar un paso en ese camino: solicitó al Ministerio de 
Agricultura que modifique la forma de clasificación de los agroquímicos, instó a que los estudios de toxicidad estén a 
cargo de instituciones independientes (no de empresas ni de científicos ligados a las compañías) y, hasta que no se 
implemente la nueva metodología, reclamó que los agroquímicos sean reubicados en la más alta categoría de 
toxicidad, lo que implicará alejar las fumigaciones de escuelas rurales, viviendas campesinas y barrios periurbanos". 
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In his opinion, the expert Leonardo Melgarejo stated that members from CTNBio could 
respond in solidarity for damage caused by the new stacked transgenes78 (Zanatta, 2009c).  
In Mexico the main issue evoking the connection between risk and responsibility is the 
contamination of native species of corn with genetic material from GM corn. Some actors not only 
blame firms for the contamination, they also accuse them of pursuing it intentionally as part of a 
strategy which was previously adopted in Brazil: 
Ana de Ita, from Centro de Estudios para el Cambio en el Campo Mexicano, warned that the 
authorities have accepted that since 2001 there is contamination in the farming of the grain and it has 
been stated in Chihuahua, where it has already been demonstrated that the presence of GMOs was not 
by genes flow, but becuase there were intentionally  planted. She recalled that such mechanism for 
contamination is a strategy adopted by some firms. This, she recalled, has already happened 
previously in Brazil with soybean79 (Enciso, 2009c).  
Once again, Mexican claim makers highlight the particularity of their case: there, it is not 
enough assing responsibility or intentionality for damage, because it is beyond compensation. 
Greenpeace Mexico asks authorities to apply the precautionary principle (Sosa, 2010); for many actors 
the only solution left for Mexico is the moratorium on GM corn, including for experimental 
cultivation. This is part of the recommendations made by the scientists responsible for the study 
"Origen y diversificación del maíz, una revisión analítica", edited by the Comisión Nacional para el 
Uso y Conocimiento de la Biodiversidad (Conabio), a body from Semarnat. The recommendations 
were published in La Jornada: 
To reestablish the moratorium on the cultivation of transgenic maize in Mexico - which was 
lifted in March - and to modify the Law on Biosafety and Genetically Modified Organisms (LBOGM), 
with the aim of establishing measures for the protection of the native grain and determining the extent 
of its contamination, these are the recommendations made by scientists in a study financed by the 
Ministry of Enviroment and Natural Resources (Semanart) and Ministry of Agriculture, Livestock, 
Rural Development, Fisheries and Food (Sagarpa)80 (Enciso, 2009a).  
In extreme contrast to proposals of deregulation, the suggestion of a moratorium is based on an 
opposite conception of how politics should deal with (bio)risk. Also in Argentina, when framing 
GMOs as a risk to health and environment, some actors defend the ultimate risk management measure. 
For instance, the court from Cordoba prohibited the use of glyphosate - indirectly rendering 
impossible the use of GM seeds resistant to the pesticide -, and the Minister of Defense prohibits the 
cultivation of GM soy, as reported bellow by La Nación:  
The Minister of Defense, Nilda Garré, prohibited the Armed Forces to farm transgenic soy in 
its own fields situated in urban and suburban areas, as well as in the nearby areas of militar housing, 
as, for example, Campo de Mayo. The resolution points to "the protection of environment and human 
health", according to the official statement. The Armed Forces produce soybean and other crops that 
                                                       
78  In the original: "Em parecer, o especialista Leonardo Melgarejo afirmou que os membros da CTNBio poderiam 
responder de forma solidária por eventuais danos causados pelos novos transgênicos cruzados". 
79  In the original: "Ana de Ita, del Centro de Estudios para el Cambio en el Campo Mexicano, advirtió que las 
autoridades han aceptado que desde 2001 existe contaminación de cultivos del grano y se ha alentado en 
Chihuahua, donde ya se demostró que la presencia de transgénicos no fue por flujo de los genes, sino porque hubo 
siembras de manera intencional. Recordó que dicho mecanismo de contaminación es una estrategia que utilizan 
algunas empresas. Ello, recordó, ya sucedió de manera previa en Brasil con la soya". 
80  In the original: "Establecer nuevamente la moratoria en el cultivo de maíz transgénico en México –que se levantó 
en marzo– y modificar la Ley de Bioseguridad y Organismos Genéticamente Modificados (LBOGM), con el fin de 
establecer medidas de protección del grano nativo y determinar su grado de contaminación, son las 
recomendaciones que hicieron científicos en un estudio financiado por las secretarías de Medio Ambiente y 
Recursos Naturales (Semarnat) y Agricultura, Ganadería, Desarrollo Rural, Pesca y Alimentación (Sagarpa)". 
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they sell in the market to obtain resources destined to operational expenditures, as food for the troops 
and for the herds of cattle and horses from the Comando81 (Bertello, 2009). 
To sum up, in all countries actors similarly dispute in the health and environmental dimension 
of agrobiotechnology what are its (positive or negative) effects, the knowledge basis of their claims 
and the adequacy and desirability of regulation. Nevertheless, the concrete issues that come to media 
attention are very different and, not less important, the time orientations. In Argentina, the debate 
concerns present damages of past decisions to adopt the technological package of GM seeds resistent 
to glyphosate. In Brazil, the debate is about present decisions on how to deal with the also present 
issues of risk management such as coexistence and market monitoring. In Mexico, the main issue to 
receive media coverage is the threat to biodiversity, framed mostly in a future-oriented fashion, 
although it also includes claims about the actual incidence of contamination. The Mexican debate is at 
the same time nationalistic in tune and open to transnational influences, what is not much the case in 
the other countries.  
C. The dimension of ethics and politics  
The third dimension of the debate about GMOs refers to the broader societal implications of the 
adoption of biotechnology in agriculture. It includes claims that frame the context of the manipulation 
of genetic material applied to agriculture, making connections to other issues, with a strong ethical and 
political connotation. Among the main topics brought to debate are general beliefs and values 
regarding technology, either valuing its adoption as a sign of progress or fearing it by linking it to 
exploitation and expropriation; thus, beliefs about who are the winners and losers of technology 
adoption; beliefs about how biotechnology relates to certain pressing issues facing humanity such as 
food security and climate change; and beliefs about how the political decision-making about adopting 
technologies should be.  
“Progress frames” were clustered among three main types of claims. First, there is the view that 
adopting a new technology is part of a linear progress path. A stronger version of this type of claim is 
the perception that biotechnology signals a “technological revolution” with many positive spill-over 
effects in economy and society which benefits all. Some actors contest the claim that 
agrobiotechnology may only serve the interests of agribusiness and defend that it is not only 
accessible to small farmers, but that these are its main beneficiaries.  
Second, there is the claim that biotechnology is a solution to the challenges posed to humankind 
by climate change and food security. In some cases, particularly in Mexico, this argument assumes a 
nationalist connotation, for instance in the claim that it is the solution for the country to increase food 
production, achieve self-sufficiency and reduce dependence on imports. In other cases, mostly found 
in the Brazilian and in Argentinean debates, this argument is more global in its appeal: actors depict 
those countries as food providers to the world. A third type of claim coded as adopting a “progress 
frame” refers to the belief that political decision making regarding the adoption of technology should 
not be guided by political nor ideological considerations; instead, it should be based on technical-
scientific grounds and conducted in a rational way.  
The category “critique frames” compiles the types of claims that counter such “progress 
frames”. First, the claims that emphasize the victims of the “technological revolution” and the 
negative social effects of adopting agrobiotechnology, such as land concentration, reduction in 
employment and the threat to the coexistence of different models of agriculture. A demand for 
                                                       
81  In the original: "La ministra de Defensa, Nilda Garré, prohibió a las Fuerzas Armadas cultivar soja transgénica en 
campos propios ubicados en zonas urbanas y suburbanas, así como en adyacencias de barrios e instalaciones 
residenciales militares, como, por ejemplo, Campo de Mayo. La resolución apunta a "la protección del medio 
ambiente y a la salud de las personas", según el comunicado oficial. Las Fuerzas Armadas producen soja y otros 
cultivos que venden en el mercado para obtener recursos que destinan a gastos operativos, como son los alimentos 
para la tropa y rodeos vacunos y equinos del Comando de Remonta y Veterinaria". 
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corrective action i.e. for policies that protect agro-ecological, peasant, indigenous and familiar 
agriculture can be implied in such claims. A variation of this type of claim is the emphasis on 
collective identities and the cultural dimension - in particularly, the transmission of traditional 
knowledge - associated with peasant and indigenous agriculture. The second type of “critique frame” 
is correlated to the first and includes arguments that opt for blaming the winners of adopting 
agrobiotechnology, identifying agribusiness and transnational corporations as the main beneficiaries 
of it and criticizing their expansive and monopolistic practices.  
A third type of claim refers to the challenges posed to humankind by climate change and food 
security, but in a very contrasting way to those purported by carriers of “progress frames”. Here, 
actors not only contest the claim that food security and climate change can be solved by technology, 
they also inverting it by affirming that GMOs are actually a (foreign) threat to food security; and, 
consequently, they transform food security into food “sovereignty”, not without emphasizing the 
millenary (local, national) traditions of seed selection. Last but not least, “critique frames” also 
include beliefs about political decision making regarding the adoption of technology, however, in a 
very different way to those advocated by GMOs’ proponents. Basically, the main argument is that 
such decisions must involve not less, but more politics. There are two variations in this type of claim: 
(i) the demand for public accountability, including blaming public officials for corruption and the 
associated demand for the separation between private and public interests with precedence of the latter 
over the former; (ii) the demand for public participation in decision making.  
Overall results 
Claims about the broader societal implications of agrobiotechnology were more often found in the 
Mexican media sample than in the two other countries. While in the former country this dimension 
represented 36% of the debate, in Argentina and in Brazil it only accounted for, respectively, 10 and 
11% of all claims coded (Table 8). 
Table 12 shows the participation of actors and their frames. Similarly to the dimension of health 
and environment, in all countries market actors and social movements have contrasting framing 
strategies in the ethical-political dimension.  
 
TABLE 12 
POLITICAL CLAIMS ABOUT THE ETHICAL-POLITICAL DIMENSION OF 
BIOTECHNOLOGY PER TYPE OF ACTORS PER COUNTRY 
Number of claims  
 Argentina (N=127)  Brazil (N=199)  Mexico (N=275) 
    Progress   Critique      Progress     Critique    Progress    Critique 
Political actors 1 0 4 3 10 1 
Market actors 2 0 5 0 12 9 
Social movt. 0 4 0 3 0 36 
Scientists 0 0 2 0 3 16 
Media actors 1 5 0 5 4 9 
Total 4 9 11 11 29 71 
Source: own elaboration. 
 
Market actors are the main carriers of progress frames in all countries. However, in Mexico, 
farmers and their associations also frame GMOs as "critique". Social movements are by far the leader 
carrier of critique frames in Mexico, while in Argentina and in Brazil, although they also frame 
agrobiotechnology that way, this is first of all a media framing. In all countries, media framing is 
overwhelmingly against GMOs in this dimension, but in Mexico media actors also frame "progress". 
Another difference from the Mexican material is the strong participation of scientists in this dimension 
—what not happen in the other countries—, adopting almost always "critique" frames. Political 
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authorities are the second more active as carriers of "progress" frames in all countries, but in the 
Brazilian material these only slightly surpass claims coded as "critique". 
1. Progress  
“Progress” arguments accounted for 3,6 and 11% of all claims in the Argentinean, Brazilian 
and Mexicam debates, respectively (Table 8). In all cases, it is a frame mostly adopted by market 
actors and political actors. To a lesser extent, media and scientific actors also are carriers of this 
frame. No social movement in the sampled material defends this framing of the GMOs. The claims 
categorized as adopting a “progress frame” are clustered bellow around the main variations found in 
the material, namely: (a) "technological revolution"; (b) "the solution to food security and climate 
change" and (c) "science-based decision making: no room for politics". 
a) "Technological revolution" 
Biotechnology is the latest technological development in the path of progress and this is the necessary 
product of a linear evolution. The President of CTNBio in Brazil emphasizes that there is no coming back:  
The agronomist Edison Paiva, who was yesterday elected the president of CTNBio (National 
Technical Biosafety Comission), defended the commercial liberation of genetically modified plants 
and criticised the opposition to these organisms. “We work within the boundaries of knowledge, and 
the groups against it are very efficient in causing fear”, he told Folha. (...) To Paiva, transgenic 
varieties “are a necessity, a reality from which there is no return”. Researcher at Embrapa for 35 
years, with a PhD in genetic engineering, he points out that genetically modified cultures already 
occupy more than 140 million hectars in the world82 (Folha de São Paulo, 2010).  
In Argentina, the journalist of La Nación refers to the possibility of prohibiting glyphosate  
—and, with it of GM crops— as a return to the backward past. There is no point in stopping progress 
or going back to the “pre-GMOs era”. 
With Argentina transformed in a key player in the production, no one in the sector seems to 
want to return to such stages83 (Bertello, 2010).  
The spillover effects of the technological revolution in Argentina are not only narrated by some 
actors in that country, but also used by actors aiming at influencing the Mexican debate about 
agrobiotechnology. In the quotation bellow, Manuel Madero, commercial director from Monsanto in 
South America, was interviewed by El Economist in the Agrícola Argentina 2009 and published in the 
Mexican newspaper: 
He used as as example that in Argentina’s agriculture an increase in productivity of only 1% 
generates additional income of between 35 and 40 million dollars “and that obviously translates into 
more jobs, investments in sectors like transportation and other services”. He added that all 
technological revolutions that happened did so through the use of technology and that “they represent 
a huge opportunity, especially if one wants to supply the world’s enormous demand of food, which 
makes it necessary to increase the production of the same arable land”84 (Martínez, 2009d). 
                                                       
82  In the original: "Escolhido ontem presidente da CTNBio (Comissão Técnica Nacional de Biossegurança), o 
agrônomo Edilson Paiva defendeu a liberação comercial de plantas geneticamente modificadas e criticou a 
oposição a esses organismos. "Trabalhamos com a fronteira do conhecimento, e os grupos contrários são muito 
eficientes em assustar", disse à Folha. (...) Para Paiva, variedades transgênicas "são uma necessidade, uma realidade 
para a qual não há retorno". Pesquisador da Embrapa por 35 anos, com doutorado em engenharia genética, ele cita 
que culturas geneticamente modificadas já ocupam mais de 140 milhões de hectares no mundo". 
83  In the original: "Con la Argentina convertida en un actor clave de la producción, nadie en el sector parece querer 
volver a aquellas etapas". 
84  In the original: "Puso como ejemplo que en la agricultura de Argentina sólo 1% de mayor rendimiento genera 
divisas adicionales de 35 a 40 millones de dólares "y esto evidentemente se traduce en más empleos, derrama 
económica en sectores como transporte y otros servicios". Añadió que todas las revoluciones tecnológicas que se 
han dado han sido a través de aplicación de la tecnología y "significan una oportunidad enorme, sobre todo si se 
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Madeiro not only speaks of a technological revolution; he also frames GMOs as the solution to 
food security. Claims that focus on pressing global issues to justify the adoption of the new 
technology will be describe next.  
b) The solution to food security and climate change 
In all countries actors defend biotechnology to be a solution to food security, using Malthusian 
arguments mentioning figures of population increase in contrast to the volume of food production. In 
Brazil and Argentina there are general references for the need to feed the world, such as in the 
quotation from a Monsanto spokesperson in Brazil: 
When the world population increases by 50%, we will have to double the production of food. 
And biotechnology is the answer. Organic agriculture cannot fulfil that85 (Freitas, M. 2009).  
While Brazil and Argentina are amongst the countries considered as the food providers of the 
world (Lopes, 2010), in Mexico food security arguments have first of all a national aim, since the 
country imports corn from the USA. Some actors contrast Mexico and the US as importer and 
exporter of corn to make the argument that biotechnology accounts for that difference. In the article 
bellow, Agrobio Mexico uses that reasoning and is successful in having it adopted by the newspaper 
El Economista as well: 
According to AgroBio, Mexico is not self-sufficient in the production of corn and imports from 
transgenic producing countries more than 40% of its consumption. Thus, since over a decade Mexico 
imports, processes and consumes this kind of food, withholding the access to such technologies to the 
agricultural producers from our country86 (Martínez, Maria (2009a).  
The food security argument assumes a strong national connotation in Mexico, indicated by the 
use of words such as “our country”, “feed the Mexicans”, and “Mexico” in many quotations. 
Therefore, biotechnology is claimed to be the solution not only for the problem posed to humanity, but 
also as a means for the country to reduce its dependence on food imports. This is a common media 
frame in the country, present in the discourse of El Universal quoted bellow: 
But the commercialization of Genetically Modified Organisms (GMOs) in Mexico goes beyond 
a new source for generating more profitable businesses. It is above all the choice for our country to 
become self-sufficient in the production of food (Lombera, 2009).87  
Some actors take as their starting point the need to feed the world’s population and add to that 
challenge the negative effects of climate change. Biotechnology becomes the solution to increase 
productivity and also to address new climatic situations. On the occasion of the FAO International 
Technical Conference on Agricultural Biotechnologies in Developing Countries, which took place in 
Mexico, this strategy was the framing strategy adopted by the representative from FAO, Modibo 
Traoré: 
UN statistics show that, nowadays, the world population is 2.5 times bigger than in 1950, 
counting up to 6.800 billion people. For 2045 it is estimated that the population will be of 9 billion 
people, what will result in an enormous demand for food production. Therefore, Traoré noted, we 
consider that biotechnological innovations may represent an important assistance in duplicating the 
                                                                                                                                                                     
quiere cumplir con la enorme demanda de alimentos que se tiene en el mundo y que hace necesario ampliar los 
rendimientos en la misma tierra cultivable"." 
85  In the original: "Quando a população mundial crescer 50%, teremos que dobrar a produtividade de alimentos. E a 
biotecnologia é a saída. A agricultura de orgânicos não consegue isso". 
86  In the original: "De acuerdo con AgroBio, México no es autosuficiente en la producción de maíz e importa de 
países que cultivan transgénicos más de 40% de su consumo. Por tanto, desde hace más de una década, México 
importa, procesa y consume este tipo de alimentos, excluyendo del acceso a estas tecnologías a los productores 
agrícolas de nuestro país". 
87  In the original: "Pero la comercialización de Organismos Genéticamente Modificados (OGM) en México va más 
allá de una nueva oferta para generar negocios más rentables. Es en primera instancia la opción para que nuestro 
país sea autosuficiente en producción de alimentos". 
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food production for the year 2050 and help cope with the uncertainties raised by global warming. “In 
the last decades the field of biotechnologies has progressed at great speed and generated a number of 
innovations, particularly in the field of pharmaceuticals and in some cases in that of agriculture. The 
biotechnologies can be very useful to fulfil the needs of an urbanized population that grows each 
day”, pointed out Traoré88 (El Universal, 2010b).  
Quotations connecting biotechnology to climate change alone were not found so often in the 
material. In Brazilian media, there were announcements of GM crops being researched to address 
climate change (Barros, 2009), but the most assertive claim of biotechnology being the solution for the 
effects of this phenomenon in agriculture was again to be found in the Mexican material as the 
quotation bellow:  
With climate change the sowing cycle of corn in Sinaloa will get reduced a month by the end of 
the century, estimated the IMTA researcher. With the current varieties of the grain the seeding cycle will 
last between January and April only, and for that biotechnology is an alternative to provide seeds that 
are more resistant to the effect of the climate. Ojeda is not pessimistic about the effects of global 
warming in agriculture. He just alerts about the modifications that the production schemes will require. 
“The agriculture is not going to end, we need to adapt”, he said. The case of potato reflects the 
challenges facing the cultivation of corn. To maintain the national harvest of 60 000 hectares the use of 
biotechnology to produce new varieties that withstand climate change is required89 (Lombera, 2010). 
c) Science-based decision making: no room for politics 
Some claim makers defend that decisions regarding the adoption of biotechnology should be based 
solely on scientific and technical grounds. Bellow, a quotation from a FAO representative, Shivaji 
Pandey, published on the coverage of the mentioned conference: 
He said that at the meeting information will be given concerning the available tools, their 
advantages and disadvantages, so that the developing countries can decide what suits them to solve their 
problems. “It is a Technology conference, based on science, not on politics” 90 (Martínez, A. 2010).  
The emphasis on the scientific basis of decision-making sometimes unfolds into the attempt to 
make a clear separation between technical and political issues. From this point of view, political issues 
are laden with ideology and not amenable to a rational debate grounded in scientific information, as 
can be seen in the quotations from the President of the Brazilian Biosafety Commission (CTNBio):  
Identified as one of the main internal opponents of the groups that preach more caution at the 
liberation of transgenics, the new president affirms that the ‘new stage’ of CNTBio should have less 
                                                       
88  In the original: "Estadísticas de las Naciones Unidas indican que, hoy en día, la población mundial es 2.5 veces más 
que en 1950, llegando a los seis mil 800 millones de habitantes. Para 2045 se estima una población de nueve mil 
millones lo que se traducirá en una enorme demanda de alimentos a producir. Por ello, anotó Traoré, consideramos que 
las innovaciones de la biotecnología pueden suponer una importante ayuda para duplicar la producción alimentaria 
para el año 2050 y hacer frente a las incertidumbres que plantea el cambio climático. "En las últimas décadas el campo 
de las biotecnologías ha avanzado a una velocidad formidable y generado numerosas innovaciones, en particular en el 
campo farmacéutico y en algunos casos en el de la agricultura. Las biotecnologías pueden ser muy útiles para 
satisfacer las necesidades de una población urbanizada que cada día crece más", destacó Traoré". 
89  In the original: "Con el cambio climático el ciclo de siembra de maíz en Sinaloa se va a reducir un mes para fin de 
siglo, estimó el investigador del IMTA. Con las variedades actuales del grano el ciclo de siembra durará sólo entre 
enero y abril, por lo que la biotecnología es una alternativa para contar con semillas más resistentes al efecto del clima. 
Ojeda no es pesimista sobre los efectos del calentamiento global en la agricultura. Sólo alerta sobre las modificaciones 
que requerirán los esquemas de producción. "La agricultura no se va a acabar, tenemos que adaptarnos", afirmó. El 
caso de la papa refleja los retos que enfrentará el cultivo del maíz. Para mantener la cosecha nacional de 60 mil 
hectáreas se requiere el uso de la biotecnología para generar nuevas variedades que resistan el cambio climático". 
90  In the original: "Sostuvo que en la reunión se informará sobre las herramientas disponibles, las ventajas y 
desventajas de ellas, para que los países en desarrollo elijan lo que les conviene para solucionar sus problemas. “Es 
una conferencia de tecnología, basada en ciencia, no en política.” 
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ideological disputes. “We need to separate the technical discussion from the political matters at the 
debates” 91 (Zanatta, 2010f). 
According to this view, scientific knowledge and rationality will eventually lead to a 
consensual decision, as shown in the quotation bellow from a Mexican scientist from Centro de 
Investigación y Estudios Avanzados (Cinvestav) from Instituto Politécnico Nacional, director for the 
development of a draught-tolerant corn.  
Concerning the existing opposition to the cultivation of transgenic corns in Mexico, Beatriz 
Xoconostle said that it is “very valid” not to want to have genetically modified organisms in a place 
of origin; however, the topic should be opened towards a ‘rational debate’ between ecologists and 
specialists that possess all scientific information in order for an “appropriate consensus” to be 
reached92 (Zaragosa, 2010b).  
2. Critique  
Political claims coded as adopting a “critique” frame accounted for 7, 6 and 26% of all claims in the 
Argentinean, Brazilian and Mexican debates, respectively (Table 8). In Argentina and Brazil media 
actors are the first carriers of these frames. While in Argentina social movements share with media 
actors the role of carrying these frames, in Brazil, besides social movements, also political actors express 
critical voices regarding the relationship between technology and society. In Mexico all types of actors 
make claims using this type of frame, with some particularities. There, not only do scientists and market 
actors appear as carriers of “critique frames”, but also they are active in doing so: scientists are the 
second claim-makers of this type after social movements, and market actors share the third position with 
media actors. Only political actors are not prominent in expressing arguments of this type in Mexico.  
Examples of claims coded as adopting a “critique frame” are described below along four 
clusters: (a) "victims of the technological revolution"; (b) "blaming the winners "; (c) "challenges 
posed to humankind" and (d) "political decision making regarding the adoption of technology".  
d) Victims of the "technological revolution" 
In Brazil, the possible victims mobilize to be protected in face of the advancement of GM production; 
above all, they demand the right to coexist:  
The organisations demand the suspension in use of GM corn until there is no guarantee of 
coexistence. Representatives of civil society demanded the federal government to comply with the 
promises of "pacific coexistence" between conventional, organic, agroecological and transgenic soy 
that the president Luiz Inácio Lula da Silva made in the opening of the meeting COP 8, in Curitiba. 
They said that Lula supported the release of market cultivation of GM seeds under the condition that 
there was guarantee of coexistence between conventional and transgenic crops93 (Brito, 2009a).  
In Argentina, the expansion of the soy model and its technological package (GM soy, no till 
farming and glyphosate) is held responsible for land concentration, reduction in employment and the 
threat to the coexistence of different models of agriculture:  
                                                       
91  In the original: "Identificado como um dos principais adversários internos dos grupos que pregam mais cautela nas 
liberações de transgênicos, o novo presidente afirma que a "nova etapa" da CTNBio deveria ter menos disputas 
ideológicas. "Precisamos separar as discussões técnicas e as questões políticas nos debates". 
92  In the original: "Sobre la oposición que existe a la siembra de maíces transgénicos en México, Beatriz Xoconostle 
dijo que es “muy válido” no querer tener organismos genéticamente modificados en un sitio de origen; sin 
embargo, el tema debe abrirse a un “debate racional” entre ecólogos y especialistas con toda la información 
científica para “llegar a un consenso apropiado”. 
93  In the original: "As organizações pedem que o uso do milho OGM seja suspenso enquanto não houver garantias de 
coexistência. Representantes da sociedade civil cobram do governo federal o cumprimento de promessas de "convivência 
pacífica" entre plantios convencionais, orgânicos, agroecológicos e transgênicos feitas pelo presidente Luiz Inácio Lula da 
Silva na abertura da reunião COP 8, em Curitiba. Eles dizem que Lula apoiou a liberação do plantio comercial de 
sementes OGM sob a condição de haver garantia de coexistência de lavouras convencionais e transgênicas". 
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This productive schema has a bias towards concentration that led thousands of small producers 
to abandon their farms and to become rentiers by leasing their fields. In turn, transgenic soy caused a 
decreased in the labor days required per hectare cultivated and harvested. In sum, the generalization 
of no-till farming disminished the numerical importance of the historic explotations of family 
farming94 (Rubinzal, 2010). 
Some claims emphasize the collective identities and the cultural dimension associated with the 
modes of agriculture th,at are threatened by the expansion of GMOs. In Argentina, a survey made by 
the Red Agroforestal Chaco Argentina (Redaf) estimated that there had been 164 land and 
environmental conflicts, most of which they attribute to the expansion of GM soy.  
89% of the conflicts started in paralel to the instalation of the current agricultural model, with 
transgenic soy as emblem. (...) The indigeneous peoples affected by this spread are, only to mention 
the high lands, qom, pilagá, mocoví, wichí, chorotes, chulupies, tapietes, guaycurúes, lules, vilelas y 
tonocoté. (...) Among the conclusions, it stands out that the conflicts are not only for land, but it is also 
a conflict over the use and control of territorial space by means of imposition from a culture over the 
other. It states that for the entrepreneurs dedicated to agriculture and to the State "what is on stake is 
the in profits and the short term taxes, for them land represents an economic good necessary for 
production profits, regardless of the environmental, cultural and social costs involved". In contrast, 
they highlight that for the indigenous peoples and peasants it means much more than business. "It 
means a struggle to mantain an identity, to preserve a way of live, of producing, of living and being. 
The land is a social good and not an economic good, constitutive part from their worldview and 
religiosity", states the report95 (Aranda, 2010b). 
Among the victims, they name indigenous communities and small farmers, but above all, the 
emphasis is that the expansion of the soy model is part of a clash of cultures and identities in what 
regards land use. In Mexico, actors also build an identity, which is threatened by GM corn. In a 
petition organized by the Red en Defensa del Maíz to hand to FAO and to Mexican authorities, they 
name it "people of corn": 
This document rejects the cultivation of transgenic corn in Mexico for considering it "a 
historical crime against the people of corn, biodiversity, food sovereignty, against ten thousand years 
of peasant and indigenous agriculture that bequeathed this seed for the good of all peoples of the 
world" 96 (Norandi, 2009).  
The quotation shows also a linkage between local identities and the humankind: again, in 
Mexico, the argument assumes a more drastic tune, refering not to specific victims such as small or 
                                                       
94  In the original: "El sesgo concentrador de este esquema productivo provocó que miles de pequeños productores 
abandonaran sus explotaciones y se reconvirtieran en rentistas mediante el alquiler de sus campos. A su vez, la 
soja transgénica ocasionó una disminución de los jornales requeridos por hectárea cultivada y cosechada. En 
síntesis, la generalización de la siembra directa disminuyó la importancia numérica de las históricas 
explotaciones chacareras familiares". 
95  In the original: "El 89% de los conflictos comenzó en paralelo con la instalación del actual modelo de agropecuario, 
con la soja transgénica como emblema. (...) Los pueblos originarios perjudicados por ese avance, sólo en las 
provincias relevadas, son el qom, pilagá, mocoví, wichí, chorotes, chulupies, tapietes, guaycurúes, lules, vilelas y 
tonocoté. (...) El relevamiento demuestra que las víctimas del modelo agropecuario son pequeños productores. (...) 
Entre las conclusiones se destaca que los conflictos no son sólo por la tierra, sino que se trata de una disputa por el 
uso y control del espacio territorial a partir de la imposición de una cultura sobre otra. Afirma que para los 
empresarios dedicados al agro y para el Estado “está en juego el aumento de ganancias y retenciones en el corto 
plazo, para ellos la tierra representa un bien económico necesario para producir ganancias, sin importar los costos 
ambientales, culturales y sociales que impliquen”. En contraposición, destaca que para los pueblos indígenas y 
campesinos implica mucho más que negocios. “Se trata de una lucha por conservar una identidad, por mantener un 
modo de vida, de producir, de vivir y permanecer. La tierra es un bien social y no un bien económico, parte 
constitutiva de su cosmovisión y religiosidad”, asegura el informe". 
96  In the original: "En este documento se rechaza enérgicamente la siembra de maíz transgénico en México por 
considerarlo “un crimen histórico contra los pueblos del maíz, la biodiversidad y la soberanía alimentaria, contra 10 
mil años de agricultura campesina e indígena que legaron esta semilla para el bien de todos los pueblos del mundo”". 
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organic farmers. Rather, the whole humanity and its traditional knowledge is victim of a crime, if one 
considers that the domestication and the millenary selection of corn is a civilizational conquest in the 
human history. The adoption of GM corn is thus framed as a historical crime and a crime against 
humanity, as stated in the quotation above and, bellow, by the professor from the Universidad 
Autónoma Metropolitana, Luciano Concheiro: 
At a press conference, Luciano Concheiro, profesor and research of the Graduate School in 
Rural Developmen from the Universidad Autónoma Metropolitana (UAM), considered as a "crime 
against humanity" that in national territory, center of origin of maize, "the contamination of basic 
grains by transgenics is allowed". He added that "not only it damages the immense richness in terms 
of biodiversity, since it is worth recalling that Mexico is listed among the four megadiverse countries 
in the world, but also what is on stake is the civilizatory richness that we bequeathed to the world, 
after thousand years of selection of grains, which has not been produced by nature, but by our 
ancestors"97 (Solano, 2010).   
e) Blaming the winners  
Beyond stating that the adoption of GMOs victimizes groups of people, types of agriculture, types of 
knowledge and the whole humanity, some actors identify, on the other side of the spectrum of winners 
and losers, those who they accuse of concentrating the profits from biotechnology. They name mostly 
transnational corporations, but in Argentina there are two other targets of blaming, the representatives 
of agribusiness and their allies in the media, as published in Página/12: 
Employer organizations from the rural sector and international agricultural companies 
mantain a model of monoculture to feed with transgenic the animals from Europa and China. (...) 
They blame the firms Cargill, Dreyfus, Bunge, Nidera, Syngenta, AGD and Monsanto, among others, 
as responsible for the agriculture model in Argentina and reserve a paragraph to the role of the big 
media groups: "We repudiate the manipulation of information by the many communication media that 
have obscured the diversity of Argentinean countrysided and have desfigured the faces from the 
genuine rural worker98 (Aranda, 2010c).  
 In Mexico, social movements blame transnational corporations for using illegal means to force 
the adoption of biotechnology and thus control de market of seeds. In Mexico, social movements 
blame transnational corporations for using illegal means to force the adoption of biotechnology and 
thus control de market of seeds. But also social movements count on transnational strategies to 
counter corporations. This is what a group of German SMOs proposed:  
With the idea of avoiding that GMOs spread throughout the world —in this case, maize—, we 
will start working in international networks and will exert political pressure to attain protection of the 
center of origin, which is Mexico, said in an interview Jochen Fritz, from the Alliance GM-Free Zone 
Hohenlohe. He said that the plan from Monsanto is that "since here is the center of maize, let GMOs 
contaminate it, and as the enterprise holds patents on processes, this would be a form of 
appropriating the grains. It wants to sell its seeds to the peasants and apply its moto: 'there will be no 
plants that are not owned by us". He recalled that 80% from the seeds that are marketed globally are 
                                                       
97  In the original: "En conferencia de prensa, Luciano Concheiro, profesor-investigador del posgrado en Desarrollo 
Rural de la Universidad Autónoma Metropolitana (UAM), consideró como un “crimen de lesa humanidad” que en 
el territorio nacional, centro de origen del maíz, “se permita la contaminación con transgénicos de los granos 
básicos”. Agregó que “no sólo se daña una enorme riqueza en términos de biodiversidad, pues hay que recordar que 
México se encuentra entre los cuatro países megadiversos del mundo, sino que también está en juego la riqueza 
civilizatoria que aportamos al mundo, luego de miles de años de selección de granos, que no fue producida por la 
naturaleza, sino por nuestros ancestros”". 
98  In the original: "Las entidades patronales del campo y las compañías internacionales del agro sostienen un modelo 
de monocultivo para alimentar con transgénicos a los animales de Europa y China. (...). Apuntan contras las 
empresas Cargill, Dreyfus, Bunge, Nidera, Syngenta, AGD y Monsanto, entre otras, como las responsables del 
modelo agropecuario de Argentina y guardan un párrafo al rol de los grandes grupos mediáticos: “Repudiamos la 
manipulación de la información por parte de muchos medios de comunicación que han ocultado la diversidad del 
campo argentino y han desfigurado los rostros del genuino trabajador y trabajadora rural". 
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owned by Monsanto, "this means that it is neither the peasants nor the countries that can have seeds, 
what deepens the dependency”99 (Enciso, 2010).  
The campaign against GMOs in Mexico protested in front of the firm Monsanto with slogans 
such as "Out of Mexico, Monsanto!" (“¡Fuera Monsanto de México!”) (Perez, 2010). 
f) Threat to food sovereignty 
Given that one of the main arguments used to defend the introduction of agrobiotechnology in Mexico 
is that it is a solution to food security and climate change, actors in the sampled material from the 
Mexican debate make vehement contestations to such claims, for instance, in this news article from La 
Jornada covering a protest during the mentioned FAO Conference: 
Activists and citizens tasted cobs of creolle corn and handed in a letter addressed to Modibo 
Traore, Vice-Director from FAO to remind him that the problem of hunger in the world won't be 
solved with transgenics and that the alternative to fight poverty and hunger is peasant and sustainable 
agriculture100 (La Jornada, 2010).  
Beyond contesting the claim that biotechnology is the solution to pressing global issues such as 
food security, social movements transform it into a source of the problem, i.e., as a threat to food 
security. Notice that, as with the “progress frames”, actors in the Mexican debate move back and forth 
from national and global framings of the food security issue, sometimes adopting a nationalist appeal, 
as in the quotation above, other times extending their frame of the issue to achieve a global relevance, 
as in the quotation bellow:  
Delia Patricia Couturier, expert in rural development from UAM-Xochimilco, highlighted that 
"we are the only country that allows experimental cultivation of GMOs in a grain basic for its 
population, situation that does not occur in Asia, with rice, or in Europe, with wheat, because it is clear 
for them that it is an enormous risk for the food security of a nation (...) and this sets in risk one of the 
basic food for Mexicans, but also for many other nations that depend on this seed101 (Solano, 2009).  
One of the reasons claim makers give for why GMOs pose a threat to food security is the 
application of IPRs over seeds and, consequently, the prohibition imposed on farmers to reproduce 
seeds without paying royalties for it. As Mexico is the center of origin of corn, the claim that patents 
over seeds is a menace to food security receives an additional element that gives it more resonance. 
The intellectual property over corn means that the product of millennia of seed selection conducted by 
Mexicans is yielded over to multinationals i.e. a patent is granted over a human heritage. In a protest, 
the campaign “Sin Maiz no hay país” made a simulation in which they handed to the president of 
Monsanto the national and human heritage: the corn (Perez, 2009b). The framing strategy is to 
emphasize such historical and cultural dimension of seed improvement to strengthen the claim that 
GM corn is a threat to food security. The use of such wording as “crime against humanity” and 
                                                       
99 In the original: "Con la idea de evitar que los transgénicos se extiendan en el mundo –en este caso el maíz–, se 
comenzará a trabajar en redes internacionales y se ejercerá presión política para lograr la protección del centro de 
origen, que es México, dijo en entrevista Jochen Fritz, de la Alianza Región Hohenlohe Libre de Transgénicos. 
Indicó que el plan de Monsanto es que “como aquí está la cuna de maíz, que los transgénicos la contaminen, y 
como la empresa tiene patentes de los procesos, esto sería una forma de apropiarse de los granos. Quiere vender sus 
semillas a los campesinos y aplicar su lema: ‘no habrá plantas que no sean propiedad de nosotros’”. Recordó que 
80 por ciento de las semillas que se comercian a escala mundial son propiedad de Monsanto, “eso significa que ya 
no son los campesinos ni los países los que pueden disponer de las semillas, se profundiza la dependencia". 
100  In the original: "Activistas y ciudadanos degustaron elotes de maíz criollo y entregaron una carta dirigida a Modibo 
Traore, Director Adjunto de la FAO para recordarle que el problema del hambre en el mundo, no se solucionará con 
transgénicos y que la alternativa para combatir la pobreza y el hambre es la agricultura campesina y sustentable". 
101  In the original: "Delia Patricia Couturier, especialista en desarrollo rural de la UAM-Xochimilco, destacó que 
“somos el único país que admite siembras experimentales de transgénico en un grano básico para su población, 
situación que no ocurre en Asia, con el arroz, o en Europa con el trigo, porque se tiene claridad del enorme riesgo 
que esto implica para la seguridad alimentaria de una nación”. (...) y esto pone en riesgo uno de los alimentos 
básicos para millones de mexicanos, pero también para muchas otras naciones que dependen de esta semilla”". 
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“human heritage” imply another regime of protection than that adopted in case of IPRs. Such claims 
resort not to individual, but to collective rights, to constitutional rights and to the regime of human 
rights. At the same time, actors transform or slide the use of the expression “food security” to that of 
“food sovereignty” to advocate public control over the seeds as a means to achieve that goal. Thus, in 
the celebration of the National Day for the Corn, social movements protested against GMOs and  
(...) demanded the Congress to approve the constitutional right to food, together with a law 
with a plan regarding food and nutritional sovereignty and security, with the aim of guaranteeing 
sufficient and quality food for Mexicans102 (Zaragosa, 2010a).  
g) Not less, but more politcs 
If it is a question of guaranteeing constitutional rights, such framing unfolds into a claim that public 
decision making regarding GMOs should be guided by the principle of defining the public interest in 
contrast to the private interests, as in the case of the rhetorical question from the coordinator of the 
National Commission for the Knowledge and Use of Biodiversity (Conabio), José Sarukhán, 
commenting on the content of the Mexican Biosafety Bill: 
(...it has significant gaps, it must be revised. It was made in hurry, amidst pressures, there were 
few consultations. These are important things and there should be room to do it welldone. Yes, there 
are many economic interests behind this, but in food issues the question is: do we put economic 
interests from one, two or three firms above the social interest of the Mexican population? Private 
interest above social interest? I believe not103 (Enciso, 2009a).  
Also in Brazil, actors blame government authorities of corruption, especially that there are 
conflicts of interest, for instance, officials who have worked in the past for biotechnological firms, 
such in the quotation bellow from a social movement organization which organizes the newsletter and 
campaign "GM-Free Brazil" (Por um Brasil Livre de Transgenicos), ASPTA:  
In a tense moment, the representative of the NGO ASPTA, Gabriel Fernandes, affirmed that the 
members of CTNBio had links with the biotechnological firms. (...) The environmentalists pointed the 
agronomist and genetic engineer João Lúcio de Azevedo as a member of CTNBio who would have 
connections with Monsanto104 (Valor Econômico, 2009d).  
 Denouncing such preferential treatment that biotechnological firms have in the access to the 
authorities responsible for the decision regarding the adoption of GMOS, actors demand from the 
Mexican President to meet also with social movements. They claim for public participation in decision 
making over agrobiotechnology, emphasizing its political dimension in opposition to the view that it is 
a technical decision. In the quotation bellow, Édgar Cortez, director from the human rights network 
Todos los Derechos para Todas y Todos, states that public participation is lacking: 
It "demonstrates that there are no effective forms of participation from citizens, because it is 
the President who decides, without caring that the cultural and food heritage of the population are 
under risk", he added105 (Perez, 2009a).  
                                                       
102  In the original: "demandaron al Congreso aprobar el derecho constitucional a la alimentación, acompañado de una 
ley de planeación para la soberanía y seguridad agroalimentaria y nutricional, con el propósito de garantizar 
alimentos suficientes y de calidad para los mexicanos".  
103  In the original: "tiene huecos importantes, hay que darle una revisada. Se hizo al vapor de las presiones y prisas, 
hubo pocas consultas. Son cosas tan importantes y se debería dar espacio para hacerlo bien. Sí, hay muchos 
intereses económicos detrás de esto, pero en cuestiones de alimentación la pregunta es: ¿ponemos los intereses 
económicos, de una, dos o tres compañías por encima del interés social de la población mexicana? ¿El interés 
privado sobre el interés social? Yo creo que no". 
104  In the original: "No momento mais tenso, o representante da ONG ASPTA, Gabriel Fernandes, afirmou que os 
membros da CTNBio teriam ligações com empresas de biotecnologia. (...) Os ambientalistas apontaram o engenheiro 
agrônomo geneticista João Lúcio de Azevedo como um membro da CTNBio que teria ligações com a Monsanto". 
105 In the original: "Se “demuestra que no hay formas efectivas de participación ciudadana, porque es el Presidente 
quien decide, sin importarle que está en riesgo el patrimonio cultural y alimentario de la población”, añadió". 
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 In sum, ethical and political questions are highly disputed between proponents and opponents 
of GMOs, each taking opposing sides around the main issues: how to interpret the adoption of 
agrobiotechnology (a technological revolution or another form of expropriation which creates winners 
and victims?); how to frame it in what regards food security and climate change (either as a solution 
or as a contributing cause or menace to it); what should be the criteria and form of decision making 
about it (a technocratic or a participatory decision process; science-based or based on political 
considerations of the public good?). Although with varying intensity, such topics appear in all 
countries. However, in Mexico they are much more debated and account for 36% of all claims coded. 
As in other dimensions, Mexican claims assume often a nationalistic tune, have a higher participation 
of transnational actors such as biotechnological firms and social movements organizations, with more 
dynamic and complex framing strategies.  





The public debates about agrobiotechnology in Argentina, Brazil and 
Mexico attest to ongoing interpretative disputes regarding GMOs. This 
study identified the main actors and arguments in such debates by 
looking at media material from the period between 2009 and 2010 and 
conducting a media analysis and a frame analysis. Four research 
questions guided this project; the answers are summarized in the 
following paragraphs.  
In what regards the first research questions - namely, 1) How is 
agrobiotechnology depicted on the national media of these countries? 2) 
What are the main issues regarding GM crops that were debated between 
2009 and 2010 in these three different cases? -, the results of the media 
analysis showed that the debate about genetically engineering in agriculture 
refers, in each country, to different issues and products. In Argentina, 
GMOs are treated as part of a technological package - including glyphosate 
and no-till farming - and are almost a synomym of GM soy and, together 
with new organization principles, of the “soy model”. Accordingly, 
together with the specific coverage on the topic itself, agrobiotechnology 
received some media attention in the coverage of the controversies 
regarding glyphosate and the soy model. These issues were depicted in very 
contrasting ways according to the sources: while GMOs appear mainly as 
an economic topic in La Nación, Página/12 depicts it as pertaining more to 
politics and society in general than to economics.  
In the other countries, agrobiotechnology was more covered as 
topic in itself, but in different ways. In Mexico, GMOs come to the 
spotlight of media attention when referring to corn. The debate is about 
the specificity of applying biotechnology to this crop, which is native to 
Mexico and important part of the food culture in that country. The
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Mexican sample is very different: most articles on agrobiotechnology are published in the section of 
national politics and, also, in La Jornada, in the section “Sociedad y Justicia”. This classification made 
by that media might explain the high coverage of ethical and political considerations made by many 
claim makers. In Brazil, where there were previously product-oriented debates (prior to the approval 
of GM soy and GM corn), there is now  a debate on coexistence and on the overall legal framework 
for agrobiotechnology – but this debate was triggered with the harvests of corn because of its specific 
polinization characteristics in comparison to soy. The foregoing shows that beyond the debate in 
favour or agaist GMOs in general, there are peculiarities specific to each crop that influence the 
debate, be they agronomic, cultural, or any other. 
The majority of the Brazilian debate emphasized the economic aspects of GMOs and related to 
the issue of coexistence as well as the burden of regulation of agrobiotechnology. In Argentina, health 
and environmental aspects prevailed, given the salience of the media attention given to the debate 
about "glyphosate", but there was also very strong economic arguments about glyphosate and the soy 
model. Being mainly depicted as an economic issue of innovation in agriculture both in Brazil and 
Argentina, there is not much space for ethical and political considerations. In Mexico, by contrast, 
given the cultural resonance of corn and the successful framing strategy of actors opposing GM corn 
to adopt a pro-native corn campaign, biodiversity became a main issue of debate, and thus, the 
emphasis on impacts on health and environment. Also, given that the decision was in the making, 
Mexican material offers a particularity in that the ethical and political dimension of agrobiotechnology 
is fiercely debated.  
Such findings indicate the answers to research question 3) How are GMOs interpreted (framed)?. 
Whereas emphasizing economic benefits in Argentina and Mexico leaves no room for claims about 
"costs", these come to the spotlight and are the leading frame in Brazil, outweighing by far arguments 
about "benefits". Concerning effects to health and environment, claims about risk lead the debates in 
Argentina and in Mexico, and receive three times more coverage than claims on "biosafety"; while in 
Brazil "biosafety" claims prevail over (bio)risk. In the ethical and political dimension, critical arguments 
more than double the favourable ones in Mexico and in Argentina, whereas in Brazil there is a balanced 
coverage in this dimension. In Mexico, "critique" is the second top frame. Altogether, there is a 
prevalence of framing negative aspects of biotechnology in all countries. Next, the main similarities and 
differences among countries will be summarized for each frame. 
Benefits: Contrasting to Argentina, where the agronomic benefits of agrobiotechnology are 
taken for granted by its proponents and are not specified, but only mentioned in the context of the big 
package, actors in the Brazilian and Mexican debates clearly need to emphasize and compare the 
economic advantages of the new technology vis-à-vis the conventional seeds. The use of benefit 
claims is aimed at influencing the discourse about GMOs, because market decisions as well as policy 
regulations are evolving. The debate thus is more focused on the specific agronomic benefits of 
agrobiotechnology such as productivity, cost reduction, quality, among others. A particularity of 
claims in Mexico is that they are always future-oriented (prognostics of higher yields, less losses with 
pest control and draught) or inferred from experiences of other countries, in particular Argentina, 
Brazil and USA, in the defence of the need for Mexico to catch up in competitiveness with other 
countries. But the narrative of “delay” in innovation is not restricted to Mexico. Multinational firms 
always portray their activities in each country as crucial for its competitiveness, often in comparison 
to the other countries leaders in the use of agrobiotechnology, which are used as benchmarks. 
Nevertheless, in Argentina and Brazil, national firms are mentioned more often in their research 
activities, portrayed as bringing the country to join the club of exporters of biotechnological 
inventions, not only of crops. The Argentinean case stands out as to the issue of IPRs: the importance 
of a regime applied to seeds is especially praised, and actors claim that its absence will jeopardize the 
ability of biotechnological firms to profit from its wide adoption and of farmers to have the latest 
launchings at their disposal.  
Costs:  Possible economic costs of agrobiotechnolgy are taboo in Argentina. By contrast, in 
Brazil and Mexico these are included in the debate by actors seeking to influence policy decisions 
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about GMOs. Farmers in Brazil openly discuss their experiences and complain against the rising costs 
of pesticides and of pest resistance. In Brazil, cost arguments abound especially regarding economic 
externalities of the adoption of GM corn, the costs of which are fiercely disputed. Actors warn against 
threats to the coexistence of other crops and farmers fear market rejection, contamination and thus, 
litigation from biotech companies; they demand availability of conventional seeds; and there is a big 
debate about the distribution of the costs of segregation in the whole chain. In Brazil, resistance to GM 
crops is also framed as an issue of consumer rights to be informed and to take decisions. Another 
claim about rights come from Brazilian farmers denouncing the system of payment for IPRs as illegal 
and unfair. Without putting into question their choice for GMOs and their agreement that royalties 
must be paid for the purchase of seeds, they contest the payment of royalties over the harvest and 
claim the right to multiple seeds. Thus, the debate in Brazil is much more about regulation and mainly 
national in character. Although there are demands for rights of farmers to decide to adopt or not GM 
seeds, to coexist, to be protected from enforcement (abusive) practices from transnational 
corporations; and rights of consumers to decide, these are framed in the context of the market and in a 
regulatory view, in which each (economic) actor has a institutional framework that guarantees its 
freedom to take informed rational decisions according to preferences and interests. 
Biosafety: In all countries the authorities responsible for approving GMOs usually manifest 
themselves publicly for the safety of the products under their scrutiny. Besides those generic claims, 
arguments about the safety of GMOs vary in each country according to what is claimed to be the risks 
involved, which are systematically denied by proponents of the biotechnology. While the issue of 
pesticide is more urgent in Argentina and Brazil, which have long time exposure to the technological 
package, in Mexico it is the threat to biodiversity due to the flux of genetic material from GM corn to 
native species that is primarily addressed in the claims assuring the safety of GMOs. But also in Brazil 
the flux of genetic material from GM seeds to conventional varieties is object of disputes in what 
regards the possibility of coexistence. Accordingly, for each of these issues, actors assure that the risk 
management rules  are sufficient to guarantee safety, control and responsibility. A particularity of the 
Brazilian sample is the high presence of claims for deregulation, with actors defending that the risk 
assessment conducted by CTNBio must be trusted and, consequently, all further regulation is 
superfluous. In Argentina and in Brazil, proponents of agrobiotechnology also frame positive effects 
on health and environment, avoiding the "risk/safety" dichotomy and the focus on damage, by 
adopting a positive framing of "benefits".  
(Bio) risk: A common node of debate was the knowledge base of claim-making regarding 
damage to health and environment attributed to GMOs. Answering to the question “are there risks?”, a 
similar structure is present in all claims in a continuum that starts with the affirmation that there is no 
knowledge to assure the absence of risks, highlights the importance of the willingness to know risks, 
and ends with claims that there is enough knowledge confirming the existence of risks associated with 
GMOs. As to the specific damage related to such risk claims, there are considerable differences 
among countries: in Argentina, the debate is centered on the effects of pesticide use associated with 
the widespread adoption of GM seeds; in Mexico, while many types of damage are brought to debate, 
the threat to biodiversity of corn is the most sensitive issue; whereas in Brazil, the main issue also 
regards risks of flux of genetic material, but not its damage to biodiversity; rather, to the coexistence 
between GM and non-GM corn. Notwithstanding such differences, they share the characteristic of 
pointing to the beginning of the food chain, namely, the farming of GMOs, as the locus of the burden 
of damage from agrobiotechnology. In any case, in all countries actors advance claims that, in face of 
such risks, there is disjunction between legality and reality because they are out of control. Whereas in 
Mexico actors claim for bringing the rule of law in face of illegal presence of GM corn, in Argentina 
and in Brazil, the legal framework is considered inadequate to control risks of pesticide use and of 
contamination. The tension resides in the fact that the “reality of risks” challenges the existent legal 
measures designed to control them; according, actors argue for a revision of the rules of risk 
management. In face of such diagnosis, in all countries actors demand more responsibility from 
political authorities, but in different ways: Brazilian actors react fiercely to proposals of deregulation, 
while in Argentina and in Mexico, they advance radical risk management measures, such as moratoria.  
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Progress: The narrative of biotechnology pertaining to a path of linear progress from which 
there is no coming back is found in all countries, whereas in Argentina it is accentuated by the 
expression of a technological "revolution". In all countries actors defend biotechnology to be a 
solution to climate change and to food security, using Malthusian arguments mentioning figures of 
population increase in contrast to the volume of food production. A main difference is that, while 
Brazil and Argentina are framed as world food providers, in Mexico food security arguments have 
first of all a national aim. Finally, the claim for a clear separation between technical and political 
issues by means of grounding decision in science is mostly found in the Brazilian and Mexican 
material, since in Argentina the decision-making about GMOs in not present in the agenda.  
Critique: Although most claims of these type came from the Mexican material, in the three 
countries claim-makers identified victims of agrobiotechnology, with some variations: Brazilian farmers 
demanded the right to coexist; in Argentina, peasant movements denounced land expropriation, land 
conflicts, and the loss of the peasant identity; in Mexico, in addition to these forms of victimization, the 
identity of "pueblos del maíz" is seen as threatened. In Argentina and Mexico, multinational firms are by 
far the preferred targets of "blaming the winners" claims. Given that food security is one of the main 
arguments advanced by proponents of GMOs trying to influence the Mexican debate, movements 
against GM corn use the same agenda issue to frame opposition against GMOs. As a counter-theme for 
the claims defending a decision based on science and without political considerations, claim-makers in 
Mexican articles defend public participation to define the public interest in contrast to the private 
interests. Moreover, they blame authorities for being corrupted by biotechnological firms, an accusation 
that can also be found in the Brazilian material.  
The findings show many issues situated at the boundaries between two frames. For instance,  
intellectual property rights were an economic and a political theme of the debates about 
agrobiotechnology. It was interpreted in different ways: as a legal institution beneficial to the 
economy, as a costly regime, as part of blaming transnational corporations for being the main winners 
of the adoption of biotechnology (because the payment of royalties), and also as a threat to food 
security. In the latter case, the demand for control over seeds is different from the demand found in the 
economic dimension, since it is not a matter of costs of the royalties to be paid, which can be 
calculated by economic actors counter-weighing the benefits. Rather, the claim refers to the belief that 
there should not be patents over seeds at all and that farmers should have the right to reserve part of 
their harvest to re-use as seeds. Another example was innovation in technology: it was interpreted as 
an economic input and as part of an ideology of progress. Also, the role of scientific knowledge 
entered into different arguments when referring to risks to health and environmental risks and its place 
in the hierarchy of criteria for decision-making.  
The transnational character of the phenomena is apparent in many instances of the debates. 
When framing GMOs as an economic issue, actors situate the adoption of agrobiotechnology in the 
context of an international agriculture market, claiming both its desirability to assure competitiveness 
(progress) and its negative economic effects in the face of the possibility of market rejection in other 
countries. Thus, both proponents and opponents of GMOs in each country acknowledge that such a 
decision cannot neglect the market interdependencies. At the same time, global issues are translated 
into the national agenda, in which their legitimacy is constructed. Although intellectual property rights 
are object of multilateral agreements in the WTO and WIPO, they need to be adapted into national 
legislation; its application to seeds and farming practices poses special challenges (Morales, 2001). 
The Brazilian system of royalties and the Argentinean debate over IPRs regulation show two 
constrasting experiences. This is also why claim-makers in one country refer to the other: some 
Argentinean farmers desiring a system like the Brazilian, since biotechnological firms have stopped 
launching new products there because of intellectual property rights; Brazilian farmers criticizing the 
payment of royalties over harvest, and looking at the Argentinean model that guarantees farmers rights 
over seeds. In this translation from international to national legal regimes, the distribution of rights 
among subjects comes to the fore: transnational rights or national rights? 
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The debate about the health and environmental effects of biotechnology has a strong transnational 
character in that it is informed by international regimes of environment, health and trade rules. Thus, 
given that political decisions to either adopt or prohibit agrobiotechnology must be based on a scientific 
assessment of its risks to human, animal and plant health as well as risks to the environment, it is 
expected that such dimension of the issue will be fiercely disputed. However, the concrete issues that 
come to media attention are very different in each country. In all cases, there is a strong appeal to 
international science to validate both claims pro and against GMOs. A particularity of the Mexican 
debate is that it is at the same time nationalistic in tune and open to transnational influences —actors 
refer to the Argentinean and Brazilian examples either to prove the absence or existence of risks. 
Also, the transnationalization of the phenomena under debate becomes evident in what 
concerns ethical-political issues. The ideology of progress encourages the interpretation of GMOs as 
part of a (global) technological revolution- which will spread from centers of innovation to all 
countries. The critical dichotomy between winners and losers is also framed in a global scale: winners 
are usually identified to be multinational corporations, whereas losers are the local groups of farmers 
in their traditions and cultural heritage. Also, in national debates actors relate to issues that are on the 
global agenda such as food security and climate change. Not less important, in the competing views 
about how decisions about agrobiotechnology should be, common tales are, on one side, the authority 
of "international science" to avoid local political intereferences in the path of technological evolution; 
on the other, the subjugation of scientific considerations to (local or national) participative politics in 
order to decide what is the public interest. In the latter case, often claim makers identify transnational 
corporations as targets of blaming together with national authorities and scientists, corrupted by the 
corporations. The State level as the ultimate authority on GMOs is thus put into a fragile position for 
not being able to face such globally powerful actors in the protection of national and public interest; 
authorities are accused of conflict of interests and for lack of transparency.  
Finally, in what regards research question 4) Which actors defend each type of argument?, results 
will be summarized below per dimension. The most active claim-makers to frame GMOs as an economic 
issue are the same in all countries: not surprisingly, “market actors” i.e. farmers and their associations, 
biotechnological firms and the food industry. Political authorities in Mexico are the second most active type 
of actors in this dimension and they always frame the economic benefits of biotechnology, whereas in 
Brazil and Argentina, when politicians do make claims with economic considerations, they alerted to the 
costs of GMOs. In those countries, media framing is the second most active in this dimension of the debate, 
highlighting both benefits and costs. Scientists and social movements almost do not refer to economic 
aspects of the issue, with the exception of Brazil, where they alert to benefits and costs.  
The actors who emphasize environmental and health issues also vary from country to country. The 
common denominator is the contrasting framing of market actors and social movements, the former opting 
for biosafety, the latter, for (bio)risk. In Brazil and in Argentina, political actors are the most active to frame 
GMO as risk. A distinct characteristic of the Brazilian sample is the leadership of political actors both in 
terms of biosafety and biorisk. In Mexico, the lead carriers are social movements. It was in this dimension 
that scientists engage the most in the debate about agrobiotechnology in Argentina and Mexico, and, in 
Brazil, they frame just as much economic issues about agrobiotechnology. A distinction of the Argentinean 
case is the high participation of media framing in this dimension. 
Also in the ethical-political dimension, all countries share the characteristic constrasting 
framing from market actors and social movements: on the one side, market actors are the main carriers 
of progress frames in all countries; on the other, social movements are by far the leader carrier of 
critique frames in Mexico, while in Argentina and in Brazil this is first of all a media framing. In all 
countries, media framing is overwhelmingly against GMOs in this dimension, but in Mexico media 
actors also frame "progress". Another difference from the Mexican material is the strong participation 
of scientists in this dimension - what does not happen in the other countries - , adopting almost always 
"critique" frames. Political authorities are the second more active as carriers of "progress" frames in 
all countries, but in the Brazilian material these only slightly surpass claims coded as "critique". 
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Actors who cross the national political-administrative borders also participate in the debates, in 
particulary in Mexico, where they respond for about one third of claims. Mainly two types of actors 
are transnational: social movements (Greenpeace Mexico) and transnational corporations and their 
associations (Monsanto and AgroBio Mexico). Also political authorities appear in the context of the 
FAO meeting held in Guadalajara. The sample from Brazil and Argentina shows predominantly 
national actors, although in Brazil the participation of transnational corporations is important. 
Greenpeace also makes claims in the Brazilian debate but in a less conspicuous way as in Mexico. 
Political authorities appear in the material in two different situations: representatives of international 
organizations such as FAO and PAHO/WHO or as foreign governmental authorities, usually making 
claims about requirements for importing GM products.  
An interesting result was the degree of transnationalization of Monsanto: the corporation is 
actively present in all three countries, being the main international economic actor in Argentina and in 
Brazil and, in Mexico, the second most active one in Mexico. While in Mexico Monsanto shares its 
leadership with AgroBIO Mexico, in Brazil there is a bigger plurality of voices and different 
transnational corporations appear in the media material. In the economic dimension, Monsanto and 
biotechnological firms make similar claims on the agronomic advantages of the technology and the 
importance of innovation for the competitiveness of the countries, but Monsanto has a special demand 
on the Argentinean debate for the protection of IPRs. On the other hand, Monsanto is a target of 
blaming in Brazil for the increasing costs of adopting GM seeds. All biotechnological firms engaged 
in frame transformation strategies in what regards effects to health and environment, not only shifting 
risk to safety but also bypassing this dichotomy and framing beneficial effects of their products. They 
are blamed for hiding or not conducting risks studies. A curious feature of the Argentina debate on 
glyphosate is that farmers (national) associations speak in defense of glyphosate, while Monsanto does 
not speak up for its own product. In the ethical-political dimension, transnational corporations as a 
group —but also Monsanto in particular— are identified by critics as the winners of adopting 
agrobiotechnology and criticized for corrupting governments.  
In sum, it is important to reiterate that the focus of the study was to identify what is discussed 
about GMOs, by mapping and comparing the main dimensions of interpreting the issue, the actors and 
their arguments. It is a descriptive work and does not aim at advancing explanations for the discursive 
choices of actors. It highlights instead similarities and differences among countries and looks at how 
actors and frames cross national borders trying to shape shared meanings about a global issue, the 
adoption of biotechnology in agriculture.  
To conclude, the results has proven the value of studying these three countries for at least three 
reasons. First of all, the controversies about biodiversity (Mexico), coexistence (Brazil) and pesticide 
use (Argentina) refer to risks related to the cultivation of GM crops. Such emphasis at the farming 
level reinforces the importance of conducting research about GMOs in countries where crops are 
farmed on large scale and where agribusiness and small farming coexist. Without implying that risks 
to consumer health are less important, these findings show that an emphasis on concepts such as 
"Frankenfoods" misses many other points of controversy, such as biodiversity, small-scale farming, 
workers' health and pesticide contamination. A second reason refers to the conflicts about the 
distribution of economic benefits and costs among transnational and national actors (i.e. debates about 
IPRs in Argentina and Brazil; debates on the economic externalities in Brazil), which become even 
more pressing in a context of strong international market competition which challenges the relative 
autonomy of political authorities to decide vis-a-vis the influence of global corporations. At least in 
Brazil and in Mexico there are evidences of illegal practices which created a de facto adoption of GM 
crops. A third valuable contribution of synchronically comparing these countries is the possibility of 
bringing together three very distinct time orientations regarding agrobiotechnology: in Argentina, the 
diverging interpretations of the consequences of past decisions to adopt the technological package of 
GM seeds resistant to glyphosate; in Brazil, the debate about present decisions on how to deal with 
present risk management issues such as coexistence and market monitoring; in Mexico, the focus on 
the threat to biodiversity, framed mostly in a future-oriented fashion, although it also includes claims 
about the actual incidence of contamination. 
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assentamento 
 02/12/09 Agricultura: Lavoura transgênica no Brasil avança menos que no mundo 
  02/13/09 Vaivém das commodities 
  03/13/09 Pax Transgênica 
  03/31/09 Vaivém das commodities 
  05/10/09 Análise: Pressão de ruralistas libera transgênicos 
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    País perde controle dos transgênicos 
    Para ministério, regra não evita contaminação 
    Produtor perde dois contratos por contaminação 
    Produtores descartam separação 
    Teste não garante alimento 100% livre de transgénico 
    Veto: Milho transgênico autorizado no Brasil foi proibido na Alemanha 
  05/11/09 Idec cobra ação sobre descontrole de transgénico 
  05/12/09 Editoriais: Sem controle 
  05/17/09 Vale por um bifinho 
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    Vaivém das commodities 
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  08/15/09 PR conclui que controle de transgênicos não funciona 
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  08/22/09  Vaivém das commodities 
  09/12/09  Vaivém das commodities 
  10/13/09  Mônica Bergamo 
  10/23/09  Vaivém das commodities 
  11/02/09  Entrevista da 2ª 
  11/29/09  Mercado Aberto 
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  12/11/09  Empresa fica livre de rastrear efeitos de transgênicos 
  12/22/09  Sistema de cobrança foi adaptado ao país 
    Soja transgênica deve chegar a 67% da produção 
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  03/19/10  Vaivém das commodities 
  03/31/10  Vaivém das commodities 
  04/20/10 Milho transgênico afeta vizinhos, diz estudo 
  05/14/10  Transgênico mata uma praga e traz outra 
  06/16/10  Vaivém: Produzir soja transgenica custa mais em MT 
  06/17/10  Sabatina Folha  
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  08/17/10  Commodities: Brasil deve ter a primeira cana transgênica do mundo em 2015 
  08/25/10  Vaivém das commodities: Produtor quer mais semente de soja convencional 
  09/03/10 A agricultura que o Brasil almeja 
Valor Econômico 01/16/09 Governo avalia elevar tarifa sobre o glifosato chinês 
 01/28/09 Mudança de avaliação sobre taxa do glifosato chinês 
  02/02/09 Infraçao ambiental 
  03/19/09 Discussao e acusacoes múttuas tumultuam audiencia pública 
    Embrapa manifesta-se contra o plantio de arroz transgenico 
    Sojicultor gaúcho vai a Justiça contra a Monsanto 
  03/20/09 Começa a colheita da 1a safra brasileira de milho transgenico 
   CTNBio aprova um parecer favorável a liberacao de novo algodao modificado 
  04/30/09 País financia pesquisa da Embrapa com transgenicos 
  05/12/09 Milho reacende o debate sobre os transgenicos 
  05/13/09 Rotulagem de OGMs 
  05/22/09 CTNBio avalia liberar novos transgenicos sem análises prévias 
    UE recomenda mais controle ao Brasil 
  05/28/09 Ministério deve fiscalizar apenas as denúncias de irregularidades 
    Soja contrabandeada deflagrou disseminacao 
  05/29/09 Indústria teme 'febre' do milho transgenico 
  06/19/09 CTNBio recua em aprovacao automatica 
  07/24/09 Novo presidente da Embrapa define programas e diretrizes 
  08/14/09 Basf e Embrapa licenciam semente 
  09/23/09 CTC e Dow firmam parceria no combate a broca da cana 
  10/19/09 Aplicacao na producao de alimentos deve ser o grande "divisor de águas" 
  10/26/09 Milho transgenico ganha terreno na safra 2009/2010 
    Projeto pode barrar semente 'salva' 
  11/16/09 Milho renova o animo da Syngenta no Brasil 
  12/07/09 _CTNBio livrará transgênico de análise de risco 
  12/10/09 CTNBio terá que explicar nova regra para OGMs 
  02/10/10 CTNBio faz hoje eleição para novo presidente 
  02/11/10 
 Edilson Paiva, agrônomo geneticista da Embrapa, é eleito presidente da 
CTNBio 
  02/12/10  Syngenta eleva aposta em sementes 
     Velhas polêmicas marcam início da "nova etapa" da CTNBio 
  03/12/10  Novo cenário para transgênicos 
  03/17/10  Parecer aprova mudança em regra de transgênicos 
  03/19/10  Mudança na regra de monitoramento de transgênicos volta a perder ímpeto 
  03/29/10 Nortox pede fim de antidumping sobre glifosato chines 
  04/06/10 Adiada a decisao sobre o glifosato chines 
  04/07/10  Estudo aponta ganho com transgênicos 
  11/22/10  CTNBio aprova mais duas sementes de milho transgênico 
    Governo autoriza limite maior para resíduo em milho 
    Indústria busca nova geraçao de agrotóxico menos agressivo 
 
 
ECLAC – Production Development Series No. 193  The public debate about agrobiotechnology in Latin American countries …    
81 
Table A.2  
  12/10/10  Os impactos da Lei de Biossegurança 
Carta Maior 01/31/03 Lula e o Conselho Internacional do FSM 
  03/12/09 CTNBio se prepara para aprovar arroz transgênico 
  03/27/09 Liberação de arroz da Bayer é rechaçada em audiência pública 
  09/25/09 Agrotóxicos no seu estômago 
  05/09/10 Rio +20: o Brasil e a agende de futuro no mundo 
  09/19/10 Contra os três grandes monopólios: do dinheiro, da terra, da palabra 
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El Universal 02/11/09 Prevén duplicar producción de alimentos para 2050 
  02/24/09 Confirman contaminación de maíz salvaje en México con transgénicos 
  04/07/09 Atrasado México en biotecnología 
  05/28/09 Mercado de transgénicos valdría 2,800 mdp 
  07/28/09 Virus no está fuera de control: Salud 
  10/16/09 Autorizan siembra de maíz transgénico 
  10/26/09 Reprueban uso de transgénicos 
  10/30/09 Greenpeace: ilegales, los permisos de transgénicos 
  11/15/09 Expertos: necesario, el maíz modificado 
  01/27/10 Greenpeace alerta daños a mamíferos por transgénicos 
    Transgénicos-aprobación 
  01/29/10 Empresas reprueban estudios de Greenpace sobre transgénicos 
  01/30/10 Cofepris acepta importación de maíz transgénico 
  02/03/10 Greenpeace: transgénicos 
  02/07/10 Científicos prevén caída de 20% en producción de maíz 
  03/01/10 Campo-tecnología 
  03/31/10 Campo-sequía 
  07/19/10 Documentan perjuicios de transgénicos 
  08/13/10 En Texcoco la colección más grande de maíz y trigo 
  08/25/10 Presumen éxito en siembras de maíz transgénico 
  09/05/10 La ilegalidad del maíz transgénico 
 09/23/10 Piden en Sinaloa reflexionar sobre productos transgénicos en el campo 
 10/19/10 Invertirá Monsanto 20 mdd durante 2011 en México 
  12/03/10 Cambio climático, verdadera amenaza del maíz 
El Economista 01/09/09 En semillas mejoradas de maíz, atraso de 11 aÑos  
  03/09/09 Impulsa México la biotecnología  
  Monsanto acelera el paso  
  03/11/09 Transgénicos 
  03/27/09 Transgénicos 
  07/28/09 Permisos para transgénicos, en octubre 
  09/17/09 Alza en azúcar es mundial, dice la Sagarpa  
  09/25/09 En un pozo sin fondo 
  09/29/09 Afinan permiso para maíz transgénico 
  10/28/09 Autorizan siete permisos más para sembrar maíz transgénico  
  02/05/10 Biotecnología frenaría importación de maíz 
  08/26/10 Van por segunda ronda de permisos para siembra de maíz transgénico  
 10/20/10 Monsanto prepara tierra para invertir hasta US20 millones 
La Jornada 01/03/09 Corrupción transgénica al descubierto 
  01/27/09 El gobierno, cómplice en siembra ilegal de maíz transgénico, acusan 
 01/30/09 
El gobierno minimiza reportes sobre maíz transgénico en cultivos, lamentan 
expertos 
  Incautan 2 mil 500 toneladas de maíz transgénico en Chihuahua 
  01/31/09 Transgénicos: ¿ciencia? y ¿para quién? 
  02/10/09 Contaminar cultivos con transgénicos, estrategia de Monsanto: Greenpeace 
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  02/12/09 
Pueden coexistir transgénicos y cultivos tradicionales, revela informe de 
agrupación 
  02/19/09 Preocupante, la erosión genética del maíz, alerta Martha Astier 
  02/24/09 Exigen ONG al gobierno federal que cumpla acuerdo sobre transgénicos 
  02/25/09 Campesinos de Oaxaca reciben transgénicos 
    Etanol de maíz transgénico: peligro inminente 
  02/27/09 Transgénicos dividen a científicos 
  03/10/09 Tiene luz verde el cultivo experimental de maíz transgénico: titular de Semarnat 
  03/11/09 Maíz transgénico, funcionarios delincuentes 
  03/17/09 Origen del maíz 
  03/21/09 Tortillas transgénicas 
  03/26/09 México consume maíz transgénico desde hace 13 años: agricultores 
  04/17/09 El banderazo fallido  
  04/25/09 Maíz transgénico: ilegal e inútil 
  05/07/09 La gran pandemia: influenza, pesticidas y transgénicos 
  05/14/09 El maíz transgénico podría ser tóxico para algunos insectos, revela ONG 
  05/16/09 México, nuevo basurero de Monsanto 
  
05/20/09 Planea Monsanto iniciar la siembra experimental de maíz transgénico en 
septiembre u octubre 
  05/24/09 Científicos piden rigor con solicitudes para la siembra de maíz transgénico 
  06/06/09 Alerta médica: los transgénicos amenazan la salud 
  06/09/09 Piden frenar cultivo de maíz transgénico 
  06/26/09 Agravará el maíz transgénico los problemas económicos y sociales 
  07/01/09 Estudio involucra a Sagarpa en la contaminación transgénica del maíz 
  07/10/09 
Rechazan 796 organizaciones de 59 países la siembra de maíz transgénico en 
México 
  07/11/09 Monsanto amenaza plantíos del orbe, alertan 
  07/12/09 Transgénicos ponen en riesgo 59 variedades de maíz criollo 
  07/27/09 Campaña contra Monsanto 
   
  08/18/09 Enfrentar minerias y transgénicos 
  08/24/09 Greenpeace, en alerta por transgénicos 
  10/02/09 Recomiendan científicos medidas para proteger el maíz nativo 
  10/05/09 Avala Sagarpa algunas solicitudes para sembrar maíz transgénico 
  10/09/09 
Revela Greenpeace infiltración en el gobierno de dos ex empleadas de DuPont 
y Agrobio 
  10/16/09 Luz verde al cultivo de maíz transgénico 
  10/20/09 ONG: permisos para cultivar maíz transgénico, tiro de gracia al agro 
  10/22/09 Dio Semarnat 15 permisos para maíz transgénico; no se podían retrasar 
    En riesgo, la seguridad alimentaria de México, advierte unión de científicos 
  10/23/09 Falta estudio preciso sobre distribución de maíz transgénico 
  10/24/09 Maicidio racista 
  11/04/09 Delito de lesa humanidad, imponer al maíz el modelo Monsanto: expertos 
  11/16/09 
Asamblea de Afectados Ambientales “Rechazamos la autorización de siembras 
de maíz transgénico y denunciamos que es un crimen ambiental y cultural” 
  12/01/09 Campaña en Sonora contra los transgénicos 
  12/23/09 Prueba estudio peligrosidad del maíz transgénico autorizado por México 
 
 
ECLAC – Production Development Series No. 193  The public debate about agrobiotechnology in Latin American countries …    
84 
 
Table A.3  
  01/19/10 Anuncian iniciativas para proteger conocimientos y territorios indígenas 
  01/20/10 Implacable avance de Monsanto 
  01/31/10 Los transgénicos usan más tóxicos 
  02/06/10 Científicos secuenciarán genoma del frijol y del aguacate criollo 
  02/26/10 La biotecnología garantizará la seguridad alimentaria: FAO 
  
  Presentan denuncia popular ante Profepa por siembra a campo abierto de 
maíz genéticamente modificado 
  02/27/10 Asusta a grupos europeos avance del maíz transgénico en México 
    FAO y transgénicos: apuesta equivocada 
  02/28/10 FAO, aliada de trasnacionales para impulsar biotecnología: Grupo ETC 
    FAO: transgénicos y afectaciones 
  03/02/10 La biotecnología puede ayudar a reducir en 50% la hambruna, asegura la FAO 
    Maíz transgénico y derecho indígena 
  03/03/10 
Cibiogem: deben considerarse las opciones tecnológicas para mejorar el grano 
criollo 
    Raíces neoliberales de los cultivos transgénicos 
   Severas consecuencias de salud en México por el maíz transgénico 
  
03/04/10 El mayor riesgo en el cultivo del maíz son los bajos rendimientos: director del 
Cimmyt 
  03/05/10 Piden discrepantes promover modelo de agricultura campesina ecológica 
  03/06/10 La FAO, contaminada transgénicamente 
  03/13/10 ¿TRANSGÉNICOS? ¡NO, GRACIAS! 
    El monopolio de la simiente 
  04/28/10 Exigen opositores a transgénicos que la empresa Monsanto salga de México 
  05/07/10 Pide Nestlé patente en México para grano de café transgénico 
  05/22/10 Tratado de libre comercio, transgénicos y migración, nuestros retos 
  06/09/10 Crean alianza para alertar sobre el riesgo de las semillas transgénicas 
  06/19/10 Maíz transgénico: farsa y violencia 
  07/03/10 Transgénicos y crimen organizado 
  07/17/10 Agricultura industrial vs agricultura campesina 
    Amenaza transgénica 
    Movimiento nacional para la protección de maíces nativos 
  07/31/10 Transgénicos: pérdidas para los agricultores 
  08/17/10 Maíz transgénico llega a etapa piloto: Agrobio 
  08/19/10 Reclaman suspender la siembra de maíz transgénico 
  08/28/10 Celebrando la dependencia: el maíz a las trasnacionales 
  09/07/10 Reitera Sagarpa: continuará la siembra de transgénicos 
  09/21/10 Desarrollan en el Cinvestav planta de maíz resistente a la sequía 
  09/27/10 Realizarán ONG feria en el Zócalo para instituir el día nacional del maíz 
  09/28/10 Celebrar al maíz 
  09/30/10 Calderón simula interés por la gente ante el cambio climático: campesinos 
  10/06/10 Transgénicos atentan contra el país, dicen 
  10/09/10 Máquinas de guerra: Blackwater, Monsanto y Bill Gates 
  11/13/10 El maíz corazón del pueblo 
  11/16/10 Absurdo, importar chile habanero transgénico, opinan productores 
 
 
ECLAC – Production Development Series No. 193  The public debate about agrobiotechnology in Latin American countries …    
85 
Table A.3 
  11/22/10 Expertos en biotecnología avalan el consumo de los transgénicos 
  12/04/10 Constituyen programa para rescatar y cuidar el maíz criollo 
  12/18/10 Las promesas de la industria biotecnológica: ignorancia o engaño? 






















A complete list as well as pdf files are available at 
www.eclac.org/publicaciones 
 
193.  The public debate about agrobiotechnology in Latin American countries: A comparative study of Argentina, Brazil 
and Mexico. Renata Campos Motta (LC/L.3591), 2013.   
192.  The top 20 multinationals in Chile in 2010: retail, forestry and transport lead the international expansion. Miguel 
Pérez Ludeña (LC/L.3399), 2011.   
191.  Crecimiento en base a los recursos naturales. Tragedia de los comunes y el futuro de la industria salmonera chilena. 
Jorge Katz, Mishiko Lizuka y Samuel Muñoz (LC/L.3307-P), No de venta S.11.II.G.28, (US$10.00), 2011.  
190. Transmisión de precios en los mercados del maíz y arroz en América Latina, Laure Dutoit, Karla Hernández y 
Cristóbal Urrutia (LC/L.3271-P ), Nº venta S.10.II.G.77 (US$10.00), 2010.  
189.  Evolución en las estrategias de expansión internacional del sector turísticos vacacional: el papel de las empresas 
españolas en Latinoamérica, Ana Ramón (LC/L.3134.P), Nº venta S.09.II.G.109 (US$10.00), 2010.  
188.  Arbitraje internacional basado en cláusulas de solución de controversias entre los inversionistas y el estado en 
acuerdos internacionales de inversión: desafíos para América Latina y el Caribe, Michael Mortimore (LC/L.3049-P) 
Nº de venta S.09. II. G.51 (US$10.00), 2009.  
187.  Theory and Practice of Industrial Policy. Evidence from the Latin American Experience, Wilson Peres, Annalisa 
Primi (LC/L.3013-P) Nº de venta E.09.II.G.34 (US$10.00), 2009.  
186. Aglomeraciones productivas locales en Brasil,  formación de recursos humanos y resultados de la experiencia 
CEPAL/SEBRAE, Francisco Teixeira, Carlo Ferraro (LC/L.3005-P) Nº de venta S.09.II.G.13 (US$10.00), 2009.  
185. Del monopolio de Estado a la convergencia tecnológica: evolución y retos de la regulación de telecomunicaciones 
en América Latina, Carlos Razo, Fernando Rojas (LC/L.2849-P) Nº de venta S.07.II.G.172 (US$10.00), 2007  
184. Evaluación de un programa de innovación y sistemas de producción en América Latina: estudio sobre la dinámica 
de redes, Mario Cimoli (LC/L.2842-P) Nº de venta S.07.II.G.165 (US$10.00), 2007.  
183. Pobreza rural y políticas de desarrollo: avances hacia los Objetivos de Desarrollo del Milenio y retrocesos de la 




• Readers wishing to obtain the listed issues can do so by writing to: Distribution Unit, ECLAC, Casilla 179-D, Santiago, Chile, Fax (562) 















Name: ............................................................................................................................................  
Activity: .........................................................................................................................................  
Address: .........................................................................................................................................  
Postal code, city, country: ..............................................................................................................  
Tel.:................................... Fax: ..................................... E.mail: ...................................................  
 
